The goal for the treatment of patients with diabetes has today shifted from merely reducing glucose concentrations to preventing the natural decline in β-cell function and delay the progression of disease. Pancreatic β-cell dysfunction and decreased β-cell mass are crucial in the development of diabetes. The β-cell defects are the main pathogenesis in patients with type 1 diabetes and are associated with type 2 diabetes as the disease progresses. Recent studies suggest that human pancreatic β-cells have a capacity for increased proliferation according to increased demands for insulin. In humans, β-cell mass has been shown to increase in patients showing insulin-resistance states such as obesity or in pregnancy. This capacity might be useful for identifying new therapeutic strategies to reestablish a functional β-cell mass. In this context, therapeutic approaches designed to increase β-cell mass might prove a significant way to manage diabetes and prevent its progression. This review describes the various β-cell defects that appear in patients with diabetes and outline the mechanisms of β-cell failure. We also review common methods for assessing β-cell function and mass and methodological limitations in vivo. Finally, we discuss the current therapeutic approaches to improve β-cell function and increase β-cell mass.

Citations

Citations to this article as recorded by  

• Polychlorinated biphenyls exposure and type 2 diabetes: Molecular mechanism that causes insulin resistance and islet damage
  Qiuli Shan, Jingyu Liu, Fan Qu, Anhui Chen, Wenxing He
  Environmental Toxicology.2024; 39(4): 2466.     CrossRef
• Beta‐cell function in type 2 diabetes (T2DM): Can it be preserved or enhanced?
  Laure Sayyed Kassem, Aman Rajpal, Margarita Victoria Barreiro, Faramarz Ismail‐Beigi
  Journal of Diabetes.2023; 15(10): 817.     CrossRef
• Preliminary Evaluation of Potential Properties of Three Probiotics and Their Combination with Prebiotics on GLP-1 Secretion and Type 2 Diabetes Alleviation
  Ran Xiao, Ran Wang, Shusen Li, Xiaohong Kang, Yimei Ren, Erna Sun, Chenyuan Wang, Jingjing He, Jing Zhan, Wen Yi Kang
  Journal of Food Quality.2022; 2022: 1.     CrossRef
• Preservation effect of imeglimin on pancreatic β-cell mass: Noninvasive evaluation using 111In-exendin-4 SPECT/CT imaging and the perspective of mitochondrial involvements
  Muhammad Fauzi, Takaaki Murakami, Hiroyuki Fujimoto, Ainur Botagarova, Kentaro Sakaki, Sakura Kiyobayashi, Masahito Ogura, Nobuya Inagaki
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Effects of boschnaloside from Boschniakia rossica on dysglycemia and islet dysfunction in severely diabetic mice through modulating the action of glucagon-like peptide-1
  Lie-Chwen Lin, Lin-Chien Lee, Cheng Huang, Chiung-Tong Chen, Jen-Shin Song, Young-Ji Shiao, Hui-Kang Liu
  Phytomedicine.2019; 62: 152946.     CrossRef
• The Potential of Hibiscus sabdariffa Linn in Inducing Glucagon-Like Peptide-1 via SGLT-1 and GLPR in DM Rats
  Neng Tine Kartinah, Fadilah Fadilah, Ermita Ilyas Ibrahim, Yuliana Suryati
  BioMed Research International.2019; 2019: 1.     CrossRef
• Efficacy of short‑term intensive treatment with insulin pump to improve islet β‑cell function in newly diagnosed type 2 diabetes via inhibition of oxidative stress
  Hai‑Tong Liu, Yan Gao
  Experimental and Therapeutic Medicine.2019;[Epub]     CrossRef
• When metformin is not enough: Pros and cons of SGLT2 and DPP‐4 inhibitors as a second line therapy
  Angelo Avogaro, Elías Delgado, Ildiko Lingvay
  Diabetes/Metabolism Research and Reviews.2018;[Epub]     CrossRef
• Metformin prevents glucotoxicity by alleviating oxidative and ER stress–induced CD36 expression in pancreatic beta cells
  Jun Sung Moon, Udayakumar Karunakaran, Suma Elumalai, In-Kyu Lee, Hyoung Woo Lee, Yong-Woon Kim, Kyu Chang Won
  Journal of Diabetes and its Complications.2017; 31(1): 21.     CrossRef
• The variability in beta‐cell function in placebo‐treated subjects with type 2 diabetes: application of the weight‐HbA1c‐insulin‐glucose (WHIG) model
  Janna K. Duong, Willem de Winter, Steve Choy, Nele Plock, Himanshu Naik, Walter Krauwinkel, Sandra A.G. Visser, Katia M. Verhamme, Miriam C. Sturkenboom, B.H. Stricker, Meindert Danhof
  British Journal of Clinical Pharmacology.2017; 83(3): 487.     CrossRef
• Regulation of pancreatic β-cell function and mass dynamics by prostaglandin signaling
  Bethany A. Carboneau, Richard M. Breyer, Maureen Gannon
  Journal of Cell Communication and Signaling.2017; 11(2): 105.     CrossRef
• Effects of low intensity laser acupoint irradiation on inhibiting islet beta-cell apoptosis in rats with type 2 diabetes
  Guoxin Xiong, Leilei Xiong, Xinzhong Li
  Laser Physics.2016; 26(9): 095605.     CrossRef
• Effects of continuous positive airway pressure treatment on glucose metabolism in patients with obstructive sleep apnea
  Elisabet Martínez-Ceron, Isabel Fernández-Navarro, Francisco Garcia-Rio
  Sleep Medicine Reviews.2016; 25: 121.     CrossRef
• Efficacy and safety of teneligliptin, a novel dipeptidyl peptidase‐4 inhibitor, in Korean patients with type 2 diabetes mellitus: a 24‐week multicentre, randomized, double‐blind, placebo‐controlled phase III trial
  S. Hong, C.‐Y. Park, K. A. Han, C. H. Chung, B. J. Ku, H. C. Jang, C. W. Ahn, M.‐K. Lee, M. K. Moon, H. S. Son, C. B. Lee, Y.‐W. Cho, S.‐W. Park
  Diabetes, Obesity and Metabolism.2016; 18(5): 528.     CrossRef
• Senp2 expression was induced by chronic glucose stimulation in INS1 cells, and it was required for the associated induction of Ccnd1 and Mafa
  Hye Seung Jung, Yu Mi Kang, Ho Seon Park, Byung Yong Ahn, Hakmo Lee, Min Joo Kim, Jin Young Jang, Sun-Whe Kim
  Islets.2016; 8(6): 207.     CrossRef
• ANTIDIABETIC EVALUATION OF CHONEMORPHA MACROPHYLLA ROOTS BY IN VIVO METHODS USING MALE WISTAR ALBINO RATS AND ITS MECHANISM OF ACTION
  K. R. Krishna Kumar, K. K. Srinivasan
  INDIAN DRUGS.2016; 53(12): 42.     CrossRef
• Comparative gene expression profiles in pancreatic islets associated with agouti yellow mutation and PACAP overexpression in mice
  Kazuya Ikeda, Shuhei Tomimoto, Soken Tsuchiya, Ken-ichi Hamagami, Norihito Shintani, Yukihiko Sugimoto, Atsushi Ichikawa, Atsushi Kasai, Takanobu Nakazawa, Kazuki Nagayasu, Atsuko Hayata-Takano, Akemichi Baba, Hitoshi Hashimoto
  Biochemistry and Biophysics Reports.2015; 2: 179.     CrossRef
• Therapeutic efficacy of umbilical cord-derived mesenchymal stem cells in patients with type 2 diabetes
  LI-XUE GUAN, HUI GUAN, HAI-BO LI, CUI-AI REN, LIN LIU, JIN-JIN CHU, LONG-JUN DAI
  Experimental and Therapeutic Medicine.2015; 9(5): 1623.     CrossRef
• p13 overexpression in pancreatic β-cells ameliorates type 2 diabetes in high-fat-fed mice
  Shintaro Higashi, Kazuhiko Katagi, Norihito Shintani, Kazuya Ikeda, Yukihiko Sugimoto, Soken Tsuchiya, Naoki Inoue, Shota Tanaka, Mai Koumoto, Atsushi Kasai, Takanobu Nakazawa, Atsuko Hayata-Takano, Ken-Ichi Hamagami, Shuhei Tomimoto, Takuya Yoshida, Tada
  Biochemical and Biophysical Research Communications.2015; 461(4): 612.     CrossRef

For the past several decades, tremendous efforts have been made to decrease the complications of diabetes, including diabetic retinopathy. New diagnostic modalities like ultrawide field fundus fluorescein angiography and spectral domain optical coherence tomography has allowed more accurate diagnosis of early diabetic retinopathy and diabetic macular edema. Antivascular endothelial growth factors are now extensively used to treat diabetic retinopathy and macular edema with promising results. There remains uncertainty over the long term effects and the socioeconomic costs of these agents.

Citations

Citations to this article as recorded by  

• Ocular microvascular alteration in patients with myocardial infarction—a new OCTA study
  Jun-Yi Wu, Jin-Yu Hu, Qian-Min Ge, San-Hua Xu, Jie Zou, Min Kang, Ping Ying, Hong Wei, Qian Ling, Liang-Qi He, Cheng Chen, Yi Shao
  Scientific Reports.2024;[Epub]     CrossRef
• Aldose Reductase as a Key Target in the Prevention and Treatment of Diabetic Retinopathy: A Comprehensive Review
  Alexandra-Ioana Dănilă, Laura Andreea Ghenciu, Emil Robert Stoicescu, Sorin Lucian Bolintineanu, Roxana Iacob, Mihai-Alexandru Săndesc, Alexandra Corina Faur
  Biomedicines.2024; 12(4): 747.     CrossRef
• Correlation Between Thyroid-Related Hormones and Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients with Normal Thyroid Function: A Retrospective Study
  Mei Xiao, Guangwen Luo, Zhaowei Zhang, Yanfen Liu, Rui Gong, Jianghuan Ke
  Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 1481.     CrossRef
• Novel risk score model for non-proliferative diabetic retinopathy based on untargeted metabolomics of venous blood
  Xinyu Wang, Shu Yang, Guangyan Yang, Jialong Lin, Pengfei Zhao, Jingyun Ding, Hongyan Sun, Ting Meng, Ming Ming Yang, Lin Kang, Zhen Liang
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Diabetic Retinopathy: An Overview on Mechanisms, Pathophysiology and Pharmacotherapy
  Prawej Ansari, Noushin Tabasumma, Nayla Nuren Snigdha, Nawfal Hasan Siam, Rachana V. N. R. S. Panduru, Shofiul Azam, J. M. A. Hannan, Yasser H. A. Abdel-Wahab
  Diabetology.2022; 3(1): 159.     CrossRef
• Effect of retinol and α-tocopherol supplementation on photoreceptor and retinal ganglion cell apoptosis in diabetic rats model
  Andi Muhammad Ichsan, Agussalim Bukhari, Subehan Lallo, Upik Anderiani Miskad, Andi Afdal Dzuhry, Itzar Chaidir Islam, Habibah Setyawati Muhiddin
  International Journal of Retina and Vitreous.2022;[Epub]     CrossRef
• Diabetic retinopathy risk prediction in patients with type 2 diabetes mellitus using a nomogram model
  Qian Wang, Ni Zeng, Hongbo Tang, Xiaoxia Yang, Qu Yao, Lin Zhang, Han Zhang, Ying Zhang, Xiaomei Nie, Xin Liao, Feng Jiang
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Dietary glutamic acid and aspartic acid as biomarkers for predicting diabetic retinopathy
  So Young Park, Jieun Kim, Jung Il Son, Sang Youl Rhee, Do-Yeon Kim, Suk Chon, Hyunjung Lim, Jeong-Taek Woo
  Scientific Reports.2021;[Epub]     CrossRef
• Plasma amino acids and oxylipins as potential multi-biomarkers for predicting diabetic macular edema
  Sang Youl Rhee, Eun Sung Jung, Dong Ho Suh, Su Jin Jeong, Kiyoung Kim, Suk Chon, Seung-Young Yu, Jeong-Taek Woo, Choong Hwan Lee
  Scientific Reports.2021;[Epub]     CrossRef
• Dysbiosis in the Gut Microbiome in Streptozotocin-Induced Diabetes Rats and Follow-Up During Retinal Changes
  Shalem Raj Padakandla, Taraprasad Das, Gumpili Sai Prashanthi, Kiran Kumar Angadi, S. Sreenivasa Reddy, G. Bhanuprakash Reddy, Sisinthy Shivaji
  Investigative Opthalmology & Visual Science.2021; 62(10): 31.     CrossRef
• Importance of medication adherence in treatment needed diabetic retinopathy
  Chia-Chen Kao, Hui-Min Hsieh, Daniel Yu Lee, Kun-Pin Hsieh, Shwu-Jiuan Sheu
  Scientific Reports.2021;[Epub]     CrossRef

• Targeting Netrin-1 and -4 as a Novel Diagnostic Parameter and Treatment Option for Diabetic Retinopathy

  
  Kaleab Alemayehu Zewdie, Muluken Altaye Ayza, Bekalu Amare, Ebrahim M. Yimer
  Clinical Ophthalmology.2020; Volume 14: 1741.     CrossRef
• Lipoprotein(a) and Apolipoproteins as Predictors for Diabetic Retinopathy and Its Severity in Adults With Type 2 Diabetes: A Case-Cohort Study
  Fatemeh Moosaie, Reza Mohamadhosseinzadeh Davatgari, Fatemeh Dehghani Firouzabadi, Sadaf Esteghamati, Niloofar Deravi, Alipasha Meysamie, Pegah Khaloo, Manouchehr Nakhjavani, Alireza Esteghamati
  Canadian Journal of Diabetes.2020; 44(5): 414.     CrossRef
• Microfluidic Immunosensor for Point-of-Care-Testing of Beta-2-Microglobulin in Tear
  Surjendu Maity, Subhradip Ghosh, Tamanna Bhuyan, Dipankar Das, Dipankar Bandyopadhyay
  ACS Sustainable Chemistry & Engineering.2020; 8(25): 9268.     CrossRef
• Correlations of blood lipids with early changes in macular thickness in patients with diabetes
  J. Liang, W. Lei, J. Cheng
  Journal Français d'Ophtalmologie.2019; 42(3): 276.     CrossRef
• Evaluation of microvascular changes in the perifoveal vascular network using optical coherence tomography angiography (OCTA) in type I diabetes mellitus: a large scale prospective trial
  Javier Zarranz-Ventura, Marina Barraso, Anibal Alé-Chilet, Teresa Hernandez, Cristian Oliva, Jesus Gascón, Anna Sala-Puigdollers, Marc Figueras-Roca, Irene Vinagre, Emilio Ortega, Enric Esmatjes, Alfredo Adan
  BMC Medical Imaging.2019;[Epub]     CrossRef
• Hyperglycemia Induces Neutrophil Extracellular Traps Formation Through an NADPH Oxidase-Dependent Pathway in Diabetic Retinopathy
  Luoziyi Wang, Xin Zhou, Yizhou Yin, Yuxin Mai, Desai Wang, Xuedong Zhang
  Frontiers in Immunology.2019;[Epub]     CrossRef
• The relationship of dietary fish intake to diabetic retinopathy and retinal vascular caliber in patients with type 2 diabetes
  Jacqueline Chua, Ai-Ru Chia, Miao Li Chee, Ryan Eyn Kidd Man, Gavin Siew Wei Tan, Ecosse L. Lamoureux, Tien Yin Wong, Mary Foong-Fong Chong, Leopold Schmetterer
  Scientific Reports.2018;[Epub]     CrossRef
• Intravitreal pro-inflammatory cytokines in non-obese diabetic mice: Modelling signs of diabetic retinopathy
  Odunayo O. Mugisho, Ilva D. Rupenthal, David M. Squirrell, Sarah J. Bould, Helen V. Danesh-Meyer, Jie Zhang, Colin R. Green, Monica L. Acosta, Alfred S Lewin
  PLOS ONE.2018; 13(8): e0202156.     CrossRef
• Correlation Analysis between Foveal Avascular Zone and Peripheral Ischemic Index in Diabetic Retinopathy: A Pilot Study
  Alessandro Rabiolo, Maria Vittoria Cicinelli, Eleonora Corbelli, Giovanni Baldin, Adriano Carnevali, Rosangela Lattanzio, Lea Querques, Francesco Bandello, Giuseppe Querques
  Ophthalmology Retina.2018; 2(1): 46.     CrossRef
• Plasma glutamine and glutamic acid are potential biomarkers for predicting diabetic retinopathy
  Sang Youl Rhee, Eun Sung Jung, Hye Min Park, Su Jin Jeong, Kiyoung Kim, Suk Chon, Seung-Young Yu, Jeong-Taek Woo, Choong Hwan Lee
  Metabolomics.2018;[Epub]     CrossRef
• Clinical Characteristics of Patients with Newly Diagnosed Diabetic Macular Edema in Turkey: A Real-Life Registry Study—TURK-DEM
  Bora Eldem, Sengul Ozdek, Ali Osman Saatci, Emin Ozmert, Esat Ulay, Gulsah Nomak
  Journal of Ophthalmology.2017; 2017: 1.     CrossRef
• Letter: Features of Long-Standing Korean Type 2 Diabetes Mellitus Patients with Diabetic Retinopathy: A Study Based on Standardized Clinical Data (Diabetes Metab J 2017;41:393-404)
  Jae-Seung Yun
  Diabetes & Metabolism Journal.2017; 41(6): 492.     CrossRef
• Targeting VEGF in eye neovascularization: What's new?
  Marialaura Amadio, Stefano Govoni, Alessia Pascale
  Pharmacological Research.2016; 103: 253.     CrossRef
• Actualización de la retinopatía diabética para médicos de atención primaria: hacia una mejora de la medicina telemática
  J.E. Muñoz de Escalona-Rojas, A. Quereda-Castañeda, O. García-García
  SEMERGEN - Medicina de Familia.2016; 42(3): 172.     CrossRef
• Anatomical effects of dexamethasone intravitreal implant in diabetic macular oedema: a pooled analysis of 3-year phase III trials
  Ronald P Danis, Srinivas Sadda, Xiao-Yan Li, Harry Cui, Yehia Hashad, Scott M Whitcup
  British Journal of Ophthalmology.2016; 100(6): 796.     CrossRef
• Association between LEKR1‐CCNL1 and IGSF21‐KLHDC7A gene polymorphisms and diabetic retinopathy of type 2 diabetes mellitus in the Chinese Han population
  Xiaohui Lin, Jihong Wang, Lixia Yun, Shuhong Jiang, Langen Li, Xiaohai Chen, Zhen Li, Qiang Lu, Yihui Zhang, Xiaocheng Ma
  The Journal of Gene Medicine.2016; 18(10): 282.     CrossRef
• Current Challenges in Diabetic Retinopathy: Are We Really Doing Better?
  Jae Hyuck Lee, Su Jeong Song
  Endocrinology and Metabolism.2016; 31(2): 254.     CrossRef
• Nanosystems based on siRNA silencing HuR expression counteract diabetic retinopathy in rat
  Marialaura Amadio, Alessia Pascale, Sarha Cupri, Rosario Pignatello, Cecilia Osera, Velia D⿿Agata, Agata Grazia D⿿Amico, Gian Marco Leggio, Barbara Ruozi, Stefano Govoni, Filippo Drago, Claudio Bucolo
  Pharmacological Research.2016; 111: 713.     CrossRef
• Lipoprotein(a) predicts the development of diabetic retinopathy in people with type 2 diabetes mellitus
  Jae-Seung Yun, Tae-Seok Lim, Seon-Ah Cha, Yu-Bae Ahn, Ki-Ho Song, Jin A. Choi, Jinwoo Kwon, Donghyun Jee, Yang Kyung Cho, Yong-Moon Park, Seung-Hyun Ko
  Journal of Clinical Lipidology.2016; 10(2): 426.     CrossRef
• Nanoengineering of therapeutics for retinal vascular disease
  Nivriti Gahlaut, Sandra Suarez, Md. Imam Uddin, Andrew Y. Gordon, Stephanie M. Evans, Ashwath Jayagopal
  European Journal of Pharmaceutics and Biopharmaceutics.2015; 95: 323.     CrossRef
• Functional outcome of macular edema in different retinal disorders
  Oren Tomkins-Netzer, Filis Ismetova, Asaf Bar, Sophie Seguin-Greenstein, Michal Kramer, Sue Lightman
  Progress in Retinal and Eye Research.2015; 48: 119.     CrossRef
• Recent developments in ocular drug delivery
  Hongming Chen
  Journal of Drug Targeting.2015; 23(7-8): 597.     CrossRef
• Potential New Modes of Treatment of Neurotrophic Keratopathy
  Ryoji Yanai, Teruo Nishida, Tai-Ichiro Chikama, Naoyuki Morishige, Naoyuki Yamada, Koh-Hei Sonoda
  Cornea.2015; 34(Supplement): S121.     CrossRef
• What have we learnt about the management of diabetic macular edema in the antivascular endothelial growth factor and corticosteroid era?
  Aniruddha Agarwal, Salman Sarwar, Yasir J. Sepah, Quan D. Nguyen
  Current Opinion in Ophthalmology.2015; 26(3): 177.     CrossRef

A cure for type 2 diabetes was once a mere dream but has now become a tangible and achievable goal with the unforeseen success of bariatric surgery in the treatment of both obesity and type 2 diabetes. Popular bariatric procedures such as Roux-en-Y gastric bypass and sleeve gastrectomy exhibit high rates of diabetes remission or marked improvement in glycemic control. However, the mechanism of diabetes remission following these procedures is still elusive and appears to be very complex and encompasses multiple anatomical and physiological changes. In this article, calorie restriction, improved β-cell function, improved insulin sensitivity, and alterations in gut physiology, bile acid metabolism, and gut microbiota are reviewed as potential mechanisms of diabetes remission after Roux-en-Y gastric bypass and sleeve gastrectomy.

Citations

Citations to this article as recorded by  

• The Effect of Diet Composition on the Post-operative Outcomes of Roux-en-Y Gastric Bypass in Mice
  Matthew Stevenson, Ankita Srivastava, Maria Nacher, Christopher Hall, Thomas Palaia, Jenny Lee, Chaohui Lisa Zhao, Raymond Lau, Mohamed A. E. Ali, Christopher Y. Park, Florencia Schlamp, Sean P. Heffron, Edward A. Fisher, Collin Brathwaite, Louis Ragolia
  Obesity Surgery.2024; 34(3): 911.     CrossRef
• A Matched Comparative Analysis of Type-2 Diabetes Mellitus Remission Between Roux-en-Y Gastric Bypass and Sleeve Gastrectomy
  Karl Hage, Pearl Ma, Wissam Ghusn, Kayla Ikemiya, Andres Acosta, Robert A. Vierkant, Barham K. Abu Dayyeh, Kelvin D. Higa, Omar M. Ghanem
  Surgical Innovation.2024; 31(2): 148.     CrossRef
• Sex-Specific Changes in Body Composition Following Metabolic and Bariatric Surgery Are Associated with the Remission of Metabolic Syndrome
  Xianhao Yi, Weizheng Li, Guohui Wang, Pengzhou Li, Xulong Sun, Haibo Tang, Beibei Cui, Jiapu Ling, Ping Luo, Zhibing Fu, Hui Zhou, Liyong Zhu, Shaihong Zhu
  Obesity Surgery.2023; 33(9): 2780.     CrossRef
• East Asian perspectives in metabolic and bariatric surgery
  Tae Jung Oh, Hyuk‐Joon Lee, Young Min Cho
  Journal of Diabetes Investigation.2022; 13(5): 756.     CrossRef
• Long-Term Trajectories in Weight and Health Outcomes Following Multidisciplinary Publicly Funded Bariatric Surgery in Patients with Clinically Severe Obesity (≥ 3 Associated Comorbidities): A Nine-Year Prospective Cohort Study in Australia
  Michelle M.C. Tan, Xingzhong Jin, Craig Taylor, Adrian K. Low, Philip Le Page, David Martin, Ang Li, David Joseph, Nic Kormas
  Journal of Clinical Medicine.2022; 11(15): 4466.     CrossRef
• Impact of Bariatric Surgery in Reducing Macrovascular Complications in Severely Obese T2DM Patients
  Salman Hussain, Mohd Shahnawaz Khan, Mohammad Chand Jamali, Ali Nasir Siddiqui, Gaurav Gupta, Md Sarfaraj Hussain, Fohad Mabood Husain
  Obesity Surgery.2021; 31(5): 1929.     CrossRef
• Vertical sleeve gastrectomy induces distinctive transcriptomic responses in liver, fat and muscle
  Chang Ho Ahn, Eun Hye Choi, Hyunjung Lee, Woochan Lee, Jong-Il Kim, Young Min Cho
  Scientific Reports.2021;[Epub]     CrossRef
• Which predictors could effect on remission of type 2 diabetes mellitus after the metabolic surgery: A general perspective of current studies?
  Gamze Akkus, Tamer Tetiker
  World Journal of Diabetes.2021; 12(8): 1312.     CrossRef
• Impact of Metabolic Surgery on Type-2 Diabetes Remission
  Cejana de Abrantes Figueiredo Baiocchi, Diana Aristótelis Rocha de Sá
  Current Diabetes Reviews.2021;[Epub]     CrossRef
• Ileal Transposition Increases Pancreatic β Cell Mass and Decreases β Cell Senescence in Diet-Induced Obese Rats
  Chang Ho Ahn, Eun Hye Choi, Tae Jung Oh, Young Min Cho
  Obesity Surgery.2020; 30(5): 1849.     CrossRef
• Does Reconstruction Type After Gastric Resection Matters for Type 2 Diabetes Improvement?
  Mariana Costa, Artur Trovão Lima, Tiago Morais, Rui F. Almeida, Mário Nora, Marta Guimarães, Mariana P. Monteiro
  Journal of Gastrointestinal Surgery.2020; 24(6): 1269.     CrossRef
• Epidemiology, pathophysiology and etiology of obesity in children and adolescents
  Jessica Kerns, Martin Fisher
  Current Problems in Pediatric and Adolescent Health Care.2020; 50(9): 100869.     CrossRef
• Obesity in Adolescents and Youth: The Case for and against Bariatric Surgery
  Ahmed Khattab, Mark A. Sperling
  The Journal of Pediatrics.2019; 207: 18.     CrossRef
• Outcomes of Bariatric Surgery Versus Medical Management for Type 2 Diabetes Mellitus: a Meta-Analysis of Randomized Controlled Trials
  Zhamak Khorgami, Saeed Shoar, Alan A. Saber, C. Anthony Howard, Goodarz Danaei, Guido M. Sclabas
  Obesity Surgery.2019; 29(3): 964.     CrossRef
• Validating Risk Prediction Models of Diabetes Remission After Sleeve Gastrectomy
  Shih-Chiang Shen, Weu Wang, Ka-Wai Tam, Hsin-An Chen, Yen-Kuang Lin, Shih-Yun Wang, Ming-Te Huang, Yen-Hao Su
  Obesity Surgery.2019; 29(1): 221.     CrossRef
• Long-term diabetes outcomes after bariatric surgery—managing medication withdrawl
  Pedro Souteiro, Sandra Belo, Daniela Magalhães, Jorge Pedro, João Sérgio Neves, Sofia Castro Oliveira, Paula Freitas, Ana Varela, Davide Carvalho
  International Journal of Obesity.2019; 43(11): 2217.     CrossRef
• What is type 2 diabetes?
  Maria Daniela Hurtado, Adrian Vella
  Medicine.2019; 47(1): 10.     CrossRef
• Intestinal Glucose Absorption Was Reduced by Vertical Sleeve Gastrectomy via Decreased Gastric Leptin Secretion
  Jinpeng Du, Chaojie Hu, Jie Bai, Miaomiao Peng, Qingbo Wang, Ning Zhao, Yu Wang, Guobin Wang, Kaixiong Tao, Geng Wang, Zefeng Xia
  Obesity Surgery.2018; 28(12): 3851.     CrossRef
• Non-pharmacological Treatment Options in the Management of Diabetes Mellitus
  Arkiath V Raveendran
  European Endocrinology.2018; 14(2): 31.     CrossRef
• Ileal transposition rapidly improves glucose tolerance and gradually improves insulin resistance in non-obese type 2 diabetic rats
  Hengliang Zhu, Huaiming Wang, Zhihai Zheng, Bailiang Ye, Xiaojiao Ruan, Xiaofeng Zheng, Guoxin Li
  Gastroenterology Report.2018; 6(4): 291.     CrossRef
• Small Intestinal Bypass Induces a Persistent Weight-Loss Effect and Improves Glucose Tolerance in Obese Rats
  Jiaqing Cao, Quan Ren, Cai Tan, Jinyuan Duan
  Obesity Surgery.2017; 27(7): 1859.     CrossRef
• Diabetes improvement and resolution following laparoscopic vertical sleeve gastrectomy (LVSG) versus laparoscopic Roux-en-Y gastric bypass (LRYGB) procedures: a systematic review of randomized controlled trials
  Emma Osland, Rossita Mohamad Yunus, Shahjahan Khan, Breda Memon, Muhammed Ashraf Memon
  Surgical Endoscopy.2017; 31(4): 1952.     CrossRef
• The Long-Term Effects of Bariatric Surgery on Type 2 Diabetes Remission, Microvascular and Macrovascular Complications, and Mortality: a Systematic Review and Meta-Analysis
  Binwu Sheng, Khoa Truong, Hugh Spitler, Lu Zhang, Xuetao Tong, Liwei Chen
  Obesity Surgery.2017; 27(10): 2724.     CrossRef
• Long-term effects of duodenojejunal bypass on diabetes in Otsuka Long–Evans Tokushima Fatty rats
  Sang Kuon Lee, Oh-Joo Kwon, Hae Myung Jeon, Say-June Kim
  Asian Journal of Surgery.2017; 40(4): 262.     CrossRef
• Interaction Between Atypical Antipsychotics and the Gut Microbiome in a Bipolar Disease Cohort
  Stephanie A. Flowers, Simon J. Evans, Kristen M. Ward, Melvin G. McInnis, Vicki L. Ellingrod
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.2017; 37(3): 261.     CrossRef
• THE ROLE OF THE SLEEVE GASTRECTOMY AND THE MANAGEMENT OF TYPE 2 DIABETES
  Taíse FUCHS, Marcelo LOUREIRO, Gabriela Heloise BOTH, Heloise Helena SKRABA, Thaís Andrade COSTA-CASAGRANDE
  ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo).2017; 30(4): 283.     CrossRef
• Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in ob/ob mice
  Satoko Shimazu-Kuwahara, Norio Harada, Shunsuke Yamane, Erina Joo, Akiko Sankoda, Timothy J. Kieffer, Nobuya Inagaki
  Molecular Metabolism.2017; 6(3): 288.     CrossRef
• Adipose tissue supports normalization of macrophage and liver lipid handling in obesity reversal
  Maayan Vatarescu, Sapir Bechor, Yulia Haim, Tal Pecht, Tanya Tarnovscki, Noa Slutsky, Ori Nov, Hagit Shapiro, Avishai Shemesh, Angel Porgador, Nava Bashan, Assaf Rudich
  Journal of Endocrinology.2017; 233(3): 293.     CrossRef
• Sleeve Gastrectomy Alters Intestinal Permeability in Diet-Induced Obese Mice
  Claire Blanchard, François Moreau, Julien Chevalier, Audrey Ayer, Damien Garcon, Lucie Arnaud, Jean-Paul Pais de Barros, Thomas Gautier, Michel Neunlist, Bertrand Cariou, Cédric Le May
  Obesity Surgery.2017; 27(10): 2590.     CrossRef
• Long-term Follow-up for Type 2 Diabetes Mellitus after Gastrectomy in Non-morbidly Obese Patients with Gastric Cancer: the Legitimacy of Onco-metabolic Surgery
  Tae-Hoon Lee, Chang Min Lee, Sungsoo Park, Do Hyun Jung, You Jin Jang, Jong-Han Kim, Seong-Heum Park, Young-Jae Mok
  Journal of Gastric Cancer.2017; 17(4): 283.     CrossRef
• Preoperative Beta Cell Function Is Predictive of Diabetes Remission After Bariatric Surgery
  Pedro Souteiro, Sandra Belo, João Sérgio Neves, Daniela Magalhães, Rita Bettencourt Silva, Sofia Castro Oliveira, Maria Manuel Costa, Ana Saavedra, Joana Oliveira, Filipe Cunha, Eva Lau, César Esteves, Paula Freitas, Ana Varela, Joana Queirós, Davide Carv
  Obesity Surgery.2017; 27(2): 288.     CrossRef
• Ileal Transposition Decreases Plasma Lipopolysaccharide Levels in Association with Increased L Cell Secretion in Non-obese Non-diabetic Rats
  Tae Jung Oh, Hyuk-Joon Lee, Young Min Cho
  Obesity Surgery.2016; 26(6): 1287.     CrossRef
• The Mechanism of Metabolic Surgery: Gastric Center Hypothesis
  Jiangfan Zhu, Radheshyam Gupta, Mahmood Safwa
  Obesity Surgery.2016; 26(7): 1639.     CrossRef
• Lipids and bariatric procedures Part 2 of 2: scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA)
  Harold Bays, Shanu N. Kothari, Dan E. Azagury, John M. Morton, Ninh T. Nguyen, Peter H. Jones, Terry A. Jacobson, David E. Cohen, Carl Orringer, Eric C. Westman, Deborah B. Horn, Wendy Scinta, Craig Primack
  Surgery for Obesity and Related Diseases.2016; 12(3): 468.     CrossRef
• Metabolic Surgery for Type 2 Diabetes Mellitus: Experience from Asia
  Wei-Jei Lee, Lwin Aung
  Diabetes & Metabolism Journal.2016; 40(6): 433.     CrossRef
• Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome
  Lukasz Kaska, Tomasz Sledzinski, Agnieszka Chomiczewska, Agnieszka Dettlaff-Pokora, Julian Swierczynski
  World Journal of Gastroenterology.2016; 22(39): 8698.     CrossRef
• In Vivo Models for Incretin Research: From the Intestine to the Whole Body
  Tae Jung Oh
  Endocrinology and Metabolism.2016; 31(1): 45.     CrossRef
• Contribution of the distal small intestine to metabolic improvement after bariatric/metabolic surgery: Lessons from ileal transposition surgery
  Tae Jung Oh, Chang Ho Ahn, Young Min Cho
  Journal of Diabetes Investigation.2016; 7(S1): 94.     CrossRef
• EFFECTS OF LONG-TERM ROUX-EN-Y GASTRIC BYPASS ON BODY WEIGHT AND CLINICAL METABOLIC COMORBIDITIES IN BARIATRIC SURGERY SERVICE OF A UNIVERSITY HOSPITAL
  Cátia Ferreira da SILVA, Larissa COHEN, Luciana d'Abreu SARMENTO, Felipe Monnerat Marino ROSA, Eliane Lopes ROSADO, João Régis Ivar CARNEIRO, Antônio Augusto Peixoto de SOUZA, Fernanda Cristina Carvalho Mattos MAGNO
  ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo).2016; 29( suppl 1): 20.     CrossRef
• Medication Use Among Patients Prior to Bariatric Surgery
  Jennifer Padden Elliott, Erica L. Gray, Jessie Yu, Melissa A. Kalarchian
  Bariatric Surgical Practice and Patient Care.2015; 10(3): 105.     CrossRef
• Changes in the salivary protein profile of morbidly obese women either previously subjected to bariatric surgery or not
  Elsa Lamy, Carla Simões, Lénia Rodrigues, Ana Rodrigues Costa, Rui Vitorino, Francisco Amado, Célia Antunes, Isabel do Carmo
  Journal of Physiology and Biochemistry.2015; 71(4): 691.     CrossRef

Diabetic cardiomyopathy (DCM), as one of the major cardiac complications in diabetic patients, is known to related with oxidative stress that is due to a severe imbalance between reactive oxygen species (ROS) and/or reactive nitrogen species (RNS) generation and their clearance by antioxidant defense systems. Transcription factor nuclear factor NF-E2-related factor 2 (Nrf2) plays an important role in maintaining the oxidative homeostasis by regulating multiple downstream antioxidants. Diabetes may up-regulate several antioxidants in the heart as a compensative mechanism at early stage, but at late stage, diabetes not only generates extra ROS and/or RNS but also impairs antioxidant capacity in the heart, including Nrf2. In an early study, we have established that Nrf2 protect the cardiac cells and heart from high level of glucose in vitro and hyperglycemia in vivo, and in the following study demonstrated the significant down-regulation of cardiac Nrf2 expression in diabetic animals and patients. Using Nrf2-KO mice or Nrf2 inducers, blooming evidence has indicated the important protection by Nrf2 from cardiac pathogenesis in the diabetes. Therefore, this brief review summarizes the status of studies on Nrf2's role in preventing DCM and even other complications, the need for new and safe Nrf2 inducer screening and the precaution for the undesirable side of Nrf2 under certain conditions.

Citations

Citations to this article as recorded by  

• Natural Products and Health
  Joanna Bartkowiak-Wieczorek, Edyta Mądry
  Nutrients.2024; 16(3): 415.     CrossRef
• Nrf2 prevents diabetic cardiomyopathy via antioxidant effect and normalization of glucose and lipid metabolism in the heart
  Ge Yang, Qihe Zhang, Chao Dong, Guowen Hou, Jinjie Li, Xin Jiang, Ying Xin
  Journal of Cellular Physiology.2024;[Epub]     CrossRef
• 3,4′,5-Trimethoxy-trans-stilbene ameliorates hepatic insulin resistance and oxidative stress in diabetic obese mice through insulin and Nrf2 signaling pathways
  Yi Tan, Chunxiu Zhou, Lingchao Miao, Xutao Zhang, Haroon Khan, Baojun Xu, Wai San Cheang
  Food & Function.2024; 15(6): 2996.     CrossRef
• Natural compounds protect against the pathogenesis of osteoarthritis by mediating the NRF2/ARE signaling
  Zhenyu Wu, Zhouxin Yang, Luying Liu, Yong Xiao
  Frontiers in Pharmacology.2023;[Epub]     CrossRef
• High fat diet exacerbates long-term metabolic, neuropathological, and behavioral derangements in an experimental mouse model of traumatic brain injury
  Stanley Ibeh, Nour-Mounira Z. Bakkar, Fatima Ahmad, Judith Nwaiwu, Chloe Barsa, Sarine Mekhjian, Mohammad Amine Reslan, Ali H. Eid, Hayat Harati, Sanaa Nabha, Yehia Mechref, Ahmed F. El-Yazbi, Firas Kobeissy
  Life Sciences.2023; 314: 121316.     CrossRef
• The Protective Effect of 11-Keto-β-Boswellic Acid against Diabetic Cardiomyopathy in Rats Entails Activation of AMPK
  Jozaa Z. AlTamimi, Nora A. AlFaris, Ghedeir M. Alshammari, Reham I. Alagal, Dalal H. Aljabryn, Mohammed Abdo Yahya
  Nutrients.2023; 15(7): 1660.     CrossRef
• Caffeic Acid Phenethyl Ester and Caffeamide Derivatives Suppress Oral Squamous Cell Carcinoma Cells
  Yin-Hwa Shih, Chieh-Chieh Chen, Yueh-Hsiung Kuo, Lih-Jyh Fuh, Wan-Chen Lan, Tong-Hong Wang, Kuo-Chou Chiu, Thanh-Hien Vu Nguyen, Shih-Min Hsia, Tzong-Ming Shieh
  International Journal of Molecular Sciences.2023; 24(12): 9819.     CrossRef
• The Role of Asiatic Acid in Preventing Dental Pulp Inflammation: An in-vivo Study
  Arlina Nurhapsari, Risya Cilmiaty, Adi Prayitno, Bambang Purwanto, Soetrisno Soetrisno
  Clinical, Cosmetic and Investigational Dentistry.2023; Volume 15: 109.     CrossRef
• Dexmedetomidine ameliorates diabetic cardiomyopathy by inhibiting ferroptosis through the Nrf2/GPX4 pathway
  Fan Li, Zhenfei Hu, Yidan Huang, Haiting Zhan
  Journal of Cardiothoracic Surgery.2023;[Epub]     CrossRef
• Metformin-mediated epigenetic modifications in diabetes and associated conditions: Biological and clinical relevance
  Roberta Giordo, Anna Maria Posadino, Arduino Aleksander Mangoni, Gianfranco Pintus
  Biochemical Pharmacology.2023; 215: 115732.     CrossRef
• Transient receptor potential vanilloid type 1: cardioprotective effects in diabetic models
  Jiaqi Bao, Zhicheng Gao, Yilan Hu, Lifang Ye, Lihong Wang
  Channels.2023;[Epub]     CrossRef
• Beyond Hepatoprotection—The Cardioprotective Effects of Bicyclol in Diabetes
  Arun Samidurai, Rakesh C. Kukreja
  Cardiovascular Drugs and Therapy.2023;[Epub]     CrossRef
• Sinapic acid ameliorates cardiac dysfunction and cardiomyopathy by modulating NF-κB and Nrf2/HO-1 signaling pathways in streptozocin induced diabetic rats
  Mohammad Raish, Ajaz Ahmad, Yousef A. Bin Jardan, Mudassar Shahid, Khalid M. Alkharfy, Abdul Ahad, Mushtaq Ahmad Ansari, Ibrahim Abdelsalam Abdelrahman, Fahad I. Al-Jenoobi
  Biomedicine & Pharmacotherapy.2022; 145: 112412.     CrossRef
• Recent Advances in KEAP1/NRF2-Targeting Strategies by Phytochemical Antioxidants, Nanoparticles, and Biocompatible Scaffolds for the Treatment of Diabetic Cardiovascular Complications
  Andrea Rampin, Michele Carrabba, Martina Mutoli, Charlotte L. Eman, Gianluca Testa, Paolo Madeddu, Gaia Spinetti
  Antioxidants & Redox Signaling.2022; 36(10-12): 707.     CrossRef
• Exercise and Urtica Dioica extract ameliorate mitochondrial function and the expression of cardiac muscle Nuclear Respiratory Factor 2 and Peroxisome proliferator-activated receptor Gamma Coactivator 1-alpha in STZ-induced diabetic rats
  Seyyedeh Masoumeh Seyydi, Asghar Tofighi, Masoud Rahmati, Javad Tolouei Azar
  Gene.2022; 822: 146351.     CrossRef
• 3,3′,4,5′-Tetramethoxy-trans-stilbene Improves Insulin Resistance by Activating the IRS/PI3K/Akt Pathway and Inhibiting Oxidative Stress
  Yi Tan, Lingchao Miao, Jianbo Xiao, Wai San Cheang
  Current Issues in Molecular Biology.2022; 44(5): 2175.     CrossRef
• The Beneficial Effects of Chinese Herbal Monomers on Ameliorating Diabetic Cardiomyopathy via Nrf2 Signaling
  Yiwei Gao, Wu Liu, Xin Su, Xinyi Li, Fangning Yu, Ning Zhang, Yuli Huang
  Oxidative Medicine and Cellular Longevity.2022; 2022: 1.     CrossRef
• Cardioprotective Effects and in-silico Antioxidant Mechanism of L-Ergothioneine in Experimental Type-2 Diabetic Rats
  Ayobami Dare, Ahmed A Elrashedy, Mahendra L. Channa, Anand Nadar
  Cardiovascular & Hematological Agents in Medicinal Chemistry.2022; 20(2): 133.     CrossRef
• Molecular Mechanisms of Ferroptosis and Relevance to Cardiovascular Disease
  Lai-Hua Xie, Nadezhda Fefelova, Sri Harika Pamarthi, Judith K. Gwathmey
  Cells.2022; 11(17): 2726.     CrossRef
• Cardiac adaptation and cardioprotection against arrhythmias and ischemia-reperfusion injury in mammalian hibernators
  Lai-Hua Xie, Judith K. Gwathmey, Zhenghang Zhao
  Pflügers Archiv - European Journal of Physiology.2021; 473(3): 407.     CrossRef
• Cardioprotective Effect of Glycyrrhizin on Myocardial Remodeling in Diabetic Rats
  Vikram Thakur, Narah Alcoreza, Monica Delgado, Binata Joddar, Munmun Chattopadhyay
  Biomolecules.2021; 11(4): 569.     CrossRef
• Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy
  Nikole J. Byrne, Namakkal S. Rajasekaran, E Dale Abel, Heiko Bugger
  Free Radical Biology and Medicine.2021; 169: 317.     CrossRef
• Punicalagin Protects Against Diabetic Cardiomyopathy by Promoting Opa1-Mediated Mitochondrial Fusion via Regulating PTP1B-Stat3 Pathway
  Feng Fu, Chaoyang Liu, Rui Shi, Man Li, Min Zhang, Yanyan Du, Qiaojuan Wang, Jun Li, Guoen Wang, Jianming Pei, Mingge Ding
  Antioxidants & Redox Signaling.2021; 35(8): 618.     CrossRef
• Elevated type I interferon responses potentiate metabolic dysfunction, inflammation, and accelerated aging in mtDNA mutator mice
  Yuanjiu Lei, Camila Guerra Martinez, Sylvia Torres-Odio, Samantha L. Bell, Christine E. Birdwell, Joshua D. Bryant, Carl W. Tong, Robert O. Watson, Laura Ciaccia West, A. Phillip West
  Science Advances.2021;[Epub]     CrossRef
• The potential role of Keap1-Nrf2 pathway in the pathogenesis of Alzheimer’s disease, type 2 diabetes, and type 2 diabetes-related Alzheimer’s disease
  Ling He, Yi Sun
  Metabolic Brain Disease.2021; 36(7): 1469.     CrossRef
• The impact of mitochondria on cancer treatment resistance
  Michelle van der Merwe, Gustav van Niekerk, Carla Fourie, Manisha du Plessis, Anna-Mart Engelbrecht
  Cellular Oncology.2021; 44(5): 983.     CrossRef
• Therapeutic Approaches Targeting Proteostasis in Kidney Disease and Fibrosis
  Jia-Huang Chen, Chia-Hsien Wu, Chih-Kang Chiang
  International Journal of Molecular Sciences.2021; 22(16): 8674.     CrossRef
• Coronary Large Conductance Ca2+-Activated K+ Channel Dysfunction in Diabetes Mellitus
  Tong Lu, Hon-Chi Lee
  Frontiers in Physiology.2021;[Epub]     CrossRef
• Ferroptosis: New Dawn for Overcoming the Cardio-Cerebrovascular Diseases
  Meng-Yi Luo, Jian-Hui Su, Shao-Xin Gong, Na Liang, Wen-Qian Huang, Wei Chen, Ai-Ping Wang, Ying Tian
  Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
• Recombinant Human Growth Hormone Inhibits Lipotoxicity, Oxidative Stress, and Apoptosis in a Mouse Model of Diabetic Cardiomyopathy
  Zuowei Pei, Xiang Wang, Chenguang Yang, Min Dong, Fang Wang, Juan Gambini
  Oxidative Medicine and Cellular Longevity.2021; 2021: 1.     CrossRef
• Hydrogen sulfide mitigates myocardial inflammation by inhibiting nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome activation in diabetic rats
  Qiang Jia, Shomaila Mehmood, Xiaofen Liu, Shanfeng Ma, Rui Yang
  Experimental Biology and Medicine.2020; 245(3): 221.     CrossRef
• Heme oxygenase-1 in protozoan infections: A tale of resistance and disease tolerance
  Rafael C. M. C. Silva, Leonardo H. Travassos, Claudia N. Paiva, Marcelo T. Bozza, Marc-Jan Gubbels
  PLOS Pathogens.2020; 16(7): e1008599.     CrossRef
• Distinct Approaches of Raloxifene: Its Far-Reaching Beneficial Effects Implicating the HO-System
  Denise Börzsei, Renáta Szabó, Alexandra Hoffmann, Médea Veszelka, Imre Pávó, Zsolt Turcsán, Csaba Viczián, Krisztina Kupai, Csaba Varga, Anikó Pósa
  Biomolecules.2020; 10(3): 375.     CrossRef
• The Mitochondria: A Target of Polyphenols in the Treatment of Diabetic Cardiomyopathy
  Humna Bhagani, Suzanne A. Nasser, Ali Dakroub, Ahmed F. El-Yazbi, Assaad A. Eid, Firas Kobeissy, Gianfranco Pintus, Ali H. Eid
  International Journal of Molecular Sciences.2020; 21(14): 4962.     CrossRef
• The Effects of Dietary Supplements that Overactivate the Nrf2/ARE System
  Robert E. Smith
  Current Medicinal Chemistry.2020; 27(13): 2077.     CrossRef
• Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats
  Jierong Luo, Dan Yan, Sisi Li, Shiming Liu, Fei Zeng, Chi Wai Cheung, Hong Liu, Michael G. Irwin, Huansen Huang, Zhengyuan Xia
  Journal of Cellular and Molecular Medicine.2020; 24(2): 1760.     CrossRef
• Rg1 protects H9C2 cells from high glucose‐/palmitate‐induced injury via activation of AKT/GSK‐3β/Nrf2 pathway
  Haitao Yu, Juan Zhen, Yang Yang, Jian Du, Jiyan Leng, Qian Tong
  Journal of Cellular and Molecular Medicine.2020; 24(14): 8194.     CrossRef
• Ranolazine protects against diabetic cardiomyopathy by activating the NOTCH1/NRG1 pathway
  Xi Chen, Long Ren, Xing Liu, Xi Sun, Chaorun Dong, Yanan Jiang, Ying Qin, Huan Qu, Jinfeng Jiao, Shuo Wang, Yunlong Bai, Baofeng Yang
  Life Sciences.2020; 261: 118306.     CrossRef
• Low Concentration of Withaferin a Inhibits Oxidative Stress-Mediated Migration and Invasion in Oral Cancer Cells
  Tzu-Jung Yu, Jen-Yang Tang, Fu Ou-Yang, Yen-Yun Wang, Shyng-Shiou F. Yuan, Kevin Tseng, Li-Ching Lin, Hsueh-Wei Chang
  Biomolecules.2020; 10(5): 777.     CrossRef
• Protective Effect of Simplicillium sp. Ethyl Acetate Extract against High Glucose-Induced Oxidative Stress in HUVECs
  Ting-Ting Tian, Qi-Rui Li, Shi-Quan Gan, Chu-Rui Chang, Xiang-Chun Shen
  Evidence-Based Complementary and Alternative Medicine.2020; 2020: 1.     CrossRef
• Deneysel Diyabet Oluşturulan Sıçanlarda Kalp ve İskelet Kası Nrf2 Yapımı ve Oksidatif Stres Üzerine Melatoninin Etkisinin İncelenmesi
  Salim ÖZENOĞLU, İnci TURAN, Hale SAYAN ÖZAÇMAK, Veysel Haktan ÖZAÇMAK
  Turkish Journal of Diabetes and Obesity.2020; 4(1): 46.     CrossRef
• Nicorandil alleviates apoptosis in diabetic cardiomyopathy through PI3K/Akt pathway
  Xuyang Wang, Jinyu Pan, Dian Liu, Mingjun Zhang, Xiaowei Li, Jingjing Tian, Ming Liu, Tao Jin, Fengshuang An
  Journal of Cellular and Molecular Medicine.2019; 23(8): 5349.     CrossRef
• Bailcalin Protects against Diabetic Cardiomyopathy through Keap1/Nrf2/AMPK-Mediated Antioxidative and Lipid-Lowering Effects
  Ran Li, Yuan Liu, Ying-guang Shan, Lu Gao, Fang Wang, Chun-guang Qiu
  Oxidative Medicine and Cellular Longevity.2019; 2019: 1.     CrossRef
• Omega 3 rich diet modulates energy metabolism via GPR120-Nrf2 crosstalk in a novel antioxidant mouse model
  Deborah Amos, Carla Cook, Nalini Santanam
  Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.2019; 1864(4): 466.     CrossRef
• Increased placental expressions of nuclear factor erythroid 2–related factor 2 and antioxidant enzymes in gestational diabetes: Protective mechanisms against the placental oxidative stress?
  Balachandiran Manoharan, Zachariah Bobby, Gowri Dorairajan, Sajini Elizabeth Jacob, Victorraj Gladwin, Vickneshwaran Vinayagam, Rajaa Muthu Packirisamy
  European Journal of Obstetrics & Gynecology and Reproductive Biology.2019; 238: 78.     CrossRef
• Another look at phenolic compounds in cancer therapy the effect of polyphenols on ubiquitin-proteasome system
  Aleksandra Golonko, Tomasz Pienkowski, Renata Swislocka, Ryszard Lazny, Marek Roszko, Wlodzimierz Lewandowski
  European Journal of Medicinal Chemistry.2019; 167: 291.     CrossRef
• Hydrogen sulfide-mediated regulation of cell death signaling ameliorates adverse cardiac remodeling and diabetic cardiomyopathy
  Sumit Kar, Tyler N. Kambis, Paras K. Mishra
  American Journal of Physiology-Heart and Circulatory Physiology.2019; 316(6): H1237.     CrossRef
• Genomic and Genetic Approaches to Deciphering Acute Respiratory Distress Syndrome Risk and Mortality
  Heather Lynn, Xiaoguang Sun, Nancy Casanova, Manuel Gonzales-Garay, Christian Bime, Joe G.N. Garcia
  Antioxidants & Redox Signaling.2019; 31(14): 1027.     CrossRef
• Enhanced Keap1-Nrf2 signaling protects the myocardium from isoproterenol-induced pathological remodeling in mice
  Gobinath Shanmugam, Anil Kumar Challa, Silvio H. Litovsky, Asokan Devarajan, Ding Wang, Dean P. Jones, Victor M. Darley-Usmar, Namakkal Soorappan Rajasekaran
  Redox Biology.2019; 27: 101212.     CrossRef
• Effects of PP2A/Nrf2 on experimental diabetes mellitus-related cardiomyopathy by regulation of autophagy and apoptosis through ROS dependent pathway
  Yanhui Guan, Lichun Zhou, Yu Zhang, Huiqin Tian, Anqi Li, Xiuzhen Han
  Cellular Signalling.2019; 62: 109339.     CrossRef
• An Aza resveratrol–chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress
  Shengban You, Jianchang Qian, Chuchu Sun, Hailing Zhang, Shiju Ye, Taiwei Chen, Zheng Xu, Jingying Wang, Weijian Huang, Guang Liang
  Journal of Cellular and Molecular Medicine.2018; 22(3): 1931.     CrossRef
• Oxidative Stress in Mesenchymal Stem Cell Senescence: Regulation by Coding and Noncoding RNAs
  Rosa Vono, Eva Jover Garcia, Gaia Spinetti, Paolo Madeddu
  Antioxidants & Redox Signaling.2018; 29(9): 864.     CrossRef
• An overview of the emerging interface between cardiac metabolism, redox biology and the circadian clock
  Rodrigo A. Peliciari-Garcia, Victor Darley-Usmar, Martin E. Young
  Free Radical Biology and Medicine.2018; 119: 75.     CrossRef
• Klotho protects the heart from hyperglycemia-induced injury by inactivating ROS and NF-κB-mediated inflammation both in vitro and in vivo
  Yue Guo, Xiaodong Zhuang, Zena Huang, Jing Zou, Daya Yang, Xun Hu, Zhimin Du, Lichun Wang, Xinxue Liao
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2018; 1864(1): 238.     CrossRef
• Paradoxical cardiotoxicity of intraperitoneally-injected epigallocatechin gallate preparation in diabetic mice
  Nora O. Abdel Rasheed, Lamiaa A. Ahmed, Dalaal M. Abdallah, Bahia M. El-Sayeh
  Scientific Reports.2018;[Epub]     CrossRef
• Oxidative stress-induced miR-27a targets the redox gene nuclear factor erythroid 2-related factor 2 in diabetic embryopathy
  Yang Zhao, Daoyin Dong, E. Albert Reece, Ashley R. Wang, Peixin Yang
  American Journal of Obstetrics and Gynecology.2018; 218(1): 136.e1.     CrossRef
• Regulation on SIRT1-PGC-1α/Nrf2 pathway together with selective inhibition of aldose reductase makes compound hr5F a potential agent for the treatment of diabetic complications
  Zhihua Wang, Sheng Yuan, Yanbing Li, Zhe Zhang, Wei Xiao, Dan Tang, Kaihe Ye, Zhijun Liu, Congcong Wang, Yixiong Zheng, Hong Nie, Heru Chen
  Biochemical Pharmacology.2018; 150: 54.     CrossRef
• Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart
  Hong Yang, Anyun Feng, Sundong Lin, Lechu Yu, Xiufei Lin, Xiaoqing Yan, Xuemian Lu, Chi Zhang
  Cell Death & Disease.2018;[Epub]     CrossRef
• Salusin-β contributes to oxidative stress and inflammation in diabetic cardiomyopathy
  Ming-Xia Zhao, Bing Zhou, Li Ling, Xiao-Qing Xiong, Feng Zhang, Qi Chen, Yue-Hua Li, Yu-Ming Kang, Guo-Qing Zhu
  Cell Death & Disease.2017; 8(3): e2690.     CrossRef
• Role of Nrf2 Signaling in the Regulation of Vascular BK Channel β1 Subunit Expression and BK Channel Function in High-Fat Diet–Induced Diabetic Mice
  Tong Lu, Xiaojing Sun, Yong Li, Qiang Chai, Xiao-Li Wang, Hon-Chi Lee
  Diabetes.2017; 66(10): 2681.     CrossRef
• Regulation of vascular large-conductance calcium-activated potassium channels by Nrf2 signalling
  Yong Li, Xiao-Li Wang, Xiaojing Sun, Qiang Chai, Jingchao Li, Benjamin Thompson, Win-Kuang Shen, Tong Lu, Hon-Chi Lee
  Diabetes and Vascular Disease Research.2017; 14(4): 353.     CrossRef
• Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy
  Junlian Gu, Yanli Cheng, Hao Wu, Lili Kong, Shudong Wang, Zheng Xu, Zhiguo Zhang, Yi Tan, Bradley B. Keller, Honglan Zhou, Yuehui Wang, Zhonggao Xu, Lu Cai
  Diabetes.2017; 66(2): 529.     CrossRef
• Kimchi methanol extracts attenuate hepatic steatosis induced by high cholesterol diet in low-density lipoprotein receptor knockout mice through inhibition of endoplasmic reticulum stress
  Minji Woo, Mijeong Kim, Jeong Sook Noh, Yeong Ok Song
  Journal of Functional Foods.2017; 32: 218.     CrossRef
• Aspalathin Protects the Heart against Hyperglycemia-Induced Oxidative Damage by Up-Regulating Nrf2 Expression
  Phiwayinkosi Dludla, Christo Muller, Elizabeth Joubert, Johan Louw, M. Essop, Kwazi Gabuza, Samira Ghoor, Barbara Huisamen, Rabia Johnson
  Molecules.2017; 22(1): 129.     CrossRef
• Intermittent hypoxia-induced cardiomyopathy and its prevention by Nrf2 and metallothionein
  Shanshan Zhou, Xia Yin, Jingpeng Jin, Yi Tan, Daniel J. Conklin, Ying Xin, Zhiguo Zhang, Weixia Sun, Taixing Cui, Jun Cai, Yang Zheng, Lu Cai
  Free Radical Biology and Medicine.2017; 112: 224.     CrossRef
• Inhibitory effects of rosmarinic acid on pterygium epithelial cells through redox imbalance and induction of extrinsic and intrinsic apoptosis
  Ya-Yu Chen, Chia-Fang Tsai, Ming-Chu Tsai, Yu-Wen Hsu, Fung-Jou Lu
  Experimental Eye Research.2017; 160: 96.     CrossRef
• Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus
  Anne Lejay, Fei Fang, Rohan John, Julie A.D. Van, Meredith Barr, Fabien Thaveau, Nabil Chakfe, Bernard Geny, James W. Scholey
  Journal of Molecular and Cellular Cardiology.2016; 91: 11.     CrossRef
• The Role of the Nrf2/ARE Antioxidant System in Preventing Cardiovascular Diseases
  Robert Smith, Kevin Tran, Cynthia Smith, Miranda McDonald, Pushkar Shejwalkar, Kenji Hara
  Diseases.2016; 4(4): 34.     CrossRef
• Prohibitin overexpression improves myocardial function in diabetic cardiomyopathy
  Wen-qian Dong, Min Chao, Qing-hua Lu, Wei-li Chai, Wei Zhang, Xue-ying Chen, Er-shun Liang, Ling-bo Wang, Hong-liang Tian, Yu-guo Chen, Ming-xiang Zhang
  Oncotarget.2016; 7(1): 66.     CrossRef
• Restoration of Nrf2 Signaling Normalizes the Regenerative Niche
  Marc A. Soares, Oriana D. Cohen, Yee Cheng Low, Rita A. Sartor, Trevor Ellison, Utkarsh Anil, Lavinia Anzai, Jessica B. Chang, Pierre B. Saadeh, Piul S. Rabbani, Daniel J. Ceradini
  Diabetes.2016; 65(3): 633.     CrossRef
• Myocardial transcription factors in diastolic dysfunction: clues for model systems and disease
  Alexander T. Mikhailov, Mario Torrado
  Heart Failure Reviews.2016; 21(6): 783.     CrossRef
• Antioxidant Properties of Whole Body Periodic Acceleration (pGz)
  Arkady Uryash, Jorge Bassuk, Paul Kurlansky, Francisco Altamirano, Jose R. Lopez, Jose A. Adams, Guillermo López Lluch
  PLOS ONE.2015; 10(7): e0131392.     CrossRef
• Mulberry leaves (Morus alba L.) ameliorate obesity-induced hepatic lipogenesis, fibrosis, and oxidative stress in high-fat diet-fed mice
  Ji-Young Ann, Hyeyoon Eo, Yunsook Lim
  Genes & Nutrition.2015;[Epub]     CrossRef
• Oxidative Stress and Human Hypertension: Vascular Mechanisms, Biomarkers, and Novel Therapies
  Augusto C. Montezano, Maria Dulak-Lis, Sofia Tsiropoulou, Adam Harvey, Ana M. Briones, Rhian M. Touyz
  Canadian Journal of Cardiology.2015; 31(5): 631.     CrossRef
• Haeme oxygenase signalling pathway: implications for cardiovascular disease
  Laura E. Fredenburgh, Allison A. Merz, Susan Cheng
  European Heart Journal.2015; 36(24): 1512.     CrossRef

As the prevalence of diabetes mellitus is substantially increasing worldwide, associated diseases such as renal failure, cardiovascular diseases, fatty liver, and cancers have also increased. A number of cancers such as pancreatic, liver, breast, and female reproductive cancers have shown an increased prevalence and a higher mortality rate in diabetic patients compared to healthy subjects. Thus, this suggests an association between diabetes, especially type 2 diabetes and cancer incidence and progression. Recent studies have suggested that hyperinsulinemia, chronic inflammation and hyperglycemia, all frequently seen in diabetics, may lead to increased tumor growth; the underlying molecular mechanisms of this association are not fully understood. In particular, chronic hyperglycemic episodes could serve as a direct or indirect mediator of the increase in tumor cell growth. Here, we will discuss our current understanding how hyperglycemia and cancer risk may be linked, and what the implications are for the treatment of diabetic cancer patients.

Citations

Citations to this article as recorded by  

• Enhanced degradation of epidermal growth factor receptor by metformin
  Mayuka Yamagata, Sen Higashi, Noboru Yaida, Akane Ichihara, Manabu Habu, Masaaki Sasaguri, Kazuhiro Tominaga, Hiroshi Takeuchi
  Oral Science International.2024; 21(1): 59.     CrossRef
• Development and Validation of a Fluorogenic Probe for Lysosomal Zinc Release
  Adarash Kumar Shukla, Ashutosh Mahale, Savita Choudhary, Pravesh Sharma, Onkar Prakash Kulkarni, Anupam Bhattacharya
  ChemBioChem.2024;[Epub]     CrossRef
• Type 2 diabetes, glycaemic traits and upper gastrointestinal cancer risk: a prospective cohort study
  Luyao Cao, Tianpei Wang, Huizhang Li, Fadoua El Hafa, Xia Zhu, Yuhui Yu, Caiwang Yan, Lingbin Du, Meng Zhu, Guangfu Jin
  Journal of Epidemiology and Community Health.2024; 78(3): 145.     CrossRef
• Extrahepatic malignancies in metabolic dysfunction‐associated fatty liver disease: A nationwide cohort study
  Min Kyung Park, Moon Haeng Hur, Hye‐Sung Moon, Hyunjae Shin, Sung Won Chung, Sungho Won, Yun Bin Lee, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Jung‐Hwan Yoon, Yoon Jun Kim
  Liver International.2024; 44(3): 799.     CrossRef
• Effects of the Mediterranean Diet on metabolic indices and quality of life in cancer patients: A systematic review and meta-analysis of randomized controlled trials
  Shuai Lu, Xibo Sun, Weihao Zhang, Xiangqi Li, Zhongbao Zhou, Ruixue Xiao, Qingchen Lv, Huazhen Tang, Bing Wang, Jinxiu Qu, Rui Cao, Jia He, Shiwan Wang, Penghui Yang, Zhenpeng Yang, Benqiang Rao
  Journal of Functional Foods.2024; 114: 106074.     CrossRef
• M1-derived extracellular vesicles polarize recipient macrophages into M2-like macrophages and alter skeletal muscle homeostasis in a hyper-glucose environment
  Stefano Tacconi, Francesco Vari, Carolina Sbarigia, Diana Vardanyan, Serena Longo, Francesco Mura, Federica Angilè, Audrey Jalabert, Ferninand Blangero, Assia Eljaafari, Laurence Canaple, Daniele Vergara, Francesco Paolo Fanizzi, Marco Rossi, Claire Crola
  Cell Communication and Signaling.2024;[Epub]     CrossRef
• The complex landscape of intracellular signalling in protein modification under hyperglycaemic stress leading to metabolic disorders
  Hamda Khan, Afreen Khanam, Adnan Ahmad Khan, Rizwan Ahmad, Arbab Husain, Safia Habib, Saheem Ahmad, Moinuddin
  The Protein Journal.2024;[Epub]     CrossRef
• Nuclear translocation of metabolic enzyme PKM2 participates in high glucose-promoted HCC metastasis by strengthening immunosuppressive environment
  Jiali Qian, Chuxin Huang, Mimi Wang, Ying Liu, Yingying Zhao, Miao Li, Xi Zhang, Xiangyu Gao, Yawen Zhang, Yi Wang, Jinya Huang, Jiajun Li, Qiwen Zhou, Rui Liu, Xuanchun Wang, Jiefeng Cui, Yehong Yang
  Redox Biology.2024; 71: 103103.     CrossRef
• Macrophages, IL-10, and nitric oxide increase, induced by hyperglycemic conditions, impact the development of murine melanoma B16F10-Nex2
  Tarciso A. Sellani, Samanta L. Tomaz, Jéssica M. Gonçalves, Adriana Lima, Carolina C. de Amat Herbozo, Gabrielli N. Silva, Mônica Gambero, Ieda M. Longo-Maugéri, Karin A. Simon, Hugo P. Monteiro, Elaine G. Rodrigues
  Nitric Oxide.2024; 148: 1.     CrossRef
• Designing of potent anti-diabetic molecules by targeting SIK2 using computational approaches
  Prajisha Jayaprakash, Jayashree Biswal, Raghu Rangaswamy, Jeyaraman Jeyakanthan
  Molecular Diversity.2023; 27(3): 1101.     CrossRef
• Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects
  Mariam Farrag, Djedjiga Ait Eldjoudi, María González-Rodríguez, Alfonso Cordero-Barreal, Clara Ruiz-Fernández, Maurizio Capuozzo, Miguel Angel González-Gay, Antonio Mera, Francisca Lago, Ahmed Soffar, Amina Essawy, Jesus Pino, Yousof Farrag, Oreste Gualil
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• HIPK2 as a Novel Regulator of Fibrosis
  Alessia Garufi, Giuseppa Pistritto, Gabriella D’Orazi
  Cancers.2023; 15(4): 1059.     CrossRef
• Cancer—A Pragmatic Switch to Combat Metabolic Syndrome?
  John Claras
  Oncology Reviews.2023;[Epub]     CrossRef
• Could Vaspin Be a Potential Diagnostic Marker in Endometrial Cancer?
  Dominika Pietrzyk, Piotr Tkacz, Mateusz Kozłowski, Sebastian Kwiatkowski, Małgorzata Rychlicka, Ewa Pius-Sadowska, Bogusław Machaliński, Aneta Cymbaluk-Płoska
  International Journal of Environmental Research and Public Health.2023; 20(6): 4999.     CrossRef
• Diabetes and Cancer
  Jae Won Hong
  The Journal of Korean Diabetes.2023; 24(1): 12.     CrossRef
• The Sweet Side of HIPK2
  Alessia Garufi, Valerio D’Orazi, Giuseppa Pistritto, Mara Cirone, Gabriella D’Orazi
  Cancers.2023; 15(10): 2678.     CrossRef
• Glucose-induced CRL4COP1-p53 axis amplifies glycometabolism to drive tumorigenesis
  Yang Su, Yifan Luo, Peitao Zhang, Hong Lin, Weijie Pu, Hongyun Zhang, Huifang Wang, Yi Hao, Yihang Xiao, Xiaozhe Zhang, Xiayun Wei, Siyue Nie, Keren Zhang, Qiuyu Fu, Hao Chen, Niu Huang, Yan Ren, Mingxuan Wu, Billy Kwok Chong Chow, Xing Chen, Wenfei Jin,
  Molecular Cell.2023; 83(13): 2316.     CrossRef
• SGLT2 Inhibitors as Potential Anticancer Agents
  Debasish Basak, David Gamez, Subrata Deb
  Biomedicines.2023; 11(7): 1867.     CrossRef
• Diabetes mellitus and cancer
  Jae Won Hong
  Cardiovascular Prevention and Pharmacotherapy.2023; 5(3): 69.     CrossRef
• Risk Factors of Renal Cell Carcinoma
  云治 秦
  Medical Diagnosis.2023; 13(03): 335.     CrossRef
• The Role of Meteorin-Like Peptide and Asprosin in Colon Carcinoma
  Elif Onat, Nevin Kocaman, Hilal Balta
  Cureus.2023;[Epub]     CrossRef
• Diabetes-associated breast cancer is molecularly distinct and shows a DNA damage repair deficiency
  Gatikrushna Panigrahi, Julián Candia, Tiffany H. Dorsey, Wei Tang, Yuuki Ohara, Jung S. Byun, Tsion Zewdu Minas, Amy Zhang, Anuoluwapo Ajao, Ashley Cellini, Harris G. Yfantis, Amy L. Flis, Dean Mann, Olga Ioffe, Xin W. Wang, Huaitian Liu, Christopher A. L
  JCI Insight.2023;[Epub]     CrossRef
• The classification of obesity based on metabolic status redefines the readmission of non-Hodgkin’s lymphoma—an observational study
  Hang Dong, Honglin Guo, Jing Du, Yiping Cheng, Dawei Wang, Junming Han, Zinuo Yuan, Zhenyu Yao, Ran An, Xiaoqin Wu, Kyle L. Poulsen, Zhixiang Wang, Shanshan Shao, Xiude Fan, Zhen Wang, Jiajun Zhao
  Cancer & Metabolism.2023;[Epub]     CrossRef
• Dose‐dependent effects of aerobic exercise on clinically relevant biomarkers among healthy women at high genetic risk for breast cancer: A secondary analysis of a randomized controlled study
  Christopher J. Ehret, Shouhao Zhou, Julia C. Tchou, Kathryn H. Schmitz, Kathleen M. Sturgeon
  Cancer Reports.2022;[Epub]     CrossRef
• Do diabetic complications influence cancer-related events in people with type 2 diabetes? A cohort approach
  Evelyne Liuu, Pierre-Jean Saulnier, Elise Gand, Gautier Defossez, Amélie Jamet, Stéphanie Ragot, Marc Paccalin, Samy Hadjadj
  Diabetes & Metabolism.2022; 48(2): 101289.     CrossRef
• Unraveling the Role of STK11/LKB1 in Non-small Cell Lung Cancer
  Vikram Sumbly, Ian Landry
  Cureus.2022;[Epub]     CrossRef
• Impact of Diabetes Mellitus and Its Comorbidities on Elderly Patients Hospitalized in Internal Medicine Wards: Data from the RePoSi Registry
  Christiano Argano, Giuseppe Natoli, Salvatore Mularo, Alessandro Nobili, Marika Lo Monaco, Pier Mannuccio Mannucci, Francesco Perticone, Antonello Pietrangelo, Salvatore Corrao
  Healthcare.2022; 10(1): 86.     CrossRef
• Type 2 Diabetes and Risk of Early-Onset Colorectal Cancer
  Zitong Li, Hanyu Chen, Cassandra D.L. Fritz, Xiaobin Zheng, Xiaoyu Zong, Katelin B. Nickel, Andrew Tipping, Long H. Nguyen, Andrew T. Chan, Edward L. Giovannucci, Graham A. Colditz, Margaret A. Olsen, Peter T. Campbell, Nicholas O. Davidson, Ryan C. Field
  Gastro Hep Advances.2022; 1(2): 186.     CrossRef
• Metformin Downregulates the Expression of Epidermal Growth Factor Receptor Independent of Lowering Blood Glucose in Oral Squamous Cell Carcinoma
  Wei-Ming Wang, Si-Si Yang, Shu-Hui Shao, Huan-Quan Nie, Jing Zhang, Tong Su
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Exploring the Impact of the Obesity Paradox on Lung Cancer and Other Malignancies
  Lindsay Joyce Nitsche, Sarbajit Mukherjee, Kareena Cheruvu, Cathleen Krabak, Rohit Rachala, Kalyan Ratnakaram, Priyanka Sharma, Maddy Singh, Sai Yendamuri
  Cancers.2022; 14(6): 1440.     CrossRef
• Modern lifestyle, stress and metabolism: possible risk factors for oral carcinogenesis in the young generation
  Monal Yuwanati, Sachin C Sarode, Amol Gadbail, Shailesh Gondivkar, Gargi Sarode
  Future Oncology.2022; 18(15): 1801.     CrossRef
• Effects of In Vitro Digestion on Anti-α-Amylase and Cytotoxic Potentials of Sargassum spp.
  Sovannary Un, Nguyen Van Quan, La Hoang Anh, Vu Quang Lam, Akiyoshi Takami, Tran Dang Khanh, Tran Dang Xuan
  Molecules.2022; 27(7): 2307.     CrossRef
• Consumption of “Diabetes Risk Reduction Diet” and Odds of Breast Cancer Among Women in a Middle Eastern Country
  Sara Ebrahimi Mousavi, Amir Bagheri, Sanaz Benisi-Kohansal, Leila Azadbakht, Ahmad Esmaillzadeh
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• Fasting Insulin and Risk of Overall and 14 Site-Specific Cancers: Evidence From Genetic Data
  Han Zhang, Doudou Li, Xiaozhuan Liu, Zhongxiao Wan, Zengli Yu, Yuming Wang, Xue Li
  Frontiers in Oncology.2022;[Epub]     CrossRef
• A Nutritional Metabolism Related Prognostic Scoring System for Patients With Newly Diagnosed Osteosarcoma
  Longqing Li, Zhuangzhuang Li, Xuanhong He, Yang Wang, Minxun Lu, Taojun Gong, Qing Chang, Jingqi Lin, Yi Luo, Li Min, Yong Zhou, Chongqi Tu
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• Review of Mendelian Randomization Studies on Endometrial Cancer
  Jian-Zeng Guo, Qi-Jun Wu, Fang-Hua Liu, Chang Gao, Ting-Ting Gong, Gang Li
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• PROBLEMS AND EDUCATIONAL NEEDS RELATED TO PORT CATHETER IN CANCER PATIENTS
  Mehmet Zeki AVCI, Sevda ŞAHİN, Betülay KILIÇ, Hatice SUTCU CICEK
  İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi.2022; 10(3): 849.     CrossRef
• Association of Physical Activity and Sedentary Behavior With the Risk of Colorectal Cancer
  Sanghyun An, Sungjin Park
  Journal of Korean Medical Science.2022;[Epub]     CrossRef
• Sleep Disruption and Cancer: Chicken or the Egg?
  Adrian Berisha, Kyle Shutkind, Jeremy C. Borniger
  Frontiers in Neuroscience.2022;[Epub]     CrossRef
• Role of anti-angiogenic factors in the pathogenesis of breast cancer: A review of therapeutic potential
  Liwei Ruan, Songou Zhang, Xiaozhen Chen, Wenqing Liang, Qiong Xie
  Pathology - Research and Practice.2022; 236: 153956.     CrossRef
• Cancer-cell-secreted extracellular vesicles suppress insulin secretion through miR-122 to impair systemic glucose homeostasis and contribute to tumour growth
  Minghui Cao, Roi Isaac, Wei Yan, Xianhui Ruan, Li Jiang, Yuhao Wan, Jessica Wang, Emily Wang, Christine Caron, Steven Neben, Denis Drygin, Donald P. Pizzo, Xiwei Wu, Xuxiang Liu, Andrew R. Chin, Miranda Y. Fong, Ziting Gao, Kaizhu Guo, Oluwole Fadare, Ric
  Nature Cell Biology.2022; 24(6): 954.     CrossRef
• Association between haemoglobin A1c and all-cause and cause-specific mortality in middle-aged and older Koreans: a prospective cohort study
  Bo Mi Song, Jung Hyun Lee, Hae Dong Woo, Mi Jin Cho, Sung Soo Kim
  Nutrition & Metabolism.2022;[Epub]     CrossRef
• Antidiabetic and antiradical effects of Garcinia kola seeds in dexamethasone-induced hyperglycemic rats
  BarnabéLucien Nkono Ya Nkono, Ablassé Rouamba, McJesus Kinyok, JeanGuy Stéphane, BalthazarTchouanka Tcheudi, BenjaminArnaud Tigui, PaulD Djomeni Dzeufiet, SélestinDongmo Sokeng, Pierre Kamtchouing
  International Journal of Applied and Basic Medical Research.2022; 12(3): 203.     CrossRef
• The “Diabetes Comorbidome”: A Different Way for Health Professionals to Approach the Comorbidity Burden of Diabetes
  Salvatore Corrao, Giuseppe Natoli, Alessandro Nobili, Pier Mannucci, Francesco Perticone, Vincenzo Arcoraci, Christiano Argano
  Healthcare.2022; 10(8): 1459.     CrossRef
• New insights into the prognosis of intraocular malignancy: Interventions for association mechanisms between cancer and diabetes
  Lingwen Gu, Guofeng Ma, Cui Li, Jing Lin, Guiqiu Zhao
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Glucose deprivation reduces proliferation and motility, and enhances the anti-proliferative effects of paclitaxel and doxorubicin in breast cell lines in vitro
  Maitham A. Khajah, Sarah Khushaish, Yunus A. Luqmani, Yi-Hsien Hsieh
  PLOS ONE.2022; 17(8): e0272449.     CrossRef
• Chronic hyperglycemia based on diabetes is independently associated with decreased survival in patients with advanced cancer treated with immune checkpoint inhibitors
  Emre Yekedüz, Elif Berna Köksoy, Sati Coşkun Yazgan, Göktürk Karataş, Filiz Çay Şenler, Güngör Utkan, Hakan Akbulut, Ahmet Demirkazik, Yüksel Ürün
  Anti-Cancer Drugs.2022; 33(10): 1145.     CrossRef
• HIF-1α Expression Increases Preoperative Concurrent Chemoradiotherapy Resistance in Hyperglycemic Rectal Cancer
  Yi-Jung Huang, Yi-Ting Chen, Chun-Ming Huang, Shih-Hsun Kuo, Yan-You Liao, Wun-Ya Jhang, Shuo-Hung Wang, Chien-Chih Ke, Yu-Hsiang Huang, Chiu-Min Cheng, Ming-Yii Huang, Chih-Hung Chuang
  Cancers.2022; 14(16): 4053.     CrossRef
• Multifaceted entrancing role of glucose and its analogue, 2-deoxy-D-glucose in cancer cell proliferation, inflammation, and virus infection
  Sananda Dey, Nensina Murmu, Tanushree Mondal, Ishita Saha, Soumendranath Chatterjee, Rahul Manna, Subhash Haldar, Sandeep K. Dash, Tapasree Roy Sarkar, Biplab Giri
  Biomedicine & Pharmacotherapy.2022; 156: 113801.     CrossRef
• Evaluation of Tissue Expression of Vaspin and Serum Vaspin Concentration as a Prognostic and Risk Factor in Endometrial Cancer
  Mateusz Kozłowski, Dominika Pietrzyk, Małgorzata Rychlicka, Katarzyna Piotrowska, Katarzyna Nowak, Sebastian Kwiatkowski, Aneta Cymbaluk-Płoska
  Cells.2022; 11(20): 3196.     CrossRef
• Exploring the role of neutrophil-to-lymphocyte ratio and blood chemistry in head and neck adenoid cystic carcinomas treated with carbon ion radiotherapy
  Amelia Barcellini, Giulia Fontana, Daria Maria Filippini, Sara Ronchi, Maria Bonora, Barbara Vischioni, Rossana Ingargiola, Anna Maria Camarda, Pierre Loap, Nadia Facchinetti, Lisa Licitra, Guido Baroni, Ester Orlandi
  Radiotherapy and Oncology.2022; 177: 143.     CrossRef
• Diabetic hyperglycemia promotes primary tumor progression through glycation-induced tumor extracellular matrix stiffening
  Wenjun Wang, Lauren A. Hapach, Lauren Griggs, Kyra Smart, Yusheng Wu, Paul V. Taufalele, Matthew M. Rowe, Katherine M. Young, Madison E. Bates, Andrew C. Johnson, Nicholas J. Ferrell, Ambra Pozzi, Cynthia A. Reinhart-King
  Science Advances.2022;[Epub]     CrossRef
• The Relationship between Type 2 Diabetes Mellitus with the Occurrence and Progression of Prostate Cancer
  树森 贾
  Advances in Clinical Medicine.2022; 12(11): 10748.     CrossRef
• Palliative urinary diversion in patients with malignant ureteric obstruction due to gynaecological cancer
  Tamar Perri, Elad Meller, Gilad Ben-Baruch, Yael Inbar, Sara Apter, Lee Heyman, Zohar Dotan, Jacob Korach
  BMJ Supportive & Palliative Care.2022; 12(e6): e855.     CrossRef
• Onkodiabetológia I.
  Róbert János Bánhegyi, Andrea Gazdag, Beatrix Rácz, Szilvia Beke, Norbert Fülöp
  Orvosi Hetilap.2022; 163(39): 1535.     CrossRef
• AGE-RAGE synergy influences programmed cell death signaling to promote cancer
  Bhargav N. Waghela, Foram U. Vaidya, Kishu Ranjan, Abu Sufiyan Chhipa, Budhi Sagar Tiwari, Chandramani Pathak
  Molecular and Cellular Biochemistry.2021; 476(2): 585.     CrossRef
• Diabetes mellitus and oral cancer/oral potentially malignant disorders: A systematic review and meta‐analysis
  Pablo Ramos‐Garcia, Maria del Mar Roca‐Rodriguez, Manuel Aguilar‐Diosdado, Miguel Angel Gonzalez‐Moles
  Oral Diseases.2021; 27(3): 404.     CrossRef
• High pre-operative fasting blood glucose levels predict a poor prognosis in patients with pancreatic neuroendocrine tumour
  Yitao Gong, Zhiyao Fan, Pin Zhang, Yunzhen Qian, Qiuyi Huang, Shengming Deng, Guopei Luo, He Cheng, Kaizhou Jin, Quanxing Ni, Xianjun Yu, Chen Liu
  Endocrine.2021; 71(2): 494.     CrossRef
• Thrombospondin‐4 mediates hyperglycemia‐ and TGF‐beta‐induced inflammation in breast cancer
  Santoshi Muppala, Roy Xiao, Jasmine Gajeton, Irene Krukovets, Dmitriy Verbovetskiy, Olga Stenina‐Adognravi
  International Journal of Cancer.2021; 148(8): 2010.     CrossRef
• The predictive power of CD3+ T cell infiltration of oral squamous cell tumors is limited to non-diabetic patients
  Gerrit Spanier, Ines Ugele, Felix Nieberle, Luisa Symeou, Sandra Schmidhofer, Almut Brand, Johannes Meier, Steffen Spoerl, Rosemarie Krupar, Petra Rümmele, Peter Siska, Kathrin Renner, Katrin Peter, Michael Gerken, Philipp Beckhove, Torsten E. Reichert, M
  Cancer Letters.2021; 499: 209.     CrossRef
• Contribution of RAGE axis activation to the association between metabolic syndrome and cancer
  Ma. Eugenia Garay-Sevilla, Armando Gomez-Ojeda, Ileana González, Claudia Luévano-Contreras, Armando Rojas
  Molecular and Cellular Biochemistry.2021; 476(3): 1555.     CrossRef
• PKC Regulates YAP Expression through Alternative Splicing of YAP 3′UTR Pre-mRNA by hnRNP F
  Wing-Keung Chu, Li-Man Hung, Chun-Wei Hou, Jan-Kan Chen
  International Journal of Molecular Sciences.2021; 22(2): 694.     CrossRef
• The Taming of Nuclear Factor Erythroid-2-Related Factor-2 (Nrf2) Deglycation by Fructosamine-3-Kinase (FN3K)-Inhibitors-A Novel Strategy to Combat Cancers
  Narasimha M. Beeraka, Venugopal R. Bovilla, Shalini H. Doreswamy, Sujatha Puttalingaiah, Asha Srinivasan, SubbaRao V. Madhunapantula
  Cancers.2021; 13(2): 281.     CrossRef
• Body Habitus Across the Lifespan and Risk of Pituitary Adenoma
  David J Cote, Timothy R Smith, Ursula B Kaiser, Edward R Laws, Meir J Stampfer
  The Journal of Clinical Endocrinology & Metabolism.2021; 106(4): 1591.     CrossRef
• Dairy Consumption and Incidence of Breast Cancer in the ‘Seguimiento Universidad de Navarra’ (SUN) Project
  Inmaculada Aguilera-Buenosvinos, Cesar Ignacio Fernandez-Lazaro, Andrea Romanos-Nanclares, Alfredo Gea, Rodrigo Sánchez-Bayona, Jose M. Martín-Moreno, Miguel Ángel Martínez-González, Estefanía Toledo
  Nutrients.2021; 13(2): 687.     CrossRef
• Hyperglycemia-Induced miR-467 Drives Tumor Inflammation and Growth in Breast Cancer
  Jasmine Gajeton, Irene Krukovets, Santoshi Muppala, Dmitriy Verbovetskiy, Jessica Zhang, Olga Stenina-Adognravi
  Cancers.2021; 13(6): 1346.     CrossRef
• Prevalent diabetes and risk of total, colorectal, prostate and breast cancers in an ageing population: meta-analysis of individual participant data from cohorts of the CHANCES consortium
  Amina Amadou, Heinz Freisling, Mazda Jenab, Konstantinos K. Tsilidis, Antonia Trichopoulou, Paolo Boffetta, Bethany Van Guelpen, Olatz Mokoroa, Tom Wilsgaard, Frank Kee, Ben Schöttker, José M. Ordóñez-Mena, Satu Männistö, Stefan Söderberg, Roel C. H. Verm
  British Journal of Cancer.2021; 124(11): 1882.     CrossRef
• Preexisting Type 2 Diabetes and Survival among Patients with Colorectal Cancer
  Chen Yuan, Xuehong Zhang, Ana Babic, Vicente Morales-Oyarvide, Yin Zhang, Stephanie A. Smith-Warner, Kana Wu, Molin Wang, Brian M. Wolpin, Jeffrey A. Meyerhardt, Andrew T. Chan, Frank B. Hu, Charles S. Fuchs, Shuji Ogino, Edward L. Giovannucci, Kimmie Ng
  Cancer Epidemiology, Biomarkers & Prevention.2021; 30(4): 757.     CrossRef
• Food anticipatory hormonal responses: A systematic review of animal and human studies
  Aleksandrina Skvortsova, Dieuwke S. Veldhuijzen, Iris E.M. Kloosterman, Gustavo Pacheco-López, Andrea W.M. Evers
  Neuroscience & Biobehavioral Reviews.2021; 126: 447.     CrossRef
• Gut Microbiota and Gynecological Cancers: A Summary of Pathogenetic Mechanisms and Future Directions
  Fulvio Borella, Andrea Roberto Carosso, Stefano Cosma, Mario Preti, Giammarco Collemi, Paola Cassoni, Luca Bertero, Chiara Benedetto
  ACS Infectious Diseases.2021; 7(5): 987.     CrossRef
• Diabetes and Cancer: Metabolic Association, Therapeutic Challenges, and the Role of Natural Products
  Wamidh H. Talib, Asma Ismail Mahmod, Sara Feras. Abuarab, Eliza Hasen, Amer A. Munaim, Shatha Khaled Haif, Amani Marwan Ayyash, Samar Khater, Intisar Hadi AL-Yasari, Lina T. Al Kury
  Molecules.2021; 26(8): 2179.     CrossRef
• Diabetes increases the risk of meningioma: A systematic review and meta-analysis of observational studies
  Dongjie Shi, Lei Ao, Hua Yu, Juan Li, Yongzhi Xia, Xuedong Wu, Dahai He, Wenjie Zhong, Haijian Xia
  Cancer Epidemiology.2021; 73: 101946.     CrossRef
• High glucose: an emerging association between diabetes mellitus and cancer progression
  Suangson Supabphol, Wunchana Seubwai, Sopit Wongkham, Charupong Saengboonmee
  Journal of Molecular Medicine.2021; 99(9): 1175.     CrossRef
• Normalizing glucose levels reconfigures the mammary tumor immune and metabolic microenvironment and decreases metastatic seeding
  Heba Allah M. Alsheikh, Brandon J. Metge, Chae‐Myeong Ha, Dominique C. Hinshaw, Mateus S.V. Mota, Sarah C. Kammerud, Tshering Lama-Sherpa, Noha Sharafeldin, Adam R. Wende, Rajeev S. Samant, Lalita A. Shevde
  Cancer Letters.2021; 517: 24.     CrossRef
• The prognostic outcome of ‘type 2 diabetes mellitus and breast cancer’ association pivots on hypoxia-hyperglycemia axis
  Ilhaam Ayaz Durrani, Attya Bhatti, Peter John
  Cancer Cell International.2021;[Epub]     CrossRef
• Insulin-like Growth Factor 2 mRNA-Binding Protein 2—a Potential Link Between Type 2 Diabetes Mellitus and Cancer
  Junguo Cao, Weijia Yan, Xiujian Ma, Haiyan Huang, Hong Yan
  The Journal of Clinical Endocrinology & Metabolism.2021; 106(10): 2807.     CrossRef
• Fatty acid synthase mediates high glucose‐induced EGFR activation in oral dysplastic keratinocytes
  David J. Wisniewski, Tao Ma, Abraham Schneider
  Journal of Oral Pathology & Medicine.2021; 50(9): 919.     CrossRef
• Moringa Oleifera Seed Extract Concomitantly Supplemented with Chemotherapy Worsens Tumor Progression in Mice with Triple Negative Breast Cancer and Obesity
  Elizabeth R. M. Zunica, Shengping Yang, Ann Coulter, Christy White, John P. Kirwan, Linda A. Gilmore
  Nutrients.2021; 13(9): 2923.     CrossRef
• Investigation of Causal Effect of Type 2 Diabetes Mellitus on Lung Cancer: A Mendelian Randomization Study
  Tongtong Hong, Na Qin, Xiaoyu Zhao, Cheng Wang, Yue Jiang, Hongxia Ma, Juncheng Dai
  Frontiers in Genetics.2021;[Epub]     CrossRef
• Glucose Intolerance and Cancer Risk: A Community-Based Prospective Cohort Study in Shanghai, China
  Juzhong Ke, Tao Lin, Xiaolin Liu, Kang Wu, Xiaonan Ruan, Yibo Ding, Wenbin Liu, Hua Qiu, Xiaojie Tan, Xiaonan Wang, Xi Chen, Zhitao Li, Guangwen Cao
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Hyperglycemic conditions proliferate triple negative breast cancer cells: role of ornithine decarboxylase
  Caleb C. Capellen, Jose Ortega-Rodas, M. Jane Morwitzer, Hadassha M. N. Tofilau, Matthew Dunworth, Robert A. Casero, Surabhi Chandra
  Breast Cancer Research and Treatment.2021; 190(2): 255.     CrossRef
• Diabetes Mellitus and Obesity as Risk Factors for Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis
  Yu Lu, Jing Tao
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Breast cancer growth and proliferation is suppressed by the mitochondrial targeted furazano[3,4-b]pyrazine BAM15
  Elizabeth R. M. Zunica, Christopher L. Axelrod, Eunhan Cho, Guillaume Spielmann, Gangarao Davuluri, Stephanie J. Alexopoulos, Martina Beretta, Kyle L. Hoehn, Wagner S. Dantas, Krisztian Stadler, William T. King, Kathryn Pergola, Brian A. Irving, Ingeborg
  Cancer & Metabolism.2021;[Epub]     CrossRef
• How cancer cells remodel lipid metabolism: strategies targeting transcription factors
  Do-Won Jeong, Seulbee Lee, Yang-Sook Chun
  Lipids in Health and Disease.2021;[Epub]     CrossRef
• Diabetes and Colorectal Cancer Risk: A New Look at Molecular Mechanisms and Potential Role of Novel Antidiabetic Agents
  Jelena Vekic, Aleksandra Zeljkovic, Aleksandra Stefanovic, Rosaria Vincenza Giglio, Marcello Ciaccio, Manfredi Rizzo
  International Journal of Molecular Sciences.2021; 22(22): 12409.     CrossRef
• Diet and Obesity-Induced Methylglyoxal Production and Links to Metabolic Disease
  Carlos Hernandez-Castillo, Sarah C. Shuck
  Chemical Research in Toxicology.2021; 34(12): 2424.     CrossRef
• Оцінка прогнозованого ризику онкологічних захворювань у хворих на цукровий діабет 2-го типу
  T.S. Vatseba, L.K. Sokolova, N.M. Koshel
  INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2021; 17(1): 86.     CrossRef
• Can novel adipokines, asprosin and meteorin-like, be biomarkers for malignant mesothelioma?
  N. Kocaman, G. Artaş
  Biotechnic & Histochemistry.2020; 95(3): 171.     CrossRef
• Metformin attenuates adhesion between cancer and endothelial cells in chronic hyperglycemia by recovery of the endothelial glycocalyx barrier
  Marta Targosz-Korecka, Katarzyna Ewa Malek-Zietek, Damian Kloska, Zenon Rajfur, Ewa Łucja Stepien, Anna Grochot-Przeczek, Marek Szymonski
  Biochimica et Biophysica Acta (BBA) - General Subjects.2020; 1864(4): 129533.     CrossRef
• Mitigation of Glucolipotoxicity-Induced Apoptosis, Mitochondrial Dysfunction, and Metabolic Stress by N-Acetyl Cysteine in Pancreatic β-Cells
  Arwa Alnahdi, Annie John, Haider Raza
  Biomolecules.2020; 10(2): 239.     CrossRef
• Antitumour Property ofPterocarpus santalinusSeeds Against DMBA-Induced Breast Cancer in Rats
  Vivek Akhouri, Arun Kumar, Manorma Kumari
  Breast Cancer: Basic and Clinical Research.2020; 14: 117822342095119.     CrossRef
• Sensitization of hepatocellular carcinoma cells towards doxorubicin and sorafenib is facilitated by glucose-dependent alterations in reactive oxygen species, P-glycoprotein and DKK4
  Surbhi Chouhan, Snahlata Singh, Dipti Athavale, Pranay Ramteke, Muralidharan Vanuopadath, Bipin G Nair, Sudarslal Sadasivan Nair, Manoj Kumar Bhat
  Journal of Biosciences.2020;[Epub]     CrossRef
• IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells
  Rehanna Mansor, Jeff Holly, Rachel Barker, Kalina Biernacka, Hanna Zielinska, Anthony Koupparis, Edward Rowe, Jon Oxley, Alex Sewell, Richard M. Martin, Athene Lane, Lucy Hackshaw-McGeagh, Claire Perks
  Oncotarget.2020; 11(26): 2543.     CrossRef
• Doxorubicin delivery by polymer nanocarrier based on N-methylglucamine resorcinarene
  Tatiana Yu. Sergeeva, Rezeda K. Mukhitova, Leysan R. Bakhtiozina, Irek R. Nizameev, Marsil K. Kadirov, Anastasia S. Sapunova, Alexandra D. Voloshina, Albina Y. Ziganshina, Igor S. Antipin
  Supramolecular Chemistry.2020; 32(2): 150.     CrossRef
• Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells
  Samson Mathews Samuel, Elizabeth Varghese, Lenka Koklesová, Alena Líšková, Peter Kubatka, Dietrich Büsselberg
  Cancers.2020; 12(9): 2482.     CrossRef
• Metformin in breast cancer: preclinical and clinical evidence
  Anindita De, Gowthamarajan Kuppusamy
  Current Problems in Cancer.2020; 44(1): 100488.     CrossRef
• The Role of Metabolic Factors in Renal Cancers
  Jacek Rysz, Beata Franczyk, Janusz Ławiński, Robert Olszewski, Anna Gluba-Brzózka
  International Journal of Molecular Sciences.2020; 21(19): 7246.     CrossRef
• Pre-operative dysglycemia is associated with decreased survival in patients with pancreatic neuroendocrine neoplasms
  Marta Sandini, Oliver Strobel, Thomas Hank, Magdalena Lewosinska, Anna Nießen, Thilo Hackert, Markus W. Büchler, Simon Schimmack
  Surgery.2020; 167(3): 575.     CrossRef
• Recent advances in cancer chemoprevention with phytochemicals
  Yen-Chun Koh, Chi-Tang Ho, Min-Hsiung Pan
  Journal of Food and Drug Analysis.2020; 28(1): 14.     CrossRef
• NF-κB and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells
  Charupong Saengboonmee, Chatchai Phoomak, Suangson Supabphol, Kyle R. Covington, Oliver Hampton, Chaisiri Wongkham, Richard A. Gibbs, Kazuo Umezawa, Wunchana Seubwai, Marie-Claude Gingras, Sopit Wongkham
  Life Sciences.2020; 262: 118548.     CrossRef
• The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives
  Bao Quoc Lam, Sushant K. Shrivastava, Anju Shrivastava, Sharmila Shankar, Rakesh K. Srivastava
  Journal of Cellular and Molecular Medicine.2020; 24(14): 7706.     CrossRef
• Chronic Diabetes Complications: The Need to Move beyond Classical Concepts
  Dídac Mauricio, Núria Alonso, Mònica Gratacòs
  Trends in Endocrinology & Metabolism.2020; 31(4): 287.     CrossRef
• O -GlcNAcylation on LATS2 disrupts the Hippo pathway by inhibiting its activity
  Eunah Kim, Jeong Gu Kang, Min Jueng Kang, Jae Hyung Park, Yeon Jung Kim, Tae Hyun Kweon, Han-Woong Lee, Eek‐hoon Jho, Yong-ho Lee, Seung-Il Kim, Eugene C. Yi, Hyun Woo Park, Won Ho Yang, Jin Won Cho
  Proceedings of the National Academy of Sciences.2020; 117(25): 14259.     CrossRef
• Circulating free methylglyoxal as a metabolic tumor biomarker in a rat colon adenocarcinoma model
  Philippe Irigaray, Dominique Belpomme
  Molecular and Clinical Oncology.2020;[Epub]     CrossRef
• Therapeutic effect of Aegle marmelos fruit extract against DMBA induced breast cancer in rats
  Vivek Akhouri, Manorma Kumari, Arun Kumar
  Scientific Reports.2020;[Epub]     CrossRef
• Biomechanical and Biophysical Properties of Breast Cancer Cells Under Varying Glycemic Regimens
  Diganta Dutta, Xavier-Lewis Palmer, Jose Ortega-Rodas, Vasundhara Balraj, Indrani Ghosh Dastider, Surabhi Chandra
  Breast Cancer: Basic and Clinical Research.2020; 14: 117822342097236.     CrossRef
• NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells
  Vincenzo Quagliariello, Michelino De Laurentiis, Stefania Cocco, Giuseppina Rea, Annamaria Bonelli, Antonietta Caronna, Maria Cristina Lombari, Gabriele Conforti, Massimiliano Berretta, Gerardo Botti, Nicola Maurea
  International Journal of Molecular Sciences.2020; 21(20): 7802.     CrossRef
• Glucose Concentration in Cell Culture Medium Influences the BRCA1-Mediated Regulation of the Lipogenic Action of IGF-I in Breast Cancer Cells
  Moses O. Koobotse, Dayane Schmidt, Jeff M. P. Holly, Claire M. Perks
  International Journal of Molecular Sciences.2020; 21(22): 8674.     CrossRef
• Diabetes, Glycated Hemoglobin, and Risk of Cancer in the UK Biobank Study
  Rita Peila, Thomas E. Rohan
  Cancer Epidemiology, Biomarkers & Prevention.2020; 29(6): 1107.     CrossRef
• ASSOCIATION OF IRISIN WITH THE OXIDANT-ANTI OXIDANT PARAMETERS IN TYPE 2 DIABETIC PATIENTS ACCORDING TO AGE IN THI-QAR PROVINCE/ IRAQ
  Saad H. Al-Badry, Khalid G. Al-Fartoosi
  International Journal of Research in Science and Technology.2020; 10(01): 10.     CrossRef
• Metabolomic profiling of blood plasma in patients with primary brain tumours: Basal plasma metabolites correlated with tumour grade and plasma biomarker analysis predicts feasibility of the successful statistical discrimination from healthy subjects – a p
  Eva Baranovičová, Tomáš Galanda, Miroslav Galanda, Jozef Hatok, Branislav Kolarovszki, Romana Richterová, Peter Račay
  IUBMB Life.2019; 71(12): 1994.     CrossRef
• Metformin as an adjuvant in breast cancer treatment
  Mohsin HK Roshan, Yan K Shing, Nikolai P Pace
  SAGE Open Medicine.2019; 7: 205031211986511.     CrossRef
• The added value of fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical cancer patients receiving neoadjuvant chemotherapy followed by radical hysterectomy
  Miao‐Fang Wu, Mei‐Mei Guan, Chang‐Hao Liu, Jie‐Ying Wu, Qun‐Xian Rao, Jing Li
  Cancer Medicine.2019; 8(11): 5068.     CrossRef
• Visit-to-Visit Hemoglobin A1c Variability Is Associated With Later Cancer Development in Patients With Diabetes Mellitus
  Yuki Saito, Hiroshi Noto, Osamu Takahashi, Daiki Kobayashi
  The Cancer Journal.2019; 25(4): 237.     CrossRef
• O-GlcNAcylation of GLI transcription factors in hyperglycemic conditions augments Hedgehog activity
  Shamik Das, Sarah K. Bailey, Brandon J. Metge, Ann Hanna, Dominique C. Hinshaw, Mateus Mota, Andres Forero-Torres, John C. Chatham, Rajeev S. Samant, Lalita A. Shevde
  Laboratory Investigation.2019; 99(2): 260.     CrossRef
• Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment
  Sunghwan Suh, Kwang-Won Kim
  Diabetes & Metabolism Journal.2019; 43(6): 733.     CrossRef
• Herbal Medicines Attenuate PD-L1 Expression to Induce Anti-Proliferation in Obesity-Related Cancers
  Yu-Chen S.H. Yang, Zi-Lin Li, Ya-Jung Shih, James A. Bennett, Jaqueline Whang-Peng, Hung-Yun Lin, Paul J. Davis, Kuan Wang
  Nutrients.2019; 11(12): 2979.     CrossRef
• Gestational diabetes mellitus and maternal breast cancer risk: a meta-analysis of the literature
  Chuanbo Xie, Wei Wang, Xiuhong Li, Nan Shao, Weidong Li
  The Journal of Maternal-Fetal & Neonatal Medicine.2019; 32(6): 1022.     CrossRef
• HIPK2 role in the tumor–host interaction: Impact on fibroblasts transdifferentiation CAF‐like
  Alessia Garufi, Gianandrea Traversi, Mara Cirone, Gabriella D'Orazi
  IUBMB Life.2019; 71(12): 2055.     CrossRef
• Blood glucose, glucose balance, and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Screening for Prostate Cancer
  Teemu J. Murtola, Samueli M. Sälli, Kirsi Talala, Kimmo Taari, Teuvo L. J. Tammela, Anssi Auvinen
  Prostate Cancer and Prostatic Diseases.2019; 22(3): 453.     CrossRef
• Reduced chemotherapeutic sensitivity in high glucose condition: implication of antioxidant response
  Alessia Garufi, Gianandrea Traversi, Maria Saveria Gilardini Montani, Valerio D’Orazi, Giuseppa Pistritto, Mara Cirone, Gabriella D’Orazi
  Oncotarget.2019; 10(45): 4691.     CrossRef
• Hyperglycemia Associated Metabolic and Molecular Alterations in Cancer Risk, Progression, Treatment, and Mortality
  Ramteke, Deb, Shepal, Bhat
  Cancers.2019; 11(9): 1402.     CrossRef
• Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets
  S. Franklyn De Silva, Jane Alcorn
  Pharmaceuticals.2019; 12(2): 68.     CrossRef
• Serum gamma-glutamyltransferase and the overall survival of metastatic pancreatic cancer
  Yuanyuan Xiao, Haijun Yang, Jian Lu, Dehui Li, Chuanzhi Xu, Harvey A. Risch
  BMC Cancer.2019;[Epub]     CrossRef
• N-acetyl cysteine attenuates oxidative stress and glutathione-dependent redox imbalance caused by high glucose/high palmitic acid treatment in pancreatic Rin-5F cells
  Arwa Alnahdi, Annie John, Haider Raza, M. Firoze Khan
  PLOS ONE.2019; 14(12): e0226696.     CrossRef
• Targeting receptors of advanced glycation end products (RAGE): Preventing diabetes induced cancer and diabetic complications
  Abu Sufiyan Chhipa, Swapnil P. Borse, Ruma Baksi, Sunali Lalotra, Manish Nivsarkar
  Pathology - Research and Practice.2019; 215(11): 152643.     CrossRef
• Methylglyoxal, a potent inducer of AGEs, connects between diabetes and cancer
  Justine Bellier, Marie-Julie Nokin, Eva Lardé, Philippe Karoyan, Olivier Peulen, Vincent Castronovo, Akeila Bellahcène
  Diabetes Research and Clinical Practice.2019; 148: 200.     CrossRef
• Molecular Mechanisms of Cancer-Induced Sleep Disruption
  William H. Walker, Jeremy C. Borniger
  International Journal of Molecular Sciences.2019; 20(11): 2780.     CrossRef
• Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01)
  Stefanie de Groot, Hanno Pijl, Ayoub Charehbili, Saskia van de Ven, Vincent T. H. B. M. Smit, Elma Meershoek-Klein Kranenbarg, Joan B. Heijns, Laurence J. C. van Warmerdam, Lonneke W. Kessels, M. Wouter Dercksen, Manon J. A. E. Pepels, Hanneke W. M. van L
  Breast Cancer Research.2019;[Epub]     CrossRef
• Assessing the Effect of Various Blood Glucose Levels on 18F-FDG Activity in the Brain, Liver, and Blood Pool
  Ismet Sarikaya, Ali Sarikaya, Prem Sharma
  Journal of Nuclear Medicine Technology.2019; 47(4): 313.     CrossRef
• Efficacy of Complementary Therapies in the Quality of Life of Breast Cancer Survivors
  Sahar Zaidi, Showket Hussain, Shalini Verma, Zubia Veqar, Asiya Khan, Sheeraz Un Nazir, Neha Singh, Jamal Ali Moiz, Pranay Tanwar, Anurag Srivastava, G. K. Rath, Ravi Mehrotra
  Frontiers in Oncology.2018;[Epub]     CrossRef
• A Role for Hypocretin/Orexin in Metabolic and Sleep Abnormalities in a Mouse Model of Non-metastatic Breast Cancer
  Jeremy C. Borniger, William H. Walker II, Surbhi, Kathryn M. Emmer, Ning Zhang, Abigail A. Zalenski, Stevie L. Muscarella, Julie A. Fitzgerald, Alexandra N. Smith, Cornelius J. Braam, Tial TinKai, Ulysses J. Magalang, Maryam B. Lustberg, Randy J. Nelson,
  Cell Metabolism.2018; 28(1): 118.     CrossRef
• Model-based in silico analysis of the PI3K/Akt pathway: the elucidation of cross-talk between diabetes and breast cancer
  Sammia Rehman, Ayesha Obaid, Anam Naz, Amjad Ali, Shahzina Kanwal, Jamil Ahmad
  PeerJ.2018; 6: e5917.     CrossRef
• Inhibitory Effect of Anoectochilus formosanus Extract on Hyperglycemia-Related PD-L1 Expression and Cancer Proliferation
  Yih Ho, Yan-Fang Chen, Li-Hsuan Wang, Kuang-Yang Hsu, Yu-Tang Chin, Yu-Chen S. H. Yang, Shwu-Huey Wang, Yi-Ru Chen, Ya-Jung Shih, Leroy F. Liu, Kuan Wang, Jacqueline Whang-Peng, Heng-Yuan Tang, Hung-Yun Lin, Hsuan-Liang Liu, Shwu-Jiuan Lin
  Frontiers in Pharmacology.2018;[Epub]     CrossRef
• Hypoxia driven glycation: Mechanisms and therapeutic opportunities
  Mohammad Imran Khan, Suvasmita Rath, Vaqar Mustafa Adhami, Hasan Mukhtar
  Seminars in Cancer Biology.2018; 49: 75.     CrossRef
• Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice
  Roxanne Weiss, Elizabeth Fernandez, Yuhong Liu, Randy Strong, Adam B. Salmon
  Aging.2018; 10(3): 386.     CrossRef
• High glucose induces epithelial‑mesenchymal transition and results in the migration and invasion of colorectal cancer cells
  Jiayan Wu, Jiayi Chen, Yang Xi, Fuyan Wang, Hongcun Sha, Lin Luo, Yabin Zhu, Xiaoming Hong, Shizhong Bu
  Experimental and Therapeutic Medicine.2018;[Epub]     CrossRef
• Laminar shear stress inhibits high glucose-induced migration and invasion in human bladder cancer cells
  Yu-Hsiang Lee, Chien-Hsuan Yeh
  In Vitro Cellular & Developmental Biology - Animal.2018; 54(2): 120.     CrossRef
• Methylglyoxal-derived stress: An emerging biological factor involved in the onset and progression of cancer
  Akeila Bellahcène, Marie-Julie Nokin, Vincent Castronovo, Casper Schalkwijk
  Seminars in Cancer Biology.2018; 49: 64.     CrossRef
• Extracellular matrix glycation and receptor for advanced glycation end-products activation: a missing piece in the puzzle of the association between diabetes and cancer
  Armando Rojas, Carolina Añazco, Ileana González, Paulina Araya
  Carcinogenesis.2018; 39(4): 515.     CrossRef
• Good glycaemic control is associated with a better prognosis in breast cancer patients with type 2 diabetes mellitus
  Yen-Lin Chang, Wayne Huey-Herng Sheu, Shih-Yi Lin, Wen-Shyong Liou
  Clinical and Experimental Medicine.2018; 18(3): 383.     CrossRef
• High glucose contributes to the proliferation and migration of non-small-cell lung cancer cells via GAS5-TRIB3 axis
  Cheng-Zhi Ding, Xu-Feng Guo, Guo-Lei Wang, Hong-Tao Wang, Guang-Hui Xu, Yuan-Yuan Liu, Zhen-Jiang Wu, Yu-Hang Chen, Jiao Wang, Wen-Guang Wang
  Bioscience Reports.2018;[Epub]     CrossRef
• Challenges and perspectives in the treatment of diabetes associated breast cancer
  Samson Mathews Samuel, Elizabeth Varghese, Sharon Varghese, Dietrich Büsselberg
  Cancer Treatment Reviews.2018; 70: 98.     CrossRef
• Linking type 2 diabetes and gynecological cancer: an introductory overview
  Emanuela Anastasi, Tiziana Filardi, Sara Tartaglione, Andrea Lenzi, Antonio Angeloni, Susanna Morano
  Clinical Chemistry and Laboratory Medicine (CCLM).2018; 56(9): 1413.     CrossRef
• Hyperglycaemia and Survival in Solid Tumours: A Systematic Review and Meta-analysis
  R. Barua, A.J. Templeton, B. Seruga, A. Ocana, E. Amir, J.-L. Ethier
  Clinical Oncology.2018; 30(4): 215.     CrossRef
• Hepatocellular carcinoma-associated hypercholesterolemia: involvement of proprotein-convertase-subtilisin-kexin type-9 (PCSK9)
  Dipti Athavale, Surbhi Chouhan, Vimal Pandey, Shyamananda Singh Mayengbam, Snahlata Singh, Manoj Kumar Bhat
  Cancer & Metabolism.2018;[Epub]     CrossRef
• An insight on the association of glycation with hepatocellular carcinoma
  Nasimudeen R. Jabir, Saheem Ahmad, Shams Tabrez
  Seminars in Cancer Biology.2018; 49: 56.     CrossRef
• Risk score system for the prediction of hepatocellular carcinoma in patients with type 2 diabetes: Taiwan Diabetes Study
  Tsai-Chung Li, Chia-Ing Li, Chiu-Shong Liu, Wen-Yuan Lin, Chih-Hsueh Lin, Sing-Yu Yang, Cheng-Chieh Lin
  Seminars in Oncology.2018; 45(5-6): 264.     CrossRef
• RAGE and Its Ligands: Molecular Interplay Between Glycation, Inflammation, and Hallmarks of Cancer—a Review
  Gowri Palanissami, Solomon F. D. Paul
  Hormones and Cancer.2018; 9(5): 295.     CrossRef
• Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation
  Catharina Bartmann, Sudha R. Janaki Raman, Jessica Flöter, Almut Schulze, Katrin Bahlke, Jana Willingstorfer, Maria Strunz, Achim Wöckel, Rainer J. Klement, Michaela Kapp, Cholpon S. Djuzenova, Christoph Otto, Ulrike Kämmerer
  Cancer & Metabolism.2018;[Epub]     CrossRef
• Obesity, Diabetes and Gastrointestinal Malignancy: The role of Metformin and other Anti-diabetic Therapy
  McFarlane Samy I
  Global Journal of Obesity, Diabetes and Metabolic Syndrome.2018; : 008.     CrossRef
• Pretreatment glycemic control status is an independent prognostic factor for cervical cancer patients receiving neoadjuvant chemotherapy for locally advanced disease
  Jing Li, Ni-ya Ning, Qun-xian Rao, Rong Chen, Li-juan Wang, Zhong-qiu Lin
  BMC Cancer.2017;[Epub]     CrossRef
• Differences in risk factors of malignancy between men and women with type 2 diabetes: A retrospective case-control study
  Mariusz Dąbrowski, Elektra Szymańska-Garbacz, Zofia Miszczyszyn, Tadeusz Dereziński, Leszek Czupryniak
  Oncotarget.2017; 8(40): 66940.     CrossRef
• Beta-glucans and cancer: The influence of inflammation and gut peptide
  Sara Baldassano, Giulia Accardi, Sonya Vasto
  European Journal of Medicinal Chemistry.2017; 142: 486.     CrossRef
• Enemies or weapons in hands: investigational anti-diabetic drug glibenclamide and cancer risk
  Rui Gao, Tao Yang, Wei Xu
  Expert Opinion on Investigational Drugs.2017; 26(7): 853.     CrossRef
• Hyperglycemia triggers HIPK2 protein degradation
  Silvia Baldari, Alessia Garufi, Marisa Granato, Laura Cuomo, Giuseppa Pistritto, Mara Cirone, Gabriella D’Orazi
  Oncotarget.2017; 8(1): 1190.     CrossRef
• Monitoring p53 by MDM2 and MDMX is required for endocrine pancreas development and function in a spatio-temporal manner
  Yiwei Zhang, Shelya X. Zeng, Qian Hao, Hua Lu
  Developmental Biology.2017; 423(1): 34.     CrossRef
• Modulation of Mammary Stromal Cell Lactate Dynamics by Ambient Glucose and Epithelial Factors
  Nicolas Tobar, Omar Porras, Patricio C. Smith, L. Felipe Barros, Jorge Martínez
  Journal of Cellular Physiology.2017; 232(1): 136.     CrossRef
• Energy metabolism in glioblastoma stem cells: PPARα a metabolic adaptor to intratumoral microenvironment
  Alessia Fidoamore, Loredana Cristiano, Chiara Laezza, Renato Galzio, Elisabetta Benedetti, Benedetta Cinque, Andrea Antonosante, Michele d’Angelo, Vanessa Castelli, Maria Grazia Cifone, Rodolfo Ippoliti, Antonio Giordano, Annamaria Cimini
  Oncotarget.2017; 8(65): 108430.     CrossRef
• Hyperglycemia is Associated with Poor Survival in Primary Central Nervous System Lymphoma Patients
  Ayumi Debata, Koichi Yoshida, Kenta Ujifuku, Haruna Yasui, Kensaku Kamada, Daisuke Niino, Takayuki Matsuo
  Tumori Journal.2017; 103(3): 272.     CrossRef
• Micronucleus, cell-free DNA, and plasma glycan composition in the newborns of healthy and diabetic mothers
  Aleksandra Fucic, Vedrana Guszak, Toma Keser, Jasenka Wagner, Emilja Juretić, Davor Plavec, Ranko Stojković, Olga Gornik, Gordan Lauc
  Mutation Research/Genetic Toxicology and Environmental Mutagenesis.2017; 815: 6.     CrossRef
• Hyperglycemia exacerbates colon cancer malignancy through hexosamine biosynthetic pathway
  A Vasconcelos-dos-Santos, H F B R Loponte, N R Mantuano, I A Oliveira, I F de Paula, L K Teixeira, J C M de-Freitas-Junior, K C Gondim, N Heise, R Mohana-Borges, J A Morgado-Díaz, W B Dias, A R Todeschini
  Oncogenesis.2017; 6(3): e306.     CrossRef
• Associations between prediagnostic blood glucose levels, diabetes, and glioma
  Judith Schwartzbaum, Michael Edlinger, Victoria Zigmont, Pär Stattin, Grzegorz A. Rempala, Gabriele Nagel, Niklas Hammar, Hanno Ulmer, Bernhard Föger, Göran Walldius, Jonas Manjer, Håkan Malmström, Maria Feychting
  Scientific Reports.2017;[Epub]     CrossRef
• Gestational diabetes mellitus may be associated with increased risk of breast cancer
  Yong-Moon Mark Park, Katie M O'Brien, Shanshan Zhao, Clarice R Weinberg, Donna D Baird, Dale P Sandler
  British Journal of Cancer.2017; 116(7): 960.     CrossRef
• The transcription factor carbohydrate-response element-binding protein (ChREBP): A possible link between metabolic disease and cancer
  Katsumi Iizuka
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2017; 1863(2): 474.     CrossRef
• The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesis
  Xiao Zhang, Yongxia Qiao, Qi Wu, Yan Chen, Shaowu Zou, Xiangfan Liu, Guoqing Zhu, Yinghui Zhao, Yuxin Chen, Yongchun Yu, Qiuhui Pan, Jiayi Wang, Fenyong Sun
  Nature Communications.2017;[Epub]     CrossRef
• Anthocyanins from Purple Corn Ameliorated Tumor Necrosis Factor‐α‐Induced Inflammation and Insulin Resistance in 3T3‐L1 Adipocytes via Activation of Insulin Signaling and Enhanced GLUT4 Translocation
  Diego Luna‐Vital, Matthew Weiss, Elvira Gonzalez de Mejia
  Molecular Nutrition & Food Research.2017;[Epub]     CrossRef
• Hyperglycaemia and aberrated insulin signalling stimulate tumour progression via induction of the extracellular matrix component hyaluronan
  Sören Twarock, Christina Reichert, Ulrike Peters, Daniel J. Gorski, Katharina Röck, Jens W. Fischer
  International Journal of Cancer.2017; 141(4): 791.     CrossRef
• Das Karzinom in der Polarität zwischen Stoffwechsel- und Nerven-Sinnes-System – Konsequenzen für die Therapie
  H. Schramm
  Der Merkurstab.2017; 70(3): 221.     CrossRef
• Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment
  Michaela A. Onstad, Rosemarie E. Schmandt, Karen H. Lu
  Journal of Clinical Oncology.2016; 34(35): 4225.     CrossRef
• Mechanisms through which diabetes mellitus influences renal cell carcinoma development and treatment: A review of the literature
  Dominika Labochka, Barbara Moszczuk, Wojciech Kukwa, Cezary Szczylik, Anna M. Czarnecka
  International Journal of Molecular Medicine.2016; 38(6): 1887.     CrossRef
• Cancer Risk in Patients With Empyema
  Chung-Jen Teng, Yu-Wen Hu, Chiu-Mei Yeh, Tzeng-Ji Chen, Chia-Jen Liu
  Medicine.2016; 95(9): e2934.     CrossRef
• High Glucose Stimulates Tumorigenesis in Hepatocellular Carcinoma Cells Through AGER-Dependent O-GlcNAcylation of c-Jun
  Yongxia Qiao, Xiao Zhang, Yue Zhang, Yulan Wang, Yanfeng Xu, Xiangfan Liu, Fenyong Sun, Jiayi Wang
  Diabetes.2016; 65(3): 619.     CrossRef
• Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories
  Rhonda Arthur, Henrik Møller, Hans Garmo, Lars Holmberg, Pår Stattin, Håkan Malmstrom, Mats Lambe, Niklas Hammar, Göran Walldius, David Robinson, Ingmar Jungner, Mieke Van Hemelrijck
  Cancer Medicine.2016; 5(6): 1307.     CrossRef
• Risk factors for cancer development in type 2 diabetes: A retrospective case-control study
  Mariusz Dąbrowski, Elektra Szymańska-Garbacz, Zofia Miszczyszyn, Tadeusz Dereziński, Leszek Czupryniak
  BMC Cancer.2016;[Epub]     CrossRef
• High-fat Western diet–induced obesity contributes to increased tumor growth in mouse models of human colon cancer
  Ann Marie O'Neill, Christine M. Burrington, Erin A. Gillaspie, Darin T. Lynch, Melissa J. Horsman, Michael W. Greene
  Nutrition Research.2016; 36(12): 1325.     CrossRef
• Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic Study
  Todd A. Mackenzie, Rebecca Zaha, Jeremy Smith, Margaret R. Karagas, Nancy E. Morden
  Diabetes Therapy.2016; 7(1): 61.     CrossRef
• Diabetes mellitus stimulates pancreatic cancer growth and epithelial-mesenchymal transition-mediated metastasis via a p38 MAPK pathway
  Lishan Wang, Ying-Ying Bai, Yang Yang, Fangfang Hu, Yonghui Wang, Zeqian Yu, Zhangjun Cheng, Jiahua Zhou
  Oncotarget.2016; 7(25): 38539.     CrossRef
• Prognostic Significance of Hyperglycemia in Patients with Brain Tumors: a Meta-Analysis
  Hongwei Liu, Zhixiong Liu, Bing Jiang, Xiping Ding, Lei Huo, Xin Wan, Jinfang Liu, Zhenyun Xia
  Molecular Neurobiology.2016; 53(3): 1654.     CrossRef
• Impact of Hyperglycemia on Outcomes among Patients Receiving Neoadjuvant Chemotherapy for Bulky Early Stage Cervical Cancer
  Jing Li, Miao-fang Wu, Huai-wu Lu, Bing-zhong Zhang, Li-juan Wang, Zhong-qiu Lin, Xing Xie
  PLOS ONE.2016; 11(11): e0166612.     CrossRef
• Obesity, Inflammation, and Cancer
  Tuo Deng, Christopher J. Lyon, Stephen Bergin, Michael A. Caligiuri, Willa A. Hsueh
  Annual Review of Pathology: Mechanisms of Disease.2016; 11(1): 421.     CrossRef
• Hyperglycemia, tumorigenesis, and chronic inflammation
  Shu-Chun Chang, Wei-Chung Vivian Yang
  Critical Reviews in Oncology/Hematology.2016; 108: 146.     CrossRef
• Methylglyoxal, a glycolysis side-product, induces Hsp90 glycation and YAP-mediated tumor growth and metastasis
  Marie-Julie Nokin, Florence Durieux, Paul Peixoto, Barbara Chiavarina, Olivier Peulen, Arnaud Blomme, Andrei Turtoi, Brunella Costanza, Nicolas Smargiasso, Dominique Baiwir, Jean L Scheijen, Casper G Schalkwijk, Justine Leenders, Pascal De Tullio, Elettra
  eLife.2016;[Epub]     CrossRef
• ZnCl2 sustains the adriamycin-induced cell death inhibited by high glucose
  A Garufi, D Trisciuoglio, M Cirone, G D'Orazi
  Cell Death & Disease.2016; 7(6): e2280.     CrossRef
• Controlling Malglycemia in Patients Undergoing Treatment for Cancer
  Susan Storey, Veronica Brady, Ashley Leak Bryant, Ellen Davis, Marilyn Hammer, Denise Hershey, Jill Olausson, Jane Seley
  Clinical Journal of Oncology Nursing.2016; 20(1): 92.     CrossRef
• Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer
  Jessica K. Paulus, Christina D. Williams, Furha I. Cossor, Michael J. Kelley, Robert E. Martell
  Cancer Epidemiology, Biomarkers & Prevention.2016; 25(10): 1418.     CrossRef
• Thymic emigration patterns in patients with type 2 diabetes treated with metformin
  Grzegorz Dworacki, Olzhas Urazayev, Yerbol Bekmukhambetov, Saule Iskakova, Bartosz A. Frycz, Paweł P. Jagodziński, Marzena Dworacka
  Immunology.2015; 146(3): 456.     CrossRef
• Resveratrol in the treatment of pancreatic cancer
  Qinhong Xu, Liang Zong, Xin Chen, Zhengdong Jiang, Ligang Nan, Jiahui Li, Wanxing Duan, Jianjun Lei, Lun Zhang, Jiguang Ma, Xuqi Li, Zheng Wang, Zheng Wu, Qingyong Ma, Zhenhua Ma
  Annals of the New York Academy of Sciences.2015; 1348(1): 10.     CrossRef
• Effect of hyperglycemia on hepatocellular carcinoma development in diabetes
  Yasuhiro Niwa, Kota Ishikawa, Masatoshi Ishigami, Takashi Honda, Koichi Achiwa, Takako Izumoto, Ryuya Maekawa, Kaori Hosokawa, Atsushi Iida, Yusuke Seino, Yoji Hamada, Hidemi Goto, Yutaka Oiso, Hiroshi Arima, Shin Tsunekawa
  Biochemical and Biophysical Research Communications.2015; 463(3): 344.     CrossRef
• The insulin-like growth factor I system: Physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome
  Jun Ren, Piero Anversa
  Biochemical Pharmacology.2015; 93(4): 409.     CrossRef
• Diabetes and risk of cancer
  Toshiya Atsumi
  Diabetology International.2015; 6(3): 190.     CrossRef
• The influencing factors associated with glycemic control among adult diabetes patients
  Kisook Kim
  Journal of the Korea Academia-Industrial cooperation Society.2015; 16(5): 3284.     CrossRef
• Reply to “Preoperative Evaluation of Pancreatic Adenocarcinoma”
  Siva P. Raman
  American Journal of Roentgenology.2015; 205(2): W226.     CrossRef

Ageing is the most significant risk factor for a range of prevalent diseases, including cancer, cardiovascular disease, and diabetes. Accordingly, interventions are needed for delaying or preventing disorders associated with the ageing process, i.e., promotion of healthy ageing. Calorie restriction is the only nongenetic and the most robust approach to slow the process of ageing in evolutionarily divergent species, ranging from yeasts, worms, and flies to mammals. Although it has been known for more than 80 years that calorie restriction increases lifespan, a mechanistic understanding of this phenomenon remains elusive. Yeast silent information regulator 2 (Sir2), the founding member of the sirtuin family of protein deacetylases, and its mammalian homologue Sir2-like protein 1 (SIRT1), have been suggested to promote survival and longevity of organisms. SIRT1 exerts protective effects against a number of age-associated disorders. Caloric restriction increases both Sir2 and SIRT1 activity. This review focuses on the mechanistic insights between caloric restriction and Sir2/SIRT1 activation. A number of molecular links, including nicotinamide adenine dinucleotide, nicotinamide, biotin, and related metabolites, are suggested to be the most important conduits mediating caloric restriction-induced Sir2/SIRT1 activation and lifespan extension.

Citations

Citations to this article as recorded by  

• Caloric Restriction Can Ameliorate Postoperative Cognitive Dysfunction by Upregulating the Expression of Sirt1, MeCP2 and BDNF in the Hippocampal CA1 Region of Aged C57BL/6 Mice
  Lan Wei, Qiang Tao, Minmin Yao, Zhimeng Zhao, Shengjin Ge
  Brain Sciences.2023; 13(3): 462.     CrossRef
• Metabolic Syndrome and Cardiac Remodeling Due to Mitochondrial Oxidative Stress Involving Gliflozins and Sirtuins
  Raúl Lelio Sanz, Felipe Inserra, Sebastián García Menéndez, Luciana Mazzei, León Ferder, Walter Manucha
  Current Hypertension Reports.2023; 25(6): 91.     CrossRef
• The Tricarboxylic Acid Cycle as a Central Regulator of the Rate of Aging: Implications for Metabolic Interventions
  Jonathan M. Borkum
  Advanced Biology.2023;[Epub]     CrossRef
• Metabolic Reprogramming by Reduced Calorie Intake or Pharmacological Caloric Restriction Mimetics for Improved Cancer Immunotherapy
  Erwan Eriau, Juliette Paillet, Guido Kroemer, Jonathan G. Pol
  Cancers.2021; 13(6): 1260.     CrossRef
• SGLT2 Inhibitors as Calorie Restriction Mimetics: Insights on Longevity Pathways and Age-Related Diseases
  Caroline W S Hoong, Marvin W J Chua
  Endocrinology.2021;[Epub]     CrossRef
• A comprehensive insight into the potential effects of resveratrol supplementation on SIRT-1: A systematic review
  Marziyeh Najafi, Omid Nikpayam, Omid Mohammad Tavakoli-Rouzbehani, Shahab Papi, Atefeh Amrollahi bioky, Elham sadat Ahmadiani, Golbon Sohrab
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2021; 15(5): 102224.     CrossRef
• Antiaging and Antioxidant Bioactivities of Asteraceae Plant Fractions on the Cellular Functions of the Yeast Schizosaccharomyces pombe
  Rika Indri Astuti, Muhammad Eka Prastya, Irmanida Batubara, Eka Budiarti, Aulia Ilmiyawati, Mounir Tilaoui
  Advances in Pharmacological and Pharmaceutical Sciences.2021; 2021: 1.     CrossRef
• Principles of brain aging: Status and challenges of modeling human molecular changes in mice
  Verena Kluever, Eugenio F. Fornasiero
  Ageing Research Reviews.2021; 72: 101465.     CrossRef
• Role of NRF2 and Sirtuin activators in COVID-19
  Hasnat Khan, Shivangi Patel, Anuradha Majumdar
  Clinical Immunology.2021; 233: 108879.     CrossRef
• Role of acetylation in nonalcoholic fatty liver disease: a focus on SIRT1 and SIRT3
  Fatiha Nassir
  Exploration of Medicine.2020; 1(4): 248.     CrossRef
• NAD metabolism in aging and cancer
  John WR Kincaid, Nathan A Berger
  Experimental Biology and Medicine.2020; 245(17): 1594.     CrossRef
• Cyclin‐dependent kinase Pho85p and its cyclins are involved in replicative lifespan through multiple pathways in yeast
  Toshio Nakajima, Tsubasa Maruhashi, Takaaki Morimatsu, Yukio Mukai
  FEBS Letters.2020; 594(7): 1166.     CrossRef
• SIRT1 Allele Frequencies in Depressed Patients of European Descent in Russia
  Lyubomir I. Aftanas, Maksim S. Anisimenko, Darya A. Berdyugina, Aleksandr Yu. Garanin, Vladimir N. Maximov, Mikhail I. Voevoda, Natalya M. Vyalova, Nikolay A. Bokhan, Svetlana A. Ivanova, Konstantin V. Danilenko, Sergei P. Kovalenko
  Frontiers in Genetics.2019;[Epub]     CrossRef
• Resveratrol attenuates myocardial hypoxia/reoxygenation-induced cell apoptosis through DJ-1-mediated SIRT1-p53 pathway
  Rui-Yuan Xu, Xing-Wang Xu, Yi-Zhang Deng, Zhao-Xia Ma, Xiao-Ran Li, Le Zhao, Le-Jia Qiu, Hao-Yue Liu, He-Ping Chen
  Biochemical and Biophysical Research Communications.2019; 514(2): 401.     CrossRef
• The pathobiology of polycystic kidney disease from a metabolic viewpoint
  Luis Fernando Menezes, Gregory G. Germino
  Nature Reviews Nephrology.2019; 15(12): 735.     CrossRef
• Six Weeks of Calorie Restriction Improves Body Composition and Lipid Profile in Obese and Overweight Former Athletes
  Joanna Hołowko, Małgorzata Magdalena Michalczyk, Adam Zając, Maja Czerwińska-Rogowska, Karina Ryterska, Marcin Banaszczak, Karolina Jakubczyk, Ewa Stachowska
  Nutrients.2019; 11(7): 1461.     CrossRef
• Sirtuins in gamete biology and reproductive physiology: emerging roles and therapeutic potential in female and male infertility
  Carla Tatone, Giovanna Di Emidio, Arcangelo Barbonetti, Gaspare Carta, Alberto M Luciano, Stefano Falone, Fernanda Amicarelli
  Human Reproduction Update.2018; 24(3): 267.     CrossRef
• Is there a role of H2S in mediating health span benefits of caloric restriction?
  Li Theng Ng, Jan Gruber, Philip Keith Moore
  Biochemical Pharmacology.2018; 149: 91.     CrossRef
• Sirtuins and Accelerated Aging in Scleroderma
  Anne E. Wyman, Sergei P. Atamas
  Current Rheumatology Reports.2018;[Epub]     CrossRef
• Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial
  Somayyeh Asghari, Mohammad Asghari-Jafarabadi, Mohammad-Hossein Somi, Seyed-Mostafa Ghavami, Maryam Rafraf
  Journal of the American College of Nutrition.2018; 37(3): 223.     CrossRef
• Amino Acid Restriction Triggers Angiogenesis via GCN2/ATF4 Regulation of VEGF and H2S Production
  Alban Longchamp, Teodelinda Mirabella, Alessandro Arduini, Michael R. MacArthur, Abhirup Das, J. Humberto Treviño-Villarreal, Christopher Hine, Issam Ben-Sahra, Nelson H. Knudsen, Lear E. Brace, Justin Reynolds, Pedro Mejia, Ming Tao, Gaurav Sharma, Rui W
  Cell.2018; 173(1): 117.     CrossRef
• Recent insights into the cellular and molecular determinants of aging
  Linhao Ruan, Xi Zhang, Rong Li
  Journal of Cell Science.2018;[Epub]     CrossRef
• SIRT1 Activity in Peripheral Blood Mononuclear Cells Correlates with Altered Lung Function in Patients with Chronic Obstructive Pulmonary Disease
  Valeria Conti, Graziamaria Corbi, Valentina Manzo, Paola Malangone, Carolina Vitale, Angelantonio Maglio, Roberta Cotugno, Damiano Capaccio, Luigi Marino, Carmine Selleri, Cristiana Stellato, Amelia Filippelli, Alessandro Vatrella
  Oxidative Medicine and Cellular Longevity.2018; 2018: 1.     CrossRef
• Sirt1: Role Under the Condition of Ischemia/Hypoxia
  Xiaofei Meng, Jin Tan, Mengmeng Li, Shuling Song, Yuyang Miao, Qiang Zhang
  Cellular and Molecular Neurobiology.2017; 37(1): 17.     CrossRef
• Salidroside protects PC12 cells from Aβ1–40-induced cytotoxicity by regulating the nicotinamide phosphoribosyltransferase signaling pathway
  Xujiao Huang, Sanli Xing, Chuan Chen, Zhihua Yu, Jiulin Chen
  Molecular Medicine Reports.2017; 16(3): 2700.     CrossRef
• Combined Salt and Caloric Restrictions: Potential Adverse Outcomes
  Tsuyoshi Homma, Mika Homma, Yuefei Huang, Korapat Mayurasakorn, Nurul Mahamad Rodi, Anis Amalina Abdul Hamid, Shelley Hurwitz, Tham Yao, Gail K. Adler, Luminita H. Pojoga, Gordon H. Williams, Jose R. Romero
  Journal of the American Heart Association.2017;[Epub]     CrossRef
• Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity
  Xiaoting Luo, Jinzi Wu, Siqun Jing, Liang-Jun Yan
  Aging and disease.2016; 7(1): 90.     CrossRef
• Endothelial SIRT1 prevents adverse arterial remodeling by facilitating HERC2-mediated degradation of acetylated LKB1
  Bo Bai, Andy W.C. Man, Kangmin Yang, Yumeng Guo, Cheng Xu, Hung-Fat Tse, Weiping Han, Maria Bloksgaard, Jo G.R. De Mey, Paul M. Vanhoutte, Aimin Xu, Yu Wang
  Oncotarget.2016; 7(26): 39065.     CrossRef
• Circadian clocks govern calorie restriction—mediated life span extension through BMAL1‐ and IGF‐1‐dependent mechanisms
  Sonal A. Patel, Amol Chaudhari, Richa Gupta, Nikkhil Velingkaar, Roman V. Kondratov
  The FASEB Journal.2016; 30(4): 1634.     CrossRef
• Nutrigenomics at the Interface of Aging, Lifespan, and Cancer Prevention
  Gabriela Riscuta
  The Journal of Nutrition.2016; 146(10): 1931.     CrossRef
• Haploinsufficiency of the Myc regulator Mtbp extends survival and delays tumor development in aging mice
  Brian C. Grieb, Kelli Boyd, Ramkrishna Mitra, Christine M. Eischen
  Aging.2016; 8(10): 2590.     CrossRef
• Protein Modifications as Manifestations of Hyperglycemic Glucotoxicity in Diabetes and Its Complications
  Hong Zheng, Jinzi Wu, Zhen Jin, Liang-Jun Yan
  Biochemistry Insights.2016; 9: BCI.S36141.     CrossRef
• Nutritional limitation in early postnatal life and its effect on aging and longevity in rodents
  Kallie Davis, Douja Chamseddine, James M. Harper
  Experimental Gerontology.2016; 86: 84.     CrossRef
• 1,4-Dihydropyridines Active on the SIRT1/AMPK Pathway Ameliorate Skin Repair and Mitochondrial Function and Exhibit Inhibition of Proliferation in Cancer Cells
  Sergio Valente, Paolo Mellini, Francesco Spallotta, Vincenzo Carafa, Angela Nebbioso, Lucia Polletta, Ilaria Carnevale, Serena Saladini, Daniela Trisciuoglio, Chiara Gabellini, Maria Tardugno, Clemens Zwergel, Chiara Cencioni, Sandra Atlante, Sébastien Mo
  Journal of Medicinal Chemistry.2016; 59(4): 1471.     CrossRef
• Involvement of Daphnia pulicaria Sir2 in regulating stress response and lifespan
  Charles A. Schumpert, Craig Anderson, Jeffry L. Dudycha, Rekha C. Patel
  Aging.2016; 8(2): 402.     CrossRef
• Metformin Restores Parkin-Mediated Mitophagy, Suppressed by Cytosolic p53
  Young Song, Woo Lee, Yong-ho Lee, Eun Kang, Bong-Soo Cha, Byung-Wan Lee
  International Journal of Molecular Sciences.2016; 17(1): 122.     CrossRef
• Are sirtuins markers of ovarian aging?
  Jinjin Zhang, Li Fang, Zhiyong Lu, Jiaqiang Xiong, Meng Wu, Liangyan Shi, Aiyue Luo, Shixuan Wang
  Gene.2016; 575(2): 680.     CrossRef
• Coadjuvants in the Diabetic Complications: Nutraceuticals and Drugs with Pleiotropic Effects
  Thiago Pereira, Fabio Pimenta, Marcella Porto, Marcelo Baldo, Bianca Campagnaro, Agata Gava, Silvana Meyrelles, Elisardo Vasquez
  International Journal of Molecular Sciences.2016; 17(8): 1273.     CrossRef
• Extended longevity and survivorship during amino-acid starvation in a DrosophilaSir2mutant heterozygote
  Jennifer D. Slade, Brian E. Staveley, A. Civetta
  Genome.2016; 59(5): 311.     CrossRef
• Resveratrol inhibits doxorubicin-induced cardiotoxicity via sirtuin 1 activation in H9c2 cardiomyocytes
  Mi-Hua Liu, Jian Shan, Jian Li, Yuan Zhang, Xiao-Long Lin
  Experimental and Therapeutic Medicine.2016; 12(2): 1113.     CrossRef
• Effect of caloric restriction on the SIRT1/mTOR signaling pathways in senile mice
  Lina Ma, Wen Dong, Rong Wang, Yun Li, Baolei Xu, Jingshuang Zhang, Zhiwei Zhao, Yulan Wang
  Brain Research Bulletin.2015; 116: 67.     CrossRef
• Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction
  Zaid Al-Wahab, Ismail Mert, Calvin Tebbe, Jasdeep Chhina, Miriana Hijaz, Robert T. Morris, Rouba Ali-Fehmi, Shailendra Giri, Adnan R. Munkarah, Ramandeep Rattan
  Oncotarget.2015; 6(13): 10908.     CrossRef
• Restriction on an Energy-Dense Diet Improves Markers of Metabolic Health and Cellular Aging in Mice Through Decreasing Hepatic mTOR Activity
  Anke Schloesser, Graeme Campbell, Claus-Christian Glüer, Gerald Rimbach, Patricia Huebbe
  Rejuvenation Research.2015; 18(1): 30.     CrossRef
• Calorie Restriction Prevents Metabolic Aging Caused by Abnormal SIRT1 Function in Adipose Tissues
  Cheng Xu, Yu Cai, Pengcheng Fan, Bo Bai, Jie Chen, Han-Bing Deng, Chi-Ming Che, Aimin Xu, Paul M. Vanhoutte, Yu Wang
  Diabetes.2015; 64(5): 1576.     CrossRef

Type 2 diabetes mellitus (T2DM) is a complex endocrine and metabolic disorder, and a major public health problem that is rapidly increasing in prevalence. Although a wide range of pharmacotherapies for glycemic control is now available, management of T2DM remains complex and challenging. The kidneys contribute immensely to glucose homeostasis by reabsorbing glucose from the glomerular filtrate. Sodium-glucose cotransporter 2 (SGLT2) inhibitors, a new class of antidiabetic agents that inhibit glucose absorption from the kidney independent of insulin, offer a unique opportunity to improve the outcomes of patients with T2DM. In this review, we provide an overview of two globally-approved SGLT2 inhibitors, dapagliflozin and canagliflozin, and discuss their effects and safety. This information will help clinicians to decide whether these drugs will benefit their patients.

Citations

Citations to this article as recorded by  

• Clinical outcomes with the use of sodium-glucose cotransporter-2 inhibitors in patients with atrial fibrillation and type 2 diabetes mellitus: a multi-centre, real-world cohort study
  Jaehyuk Jang, Soyoon Park, Soohyun Kim, Sung-Hwan Kim, Yong-Seog Oh, Young Kyoung Sa, Youmi Hwang, Sung-Won Jang, Sang-Hyun Ihm, Young Choi
  European Journal of Preventive Cardiology.2024; 31(3): 320.     CrossRef
• Quantitative analysis of low-content impurity crystal forms in canagliflozin tablets by NIR solid-state analysis technique
  Mingdi Liu, Jichao Liu, Qiuhong Wang, Ping Song, Haichao Li, Zan Sun, Chenglong Shi, Weibing Dong
  Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy.2024; 311: 124000.     CrossRef
• A Randomized Crossover Trial of Mixed Meal Tolerance Test Response in People with Type 1 Diabetes on Insulin Pump Therapy and YG1699 or Dapagliflozin
  Pablo Lapuerta, Silvia Urbina, Jiaojuan He, Alyssa Wittle, Chenghai Li, Tong Li, Helen Wang, Marcus Hompesch
  Clinical Pharmacology & Therapeutics.2024;[Epub]     CrossRef
• Canagliflozin independently reduced plasma volume from conventional diuretics in patients with type 2 diabetes and chronic heart failure: a subanalysis of the CANDLE trial
  Kazuki Shiina, Hirofumi Tomiyama, Atsushi Tanaka, Takumi Imai, Itaru Hisauchi, Isao Taguchi, Akira Sezai, Shigeru Toyoda, Kaoru Dohi, Haruo Kamiya, Keisuke Kida, Toshihisa Anzai, Taishiro Chikamori, Koichi Node, Masayoshi Ajioka, Junya Ako, Rie Amano, Mit
  Hypertension Research.2023; 46(2): 495.     CrossRef
• Ecofriendly appraisal of stability‐indicating high‐performance chromatographic assay of canagliflozin and metformin with their toxic impurities; in silico toxicity prediction
  Raghda A. Emam, Aml A. Emam
  Journal of Separation Science.2023;[Epub]     CrossRef
• Effect of sodium‐glucose cotransporter 2 inhibitors on the rate of decline in kidney function: A systematic review and meta‐analysis
  Yanbei Duo, Junxiang Gao, Tao Yuan, Weigang Zhao
  Journal of Diabetes.2023; 15(1): 58.     CrossRef
• Quantitative analysis of low content polymorphic impurities in canagliflozin tablets by PXRD, NIR, ATR-FITR and Raman solid-state analysis techniques combined with stoichiometry
  Mingdi Liu, Jichao Liu, Qiuhong Wang, Ping Song, Haichao Li, Songgu Wu, Junbo Gong
  Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy.2023; 293: 122458.     CrossRef
• SGLT2 Inhibitors vs. GLP-1 Agonists to Treat the Heart, the Kidneys and the Brain
  Bartosz Rolek, Mateusz Haber, Magdalena Gajewska, Sylwester Rogula, Arkadiusz Pietrasik, Aleksandra Gąsecka
  Journal of Cardiovascular Development and Disease.2023; 10(8): 322.     CrossRef
• Cardiorenal Protections of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes
  Somayeh Nazari, Hossein Mirkhani
  Current Diabetes Reviews.2023;[Epub]     CrossRef
• Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extensio
  Jun Sung Moon, Il Rae Park, Hae Jin Kim, Choon Hee Chung, Kyu Chang Won, Kyung Ah Han, Cheol-Young Park, Jong Chul Won, Dong Jun Kim, Gwan Pyo Koh, Eun Sook Kim, Jae Myung Yu, Eun-Gyoung Hong, Chang Beom Lee, Kun-Ho Yoon
  Diabetes & Metabolism Journal.2023; 47(6): 808.     CrossRef
• Novel perspective on cardiovascular adverse event profiles due to treatment with sodium-glucose transport protein 2 (SGLT2) inhibitors in the Japanese Adverse Drug Event Report (JADER) database
  Koji Suematsu
  Personalized Medicine Universe.2023; 12: 23.     CrossRef
• The fate of flavonoids after oral administration: a comprehensive overview of its bioavailability
  Abid Naeem, Yang Ming, Hu Pengyi, Kang Yong Jie, Liu Yali, Zhang Haiyan, Xiao Shuai, Li Wenjing, Wu Ling, Zhang Ming Xia, Liu Shan Shan, Zheng Qin
  Critical Reviews in Food Science and Nutrition.2022; 62(22): 6169.     CrossRef
• Add-on therapy with dapagliflozin in routine outpatient care of type 2 diabetes patients from Turkey: a retrospective cohort study on HbA1c, body weight, and blood pressure outcomes
  Derun Taner Ertugrul, Erdal Kan, Cigdem Bahadir Tura, Haci Bayram Tugtekin, Hayati Ayakta, Mehmet Celebioglu, Ceren Yılmaz, Onur Utebay, Ilhan Yetkin, Eren Gurkan, Kerem Sezer, Ramazan Gen, Suleyman Ozcaylak, Yildiz Okuturlar, Mehmet Coskun, Nilgun Govec
  International Journal of Diabetes in Developing Countries.2022; 42(1): 147.     CrossRef
• Sodium–glucose cotransporter 2 inhibitors do not increase the risk of fractures in real‐world clinical practice in Korea: A national observational cohort study
  Kyoung Hwa Ha, Dae Jung Kim, Yong Jun Choi
  Journal of Diabetes Investigation.2022; 13(6): 986.     CrossRef
• Luseogliflozin preserves the pancreatic beta-cell mass and function in db/db mice by improving mitochondrial function
  Yuki Yamauchi, Akinobu Nakamura, Takashi Yokota, Kiyohiko Takahashi, Shinichiro Kawata, Kazuhisa Tsuchida, Kazuno Omori, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, Toshihisa Anzai, Shinya Tanaka, Yasuo Terauchi, Hideaki Miyoshi, Tatsuya Atsumi
  Scientific Reports.2022;[Epub]     CrossRef
• Blood glucose levels and bodyweight change after dapagliflozin administration
  Hyunah Kim, Seung‐Hwan Lee, Hyunyong Lee, Hyeon Woo Yim, Jae‐Hyoung Cho, Kun‐Ho Yoon, Hun‐Sung Kim
  Journal of Diabetes Investigation.2021; 12(9): 1594.     CrossRef
• Dapagliflozin Improves Cardiac Hemodynamics and Mitigates Arrhythmogenesis in Mitral Regurgitation‐Induced Myocardial Dysfunction
  Yu‐Wen Lin, Chin‐Yu Chen, Jhih‐Yuan Shih, Bor‐Chih Cheng, Ching‐Ping Chang, Mao‐Tsun Lin, Chung‐Han Ho, Zhih‐Cherng Chen, Sudeshna Fisch, Wei‐Ting Chang
  Journal of the American Heart Association.2021;[Epub]     CrossRef
• Cardiovascular Safety of Sodium Glucose Cotransporter 2 Inhibitors as Add-on to Metformin Monotherapy in Patients with Type 2 Diabetes Mellitus
  Ja Young Jeon, Kyoung Hwa Ha, Dae Jung Kim
  Diabetes & Metabolism Journal.2021; 45(4): 505.     CrossRef
• Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 Pathway
  Ji-Yeon Lee, Minyoung Lee, Ji Young Lee, Jaehyun Bae, Eugene Shin, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha
  Diabetes & Metabolism Journal.2021; 45(6): 921.     CrossRef
• SGLT2i: beyond the glucose-lowering effect
  Lihua Ni, Cheng Yuan, Guopeng Chen, Changjiang Zhang, Xiaoyan Wu
  Cardiovascular Diabetology.2020;[Epub]     CrossRef
• Ipragliflozin Additively Ameliorates Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Controlled with Metformin and Pioglitazone: A 24-Week Randomized Controlled Trial
  Eugene Han, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha
  Journal of Clinical Medicine.2020; 9(1): 259.     CrossRef
• Stability Indicating, pH and pKa Dependent HPLC–DAD Method for the Simultaneous Determination of Weakly Ionizable Empagliflozin, Dapagliflozin and Canagliflozin in Pharmaceutical Formulations
  Shahzad Sharif, Rashida Bashir, Ahmad Adnan, Sabiha Mansoor, Izaz Ahmad, Ayoub Rashid Ch, Muhammad Saqlain Tahir
  Chromatographia.2020; 83(12): 1453.     CrossRef
• Cardiorenal protection with SGLT2: Lessons from the cardiovascular outcome trials
  José Silva‐Cardoso, Omar Sheikh, Mouhamed Nashawi, Son Pham, Kelly M. Gallegos, Laith R. Dinkha, Robert J. Chilton
  Journal of Diabetes.2020; 12(4): 279.     CrossRef
• Effect of the Sodium-Glucose Cotransporter 2 Inhibitor, Dapagliflozin, on Genitourinary Infection in an Animal Model of Type 2 Diabetes
  Jin Bong Choi, Je Mo Yoo, Ye-Jee Lee, Jae Woong Kim, Seung-Ju Lee, Hee Youn Kim, Dong Sup Lee, Seung-Hyun Ko, Hyun-Sop Choe
  International Neurourology Journal.2020; 24(1): 21.     CrossRef
• Sodium‐glucose cotransporter 2 inhibitors regulate ketone body metabolism via inter‐organ crosstalk
  Jin Hee Kim, Minyoung Lee, Soo Hyun Kim, So Ra Kim, Byung‐Wan Lee, Eun Seok Kang, Bong‐Soo Cha, Jin Won Cho, Yong‐ho Lee
  Diabetes, Obesity and Metabolism.2019; 21(4): 801.     CrossRef
• Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  Jae Hyun Bae, Eun-Gee Park, Sunhee Kim, Sin Gon Kim, Seokyung Hahn, Nam Hoon Kim
  Scientific Reports.2019;[Epub]     CrossRef
• SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
  Chenguang Li, Jie Zhang, Mei Xue, Xiaoyu Li, Fei Han, Xiangyang Liu, Linxin Xu, Yunhong Lu, Ying Cheng, Ting Li, Xiaochen Yu, Bei Sun, Liming Chen
  Cardiovascular Diabetology.2019;[Epub]     CrossRef
• An update of SGLT1 and SGLT2 inhibitors in early phase diabetes-type 2 clinical trials
  Ernest Adeghate, Sahar Mohsin, Faisal Adi, Fares Ahmed, Ali Yahya, Huba Kalász, Kornelia Tekes, Ernest A. Adeghate
  Expert Opinion on Investigational Drugs.2019; 28(9): 811.     CrossRef
• Stability‐indicating chromatographic and chemometric methods for environmentally benign determination of canagliflozin and its major degradation product; A comparative study and greenness assessment
  Aml A. Emam, Nada S. Abdelwahab
  Biomedical Chromatography.2019;[Epub]     CrossRef
• A Lower Baseline Urinary Glucose Excretion Predicts a Better Response to the Sodium Glucose Cotransporter 2 Inhibitor
  You-Cheol Hwang, Jae Hyeon Kim, Byung-Wan Lee, Woo Je Lee
  Diabetes & Metabolism Journal.2019; 43(6): 898.     CrossRef
• Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors
  Ji-Yeon Lee, Yongin Cho, Minyoung Lee, You Jin Kim, Yong-ho Lee, Byung-Wan Lee, Bong-Soo Cha, Eun Seok Kang
  Diabetes & Metabolism Journal.2019; 43(2): 158.     CrossRef
• Comparative Efficacy and Safety Among Sodium-glucose Cotransporter-2 Inhibitors in Type 2 Diabetes – Results from a Retrospective Single-centre Study
  Manash P Baruah, Sanjay Kalra
  European Endocrinology.2019; 15(2): 113.     CrossRef
• Canagliflozin stability study and ecofriendly chromatographic determination of its degradation product: A comparative study
  Aml A. Emam
  Journal of Separation Science.2018; 41(4): 822.     CrossRef
• Efficacy and tolerability of novel triple combination therapy in drug-naïve patients with type 2 diabetes from the TRIPLE-AXEL trial: protocol for an open-label randomised controlled trial
  Nam Hoon Kim, Soo Lim, Soo Heon Kwak, Min Kyong Moon, Jun Sung Moon, Yong-ho Lee, Ho Chan Cho, Juneyoung Lee, Sin Gon Kim
  BMJ Open.2018; 8(9): e022448.     CrossRef
• Short-term outcomes of patients with Type 2 diabetes mellitus treated with canagliflozin compared with sitagliptin in a real-world setting
  YL Shao, KH Yee, SK, Koh, YF Wong, LY Yeoh, S Low, CF Sum
  Singapore Medical Journal.2018; 59(5): 251.     CrossRef
• Clinical implications of current cardiovascular outcome trials with sodium glucose cotransporter-2 (SGLT2) inhibitors
  Soo Lim, Robert H. Eckel, Kwang Kon Koh
  Atherosclerosis.2018; 272: 33.     CrossRef
• Effect of Empagliflozin, a Selective Sodium-Glucose Cotransporter 2 Inhibitor, on Kidney and Peripheral Nerves in Streptozotocin-Induced Diabetic Rats
  Kyung Ae Lee, Heung Yong Jin, Na Young Lee, Yu Ji Kim, Tae Sun Park
  Diabetes & Metabolism Journal.2018; 42(4): 338.     CrossRef
• The effect of Ramadan fasting and continuing sodium-glucose co-transporter-2 (SGLT2) inhibitor use on ketonemia, blood pressure and renal function in Muslim patients with type 2 diabetes
  Yanli Shao, Gwyneth Joy Lim, Chin Lian Chua, Yip Fong Wong, Ester Chai Kheng Yeoh, Serena Kiat Mun Low, Chee Fang Sum
  Diabetes Research and Clinical Practice.2018; 142: 85.     CrossRef
• Effect of Dapagliflozin on Alanine Aminotransferase Improvement in Type 2 Diabetes Mellitus with Non-alcoholic Fatty Liver Disease
  Dug-Hyun Choi, Chan-Hee Jung, Ji-Oh Mok, Chul-Hee Kim, Sung-Koo Kang, Bo-Yeon Kim
  Endocrinology and Metabolism.2018; 33(3): 387.     CrossRef
• Comparison between sodium–glucose cotransporter 2 inhibitors and pioglitazone as additions to insulin therapy in type 2 diabetes patients: A systematic review with an indirect comparison meta‐analysis
  Yun Kyung Cho, Ye‐Jee Kim, Yu Mi Kang, Seung Eun Lee, Joong‐Yeol Park, Woo Je Lee, Chang Hee Jung
  Journal of Diabetes Investigation.2018; 9(4): 882.     CrossRef
• Characteristics of Dapagliflozin Responders: A Longitudinal, Prospective, Nationwide Dapagliflozin Surveillance Study in Korea
  Eugene Han, Ari Kim, Sung Jae Lee, Je-Yon Kim, Jae Hyeon Kim, Woo Je Lee, Byung-Wan Lee
  Diabetes Therapy.2018; 9(4): 1689.     CrossRef
• Combining SGLT2 Inhibition With a Thiazolidinedione Additively Attenuate the Very Early Phase of Diabetic Nephropathy Progression in Type 2 Diabetes Mellitus
  Eugene Han, Eugene Shin, Gyuri Kim, Ji-Yeon Lee, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha
  Frontiers in Endocrinology.2018;[Epub]     CrossRef
• Clinical parameters affecting dapagliflozin response in patients with type 2 diabetes
  J.-Y. Lee, G. Kim, S.R. Kim, Y.-H. Lee, B.-W. Lee, B.-S. Cha, E.S. Kang
  Diabetes & Metabolism.2017; 43(2): 191.     CrossRef
• Glucagon and glucagon-like peptide-1 as novel anti-inflammatory and immunomodulatory compounds
  Daniella B.R. Insuela, Vinicius F. Carvalho
  European Journal of Pharmacology.2017; 812: 64.     CrossRef
• Efficacy and safety of tofogliflozin in Japanese patients with type 2 diabetes mellitus with inadequate glycaemic control on insulin therapy (J‐STEP/INS): Results of a 16‐week randomized, double‐blind, placebo‐controlled multicentre trial
  Yasuo Terauchi, Masahiro Tamura, Masayuki Senda, Ryoji Gunji, Kohei Kaku
  Diabetes, Obesity and Metabolism.2017; 19(10): 1397.     CrossRef
• A comparison of effects of DPP-4 inhibitor and SGLT2 inhibitor on lipid profile in patients with type 2 diabetes
  Seon-Ah Cha, Yong-Moon Park, Jae-Seung Yun, Tae-Seok Lim, Ki-Ho Song, Ki-Dong Yoo, Yu-Bae Ahn, Seung-Hyun Ko
  Lipids in Health and Disease.2017;[Epub]     CrossRef
• Morning Spot Urine Glucose-to-Creatinine Ratios Predict Overnight Urinary Glucose Excretion in Patients With Type 2 Diabetes
  So Ra Kim, Yong-ho Lee, Sang-Guk Lee, Sun Hee Lee, Eun Seok Kang, Bong-Soo Cha, Hyun Chul Lee, Jeong-Ho Kim, Byung-Wan Lee
  Annals of Laboratory Medicine.2017; 37(1): 9.     CrossRef
• The Relationship between Increases in Morning Spot Urinary Glucose Excretion and Decreases in HbA1C in Patients with Type 2 Diabetes After Taking an SGLT2 Inhibitor: A Retrospective, Longitudinal Study
  So Ra Kim, Yong-ho Lee, Eun Seok Kang, Bong-Soo Cha, Byung-Wan Lee
  Diabetes Therapy.2017; 8(3): 601.     CrossRef
• Clinical and Genetic Features of Patients With Type 2 Diabetes and Renal Glycosuria
  Siqian Gong, Jiandong Guo, Xueyao Han, Meng Li, Lingli Zhou, Xiaoling Cai, Yu Zhu, Yingying Luo, Simin Zhang, Xianghai Zhou, Yumin Ma, Linong Ji
  The Journal of Clinical Endocrinology & Metabolism.2017; 102(5): 1548.     CrossRef
• Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes
  Seok Joon Shin, Sungjin Chung, Soo Jung Kim, Eun-Mi Lee, Young-Hye Yoo, Ji-Won Kim, Yu-Bae Ahn, Eun-Sook Kim, Sung-Dae Moon, Myung-Jun Kim, Seung-Hyun Ko, Kwang-Hyun Baek
  PLOS ONE.2016; 11(11): e0165703.     CrossRef
• Sodium–glucose cotransporter 2 inhibitors: an evidence-based practice approach to their use in the natural history of type 2 diabetes
  Stanley S. Schwartz, Intekhab Ahmed
  Current Medical Research and Opinion.2016; 32(5): 907.     CrossRef
• Insulin resistance, role of metformin and other non-insulin therapies in pediatric type 1 diabetes
  Fida Bacha, Sara Klinepeter Bartz
  Pediatric Diabetes.2016; 17(8): 545.     CrossRef
• Renal threshold for glucose reabsorption predicts diabetes improvement by sodium‐glucose cotransporter 2 inhibitor therapy
  Aya Osaki, Shuichi Okada, Tsugumichi Saito, Eijiro Yamada, Kumeo Ono, Yawara Niijima, Hiroto Hoshi, Masanobu Yamada
  Journal of Diabetes Investigation.2016; 7(5): 751.     CrossRef
• Sodium-glucose co-transporter inhibition in the treatment of diabetes: Sweetening the pot
  Carlos A Alvarez, Ian J Neeland, Darren K McGuire
  Diabetes and Vascular Disease Research.2015; 12(2): 74.     CrossRef
• A simple and sensitive high performance liquid chromatography assay with a fluorescence detector for determination of canagliflozin in human plasma
  Muzaffar Iqbal, Nasr Y. Khalil, Amer M. Alanazi, Khalid A. Al-Rashood
  Analytical Methods.2015; 7(7): 3028.     CrossRef
• Efficacy and safety of sodium–glucose cotransporter 2 inhibitors in type 2 diabetes: a meta-analysis of randomized controlled trials for 1 to 2 years
  Xiang-Yang Liu, Ning Zhang, Rui Chen, Jia-Guo Zhao, Pei Yu
  Journal of Diabetes and its Complications.2015; 29(8): 1295.     CrossRef
• Severe hypercalcemia and hypernatremia in a patient treated with canagliflozin
  Arshpreet Kaur, Stephen J Winters
  Endocrinology, Diabetes & Metabolism Case Reports.2015;[Epub]     CrossRef
• Pharmacological treatment and therapeutic perspectives of metabolic syndrome
  Soo Lim, Robert H. Eckel
  Reviews in Endocrine and Metabolic Disorders.2014; 15(4): 329.     CrossRef

With worldwide epidemic of diabetes mellitus, diabetic nephropathy which is one of the major causes of microvascular complication has become a serious concern in Korea as well as the rest of the world. In view of its significance, there is an urgent and paramount need for proper managements that could either deter or slow the progression of diabetic nephropathy. Despite advances in care, ever increasing number of patients suffering from diabetic kidney disease and from end-stage renal disease implies that the current management is not adequate in many aspects. The reasons for these inadequacies compromise lack of early diagnosis, failure to intervene with timely and aggressive manner, and lack of understanding on the kind of interventions required. Another issue equally important for the adequate care of patients with diabetic nephropathy is an understanding of past, present and future epidemiology of diabetic nephropathy which serves, especially in Korea, as a material determining standard diagnosis and treatment and a national health-policy decision.

Citations

Citations to this article as recorded by  

• N6-methyladenosine RNA methylation in diabetic kidney disease
  Jiaan Huang, Fan Yang, Yan Liu, Yuehua Wang
  Biomedicine & Pharmacotherapy.2024; 171: 116185.     CrossRef
• Association of advanced chronic kidney disease with diabetic retinopathy severity in older patients with diabetes: a retrospective cross-sectional study
  Geun Woo Lee, Chul Ho Lee, Seong Gyu Kim
  Journal of Yeungnam Medical Science.2023; 40(2): 146.     CrossRef
• Age at Mortality in Patients with Type 2 Diabetes Who Underwent Kidney Transplantation: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018
  Sun Ok Song, Eugene Han, Kang Ju Son, Bong-Soo Cha, Byung-Wan Lee
  Journal of Clinical Medicine.2023; 12(9): 3160.     CrossRef
• Single‐cell RNA‐seq with spatial transcriptomics to create an atlas of human diabetic kidney disease
  Duo Chen, Mingwei Shao, Yi Song, Gaofei Ren, Feng Guo, Xunjie Fan, Yanyan Wang, Wei Zhang, Guijun Qin
  The FASEB Journal.2023;[Epub]     CrossRef
• Metabolomic profiling of amino acids study reveals a distinct diagnostic model for diabetic kidney disease
  Jiao Wang, Chunyu Zhou, Qing Zhang, Zhangsuo Liu
  Amino Acids.2023; 55(11): 1563.     CrossRef
• New insights into the mechanisms of diabetic kidney disease: Role of circadian rhythm and Bmal1
  Zhimei Peng, Yanting Liang, Xueying Liu, Jie Shao, Nan Hu, Xinzhou Zhang
  Biomedicine & Pharmacotherapy.2023; 166: 115422.     CrossRef
• Physical exercise as a friend not a foe in acute kidney diseases through immune system modulation
  Ana Carolina Costanti-Nascimento, Leonilia Brelaz-Abreu, Elayne Bragança-Jardim, Welbert de Oliveira Pereira, Niels Olsen Saraiva Camara, Mariane Tami Amano
  Frontiers in Immunology.2023;[Epub]     CrossRef
• Sodium-dependent glucose transporter 2 inhibitor alleviates renal lipid deposition and improves renal oxygenation levels in newly diagnosed type 2 diabetes mellitus patients: a randomized controlled trial
  Li Zhang, Tongdan Wang, Yan Kong, Haizhen Sun, Yuling Zhang, Junmei Wang, Zhida Wang, Shan Lu, Pei Yu, Saijun Zhou
  Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
• Neutrophil lymphocyte ratio: a reliable biomarker for diabetic nephropathy?
  Ashutosh Singh, Anshu Kumar Jha, Bipul Chandra Kalita, Dharmendra Kumar Jha, Yash Alok
  International Journal of Diabetes in Developing Countries.2022; 42(3): 523.     CrossRef
• miR-193a as a potential mediator of WT-1/synaptopodin in the renoprotective effect of Losartan on diabetic kidney
  Dan Gao, Pei Yu, Sanhui Jing, Chengcheng Yan, Dandan Ding, Yingjin Qiao, Ge Wu
  Canadian Journal of Physiology and Pharmacology.2022; 100(1): 26.     CrossRef
• 3-Hydroxybutyrate Ameliorates the Progression of Diabetic Nephropathy
  Jeeyoun Jung, Woo Yeong Park, Yun Jin Kim, Mikyung Kim, Misun Choe, Kyubok Jin, Ji Hae Seo, Eunyoung Ha
  Antioxidants.2022; 11(2): 381.     CrossRef
• Emerging Role of Epitranscriptomics in Diabetes Mellitus and Its Complications
  Xinqian Geng, Zheng Li, Ying Yang
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Analysis of serum circulating MicroRNAs level in Malaysian patients with gestational diabetes mellitus
  Sajad Jamalpour, Shamsul Mohd Zain, Reza Vazifehmand, Zahurin Mohamed, Yuh Fen Pung, Hesam Kamyab, Siti Zawiah Omar
  Scientific Reports.2022;[Epub]     CrossRef
• Combined Single-Cell RNA-Seq and Spatial Transcriptomics Reveal an Atlas of Human Diabetic Kidney Disease
  Duo Chen, Mingwei Shao, Yi Song, Gaofei Ren, Feng Guo, Xunjie Fan, Yanyan Wang, Wei Zhang, Guijun Qin
  SSRN Electronic Journal .2022;[Epub]     CrossRef
• How to inhibit transforming growth factor beta safely in diabetic kidney disease
  Yuxin Yang, Kexin Shi, Devang M. Patel, Fang Liu, Tieqiao Wu, Zhonglin Chai
  Current Opinion in Nephrology & Hypertension.2021; 30(1): 115.     CrossRef
• Plasma miR-193a-3p can be a potential biomarker for the diagnosis of diabetic nephropathy
  Yan Hong, Jidong Wang, Lai Zhang, Wenjuan Sun, Xuefang Xu, Kaiyue Zhang
  Annals of Clinical Biochemistry: International Journal of Laboratory Medicine.2021; 58(2): 141.     CrossRef
• Severe hypoglycemia and the risk of end stage renal disease in type 2 diabetes
  Jae-Seung Yun, Yong-Moon Park, Kyungdo Han, Hyung-Wook Kim, Seon-Ah Cha, Yu-Bae Ahn, Seung-Hyun Ko
  Scientific Reports.2021;[Epub]     CrossRef
• Integrin β3 overexpression contributes to podocyte injury through inhibiting RhoA/YAP signaling pathway
  Zhuo Li, Zhiwen Lian, Jianchao Ma, Li Zhang, Xingji Lian, Shuangxin Liu, Jianteng Xie, Zhonglin Feng, Ting Lin, Hong Zhang, Xinling Liang
  Bioengineered.2021; 12(1): 1138.     CrossRef
• A Nonlinear Relationship Between Serum 25-Hydroxyvitamin D and Urine Albumin to Creatinine Ratio in Type 2 Diabetes: A Cross-Sectional Study in China
  Qian Liang, Haofei Hu, Han Wu, Xuan Chen, Wei Wang, Ying Le, Shufen Yang, Lijing Jia
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 2581.     CrossRef
• Proteinuria as a significant predictive factor for the progression of carotid artery atherosclerosis in non-albuminuric type 2 diabetes
  Young-eun Kim, Minyoung Lee, Yong-ho Lee, Eun Seok Kang, Bong-soo Cha, Byung-Wan Lee
  Diabetes Research and Clinical Practice.2021; 181: 109082.     CrossRef
• USP9X prevents AGEs-induced upregulation of FN and TGF-β1 through activating Nrf2-ARE pathway in rat glomerular mesangial cells
  Kaipeng Huang, Xilin Zhao
  Experimental Cell Research.2020; 393(2): 112100.     CrossRef
• D-dimer Levels in Chronic Kidney Illness: A Comprehensive and Systematic Literature Review
  Sahar Vahdat, Shahrzad Shahidi
  Proceedings of the National Academy of Sciences, India Section B: Biological Sciences.2020; 90(5): 911.     CrossRef
• Circulating Expression Level of LncRNA Malat1 in Diabetic Kidney Disease Patients and Its Clinical Significance
  Lian-ji Zhou, Da-wei Yang, Li-Na Ou, Xing-Rong Guo, Biao-liang Wu
  Journal of Diabetes Research.2020; 2020: 1.     CrossRef
• Impact of chronic kidney disease definition on assessment of its incidence and risk factors in patients with newly diagnosed type 1 and type 2 diabetes in the UK: A cohort study using primary care data from the United Kingdom
  Antonio González-Pérez, Maria E. Saéz, David Vizcaya, Marcus Lind, Luis A. García Rodríguez
  Primary Care Diabetes.2020; 14(4): 381.     CrossRef

• Resveratrol Inhibits Lipopolysaccharide-Induced Extracellular Matrix Accumulation and Inflammation in Rat Glomerular Mesangial Cells by SphK1/S1P2/NF-κB Pathway

  
  Wenyan Gong, Jie Li, Wenying Chen, Fuzhen Feng, Yanhui Deng
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 4495.     CrossRef
• Effects of dietary iron restriction on kidney mitochondria function and oxidative stress in streptozotocin-diabetic rats
  Donovan J. Peña-Montes, Maribel Huerta-Cervantes, Mónica Ríos-Silva, Xóchitl Trujillo, Christian Cortés-Rojo, Miguel Huerta, Alfredo Saavedra-Molina
  Mitochondrion.2020; 54: 41.     CrossRef
• Significance of glycated LDL in different stages of diabetic nephropathy
  Khalid Siddiqui, Teena P. George, Shaik Sarfaraz Nawaz, Maram Yaslam, Ebtehal Almogbel, Khalid Al-Rubeaan
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(1): 548.     CrossRef
• Prognostic value of visit-to-visit systolic blood pressure variability related to diabetic kidney disease among patients with type 2 diabetes
  Zhe-Bin Yu, Jian-Bing Wang, Die Li, Xue-Yu Chen, Hong-Bo Lin, Kun Chen
  Journal of Hypertension.2019; 37(7): 1411.     CrossRef
• Epigenetics and epigenomics in diabetic kidney disease and metabolic memory
  Mitsuo Kato, Rama Natarajan
  Nature Reviews Nephrology.2019; 15(6): 327.     CrossRef
• Resveratrol inhibits high glucose-induced activation of AP-1 and NF-κB via SphK1/S1P2 pathway to attenuate mesangial cells proliferation and inflammation
  Yanhui Deng, Wenyan Gong, Qiang Li, Xian Wu, Liyao Wu, Xiaoxia Zheng, Wenying Chen, Heqing Huang
  Journal of Functional Foods.2019; 55: 86.     CrossRef
• Predictive Factors for Efficacy of AST-120 Treatment in Diabetic Nephropathy: a Prospective Single-Arm, Open-Label, Multi-Center Study
  You-Cheol Hwang, Se Won Kim, Kyu Yeon Hur, Bong-Soo Cha, In Joo Kim, Tae Sun Park, Sei Hyun Baik, Kun Ho Yoon, Kwan Woo Lee, In Kyu Lee, Moon-Kyu Lee
  Journal of Korean Medical Science.2019;[Epub]     CrossRef
• Potential Diagnostic Hemorheological Indexes for Chronic Kidney Disease in Patients With Type 2 Diabetes
  Hoyoon Lee, Wonwhi Na, Sang Bae Lee, Chul Woo Ahn, Jun Sung Moon, Kyu Chang Won, Sehyun Shin
  Frontiers in Physiology.2019;[Epub]     CrossRef
• Comparing the Effect of Dipeptidyl-Peptidase 4 Inhibitors and Sulfonylureas on Albuminuria in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Prospective Open-Label Study
  Po-Chung Cheng, Shang-Ren Hsu, Jeng-Fu Kuo, Yun-Chung Cheng, Yu-Hsiu Liu, Shih-Te Tu
  Journal of Clinical Medicine.2019; 8(10): 1715.     CrossRef
• Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease
  Yaeni Kim, Cheol Whee Park
  International Journal of Molecular Sciences.2019; 20(7): 1782.     CrossRef
• Regulatory T cells in acute and chronic kidney diseases
  Rahul Sharma, Gilbert R. Kinsey
  American Journal of Physiology-Renal Physiology.2018; 314(5): F679.     CrossRef
• Herba Artemisiae Capillaris Extract Prevents the Development of Streptozotocin-Induced Diabetic Nephropathy of Rat
  Jianan Geng, Xiaoyan Yu, Chunyu Liu, Chengbo Sun, Menghuan Guo, Zhen Li, Yingli Jin, Yinggang Zou, Jinghua Yu
  Evidence-Based Complementary and Alternative Medicine.2018; 2018: 1.     CrossRef
• Overview of the burden of illness and the role of once-weekly glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes
  Deborah Hinnen
  Journal of the American Association of Nurse Practitioners.2018; 30(1): S4.     CrossRef
• Previous Exercise Training Reduces Markers of Renal Oxidative Stress and Inflammation in Streptozotocin-Induced Diabetic Female Rats
  Liliany Souza de Brito Amaral, Cláudia Silva Souza, Rildo Aparecido Volpini, Maria Heloisa Massola Shimizu, Ana Carolina de Bragança, Daniele Canale, Antonio Carlos Seguro, Terezila Machado Coimbra, Amélia Cristina Mendes de Magalhães, Telma de Jesus Soar
  Journal of Diabetes Research.2018; 2018: 1.     CrossRef
• Critical Shear Stress is Associated with Diabetic Kidney Disease in Patients with Type 2 Diabetes
  Seung Min Chung, Jung Hyun Oh, Jun Sung Moon, Yu Kyung Kim, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee
  Scientific Reports.2018;[Epub]     CrossRef
• Losartan Alleviates Renal Fibrosis and Inhibits Endothelial-to-Mesenchymal Transition (EMT) Under High-Fat Diet-Induced Hyperglycemia
  Yufeng Yao, Yong Li, Xiaofei Zeng, Zheng Ye, Xia Li, Lu Zhang
  Frontiers in Pharmacology.2018;[Epub]     CrossRef
• Association between poor psychosocial conditions and diabetic nephropathy in Japanese type 2 diabetes patients: A cross‐sectional study
  Hiroyo Ninomiya, Naoto Katakami, Taka‐aki Matsuoka, Mitsuyoshi Takahara, Hitoshi Nishizawa, Norikazu Maeda, Michio Otsuki, Akihisa Imagawa, Hiroyasu Iso, Tetsuya Ohira, Iichiro Shimomura
  Journal of Diabetes Investigation.2018; 9(1): 162.     CrossRef
• Urinary Microvesicle-Bound Uromodulin: A Potential Molecular Biomarker in Diabetic Kidney Disease
  Neng-jun Lou, Yi-hong Ni, Hong-ying Jia, Jing-ti Deng, Lu Jiang, Feng-jie Zheng, Ai-li Sun
  Journal of Diabetes Research.2017; 2017: 1.     CrossRef
• Renoprotective effect of fucoidan from Acaudina molpadioides in streptozotocin/high fat diet-induced type 2 diabetic mice
  Shiwei Hu, Jinhui Wang, Jingfeng Wang, Shijie Li, Wei Jiang, Yu Liu
  Journal of Functional Foods.2017; 31: 123.     CrossRef
• Analysis and comparison of the cost-effectiveness of statins according to the baseline low-density lipoprotein cholesterol level in Korea
  Y. J. Jeong, H. Kim, S. J. Baik, T. M. Kim, S. J. Yang, S.-H. Lee, J.-H. Cho, H. Lee, H. W. Yim, I. Y. Choi, K.-H. Yoon, H.-S. Kim
  Journal of Clinical Pharmacy and Therapeutics.2017; 42(3): 292.     CrossRef
• Visualization of kidney fibrosis in diabetic nephropathy by long diffusion tensor imaging MRI with spin-echo sequence
  Jun-Ya Kaimori, Yoshitaka Isaka, Masaki Hatanaka, Satoko Yamamoto, Naotsugu Ichimaru, Akihiko Fujikawa, Hiroshi Shibata, Akira Fujimori, Sosuke Miyoshi, Takashi Yokawa, Kagayaki Kuroda, Toshiki Moriyama, Hiromi Rakugi, Shiro Takahara
  Scientific Reports.2017;[Epub]     CrossRef
• Rutin suppresses high glucose-induced ACTA2 and p38 protein expression in diabetic nephropathy
  Chun-Shan Han, Kai Liu, Ning Zhang, Shi-Wen Li, Hai-Cheng Gao
  Experimental and Therapeutic Medicine.2017; 14(1): 181.     CrossRef
• Emodin self-emulsifying platform ameliorates the expression of FN, ICAM-1 and TGF-β1 in AGEs-induced glomerular mesangial cells by promoting absorption
  Jiani Huang, Wenyan Gong, Zhiquan Chen, Junying Huang, Qiuhong Chen, Heqing Huang, Chunshun Zhao
  European Journal of Pharmaceutical Sciences.2017; 99: 128.     CrossRef
• New therapeutic agents in diabetic nephropathy
  Yaeni Kim, Cheol Whee Park
  The Korean Journal of Internal Medicine.2017; 32(1): 11.     CrossRef
• Urine clusterin/apolipoprotein J is linked to tubular damage and renal outcomes in patients with type 2 diabetes mellitus
  Sang Soo Kim, Sang Heon Song, Jong Ho Kim, Yun Kyung Jeon, Bo Hyun Kim, Min‐Cheol Kang, Sung Wan Chun, Soo Hyun Hong, Michelle Chung, Yong Ki Kim, In Joo Kim, Young‐Bum Kim
  Clinical Endocrinology.2017; 87(2): 156.     CrossRef
• Treatment of diabetic kidney disease: current and future targets
  Mi-Kyung Kim
  The Korean Journal of Internal Medicine.2017; 32(4): 622.     CrossRef
• Sphingosine kinase 1 mediates AGEs-induced fibronectin upregulation in diabetic nephropathy
  Cheng Chen, Wenyan Gong, Changzheng Li, Fengxiao Xiong, Shaogui Wang, Junying Huang, Yu Wang, Zhiquan Chen, Qiuhong Chen, Peiqing Liu, Tian Lan, Heqing Huang
  Oncotarget.2017; 8(45): 78660.     CrossRef
• Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with Diabetes
  Eugene Han, Gyuri Kim, Ji-Yeon Lee, Yong-ho Lee, Beom Seok Kim, Byung-Wan Lee, Bong-Soo Cha, Eun Seok Kang
  Endocrinology and Metabolism.2017; 32(2): 274.     CrossRef
• Glycemic Management of Patients Undergoing Dialysis
  Mi-Kyung Kim
  The Journal of Korean Diabetes.2016; 17(3): 164.     CrossRef
• Probucol in Albuminuric Type 2 Diabetes Mellitus Patients on Renin–Angiotensin System Blockade
  Sang-Man Jin, Kyung Ah Han, Jae Myung Yu, Tae Seo Sohn, Sung Hee Choi, Choon Hee Chung, Ie Byung Park, Eun Jung Rhee, Sei Hyun Baik, Tae Sun Park, In-Kyu Lee, Seung-Hyun Ko, You-Cheol Hwang, Bong Soo Cha, Hyoung Woo Lee, Moon-Suk Nam, Moon-Kyu Lee
  Arteriosclerosis, Thrombosis, and Vascular Biology.2016; 36(10): 2108.     CrossRef
• MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARγ pathway in diabetic nephropathy
  Xiaoyan Hou, Jianwei Tian, Jian Geng, Xiao Li, Xun Tang, Jun Zhang, Xiaoyan Bai
  Oncotarget.2016; 7(30): 47760.     CrossRef
• Lipoprotein(a) predicts a new onset of chronic kidney disease in people with Type 2 diabetes mellitus
  J.‐S. Yun, Y.‐B. Ahn, K.‐H. Song, K.‐D. Yoo, Y.‐M. Park, H.‐W. Kim, S.‐H. Ko
  Diabetic Medicine.2016; 33(5): 639.     CrossRef
• Metabolic biomarkers for chronic kidney disease
  Marc Breit, Klaus M. Weinberger
  Archives of Biochemistry and Biophysics.2016; 589: 62.     CrossRef
• Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes
  Seok Joon Shin, Sungjin Chung, Soo Jung Kim, Eun-Mi Lee, Young-Hye Yoo, Ji-Won Kim, Yu-Bae Ahn, Eun-Sook Kim, Sung-Dae Moon, Myung-Jun Kim, Seung-Hyun Ko, Kwang-Hyun Baek
  PLOS ONE.2016; 11(11): e0165703.     CrossRef
• Renoprotective Effect of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, in Streptozotocin-Induced Type 1 Diabetic Mice
  Gwon-Soo Jung, Jae-Han Jeon, Mi Sun Choe, Sung-Woo Kim, In-Kyu Lee, Mi-Kyung Kim, Keun-Gyu Park
  Diabetes & Metabolism Journal.2016; 40(3): 211.     CrossRef
• Beneficial effects of previous exercise training on renal changes in streptozotocin-induced diabetic female rats
  Liliany S de Brito Amaral, Fernanda A Silva, Vicente B Correia, Clara EF Andrade, Bárbara A Dutra, Márcio V Oliveira, Amélia CM de Magalhães, Rildo A Volpini, Antonio C Seguro, Terezila M Coimbra, Telma de J Soares
  Experimental Biology and Medicine.2016; 241(4): 437.     CrossRef
• Adenosine monophosphate–activated protein kinase in diabetic nephropathy
  Yaeni Kim, Cheol Whee Park
  Kidney Research and Clinical Practice.2016; 35(2): 69.     CrossRef
• Estimated Glucose Disposal Rate (eGDR) – A Marker for the Assessment of Insulin Resistance in Type 1 Diabetes Mellitus
  Mihaela L. Bîcu, Daniel Bîcu, Sigina Gârgavu, Magdalena Sandu, Mihaela I. Vladu, Diana Clenciu, Eugen Moţa, Maria Moţa
  Romanian Journal of Diabetes Nutrition and Metabolic Diseases.2016; 23(2): 177.     CrossRef
• Polydatin attenuates AGEs-induced upregulation of fibronectin and ICAM-1 in rat glomerular mesangial cells and db/db diabetic mice kidneys by inhibiting the activation of the SphK1-S1P signaling pathway
  Cheng Chen, Kaipeng Huang, Jie Hao, Junying Huang, Zhiying Yang, Fengxiao Xiong, Peiqing Liu, Heqing Huang
  Molecular and Cellular Endocrinology.2016; 427: 45.     CrossRef
• Glycated albumin and the risk of micro- and macrovascular complications in subjects with Type 1 Diabetes
  Hye-jin Yoon, Yong-ho Lee, So Ra Kim, Tyler Hyungtaek Rim, Eun Young Lee, Eun Seok Kang, Bong-Soo Cha, Hyun Chul Lee, Byung-Wan Lee
  Cardiovascular Diabetology.2015;[Epub]     CrossRef
• Tripterygium Glycosides Tablet Ameliorates Renal Tubulointerstitial Fibrosis via the Toll-Like Receptor 4/Nuclear Factor Kappa B Signaling Pathway in High-Fat Diet Fed and Streptozotocin-Induced Diabetic Rats
  Ze-jun Ma, Xiao-na Zhang, Li Li, Wei Yang, Shan-shan Wang, Xin Guo, Pei Sun, Li-ming Chen
  Journal of Diabetes Research.2015; 2015: 1.     CrossRef
• The association between abnormal heart rate variability and new onset of chronic kidney disease in patients with type 2 diabetes: A ten-year follow-up study
  Jae-Seung Yun, Yu-Bae Ahn, Ki-Ho Song, Ki-Dong Yoo, Hyung-Wook Kim, Yong-Moon Park, Seung-Hyun Ko
  Diabetes Research and Clinical Practice.2015; 108(1): 31.     CrossRef
• Finerenone: third-generation mineralocorticoid receptor antagonist for the treatment of heart failure and diabetic kidney disease
  Licette CY Liu, Elise Schutte, Ron T Gansevoort, Peter van der Meer, Adriaan A Voors
  Expert Opinion on Investigational Drugs.2015; 24(8): 1123.     CrossRef
• Effects of pentoxifylline on proteinuria and glucose control in patients with type 2 diabetes: a prospective randomized double-blind multicenter study
  Seung Jin Han, Hae Jin Kim, Dae Jung Kim, Seung Soo Sheen, Choon Hee Chung, Chul Woo Ahn, Se Hwa Kim, Yong-Wook Cho, Seok Won Park, Soo-Kyung Kim, Chul Sik Kim, Kyung Wook Kim, Kwan Woo Lee
  Diabetology & Metabolic Syndrome.2015;[Epub]     CrossRef
• Proteomic Profile in Glomeruli of Type-2 Diabetic KKAy Mice using 2-Dimensional Differential Gel Electrophoresis
  Lining Wang
  Medical Science Monitor.2014; 20: 2705.     CrossRef

Fibroblast growth factor 21 (FGF21) is an endocrine hormone that is primarily expressed in the liver and exerts beneficial effects on obesity and related metabolic diseases. In addition to its remarkable pharmacologic actions, the physiological roles of FGF21 include the maintenance of energy homeostasis in the body in conditions of metabolic or environmental stress. The expression of FGF21 is induced in multiple organs in response to diverse physiological or pathological stressors, such as starvation, nutrient excess, autophagy deficiency, mitochondrial stress, exercise, and cold exposure. Thus, the FGF21 induction caused by stress plays an important role in adaptive response to these stimuli. Here, we highlight our current understanding of the functional importance of the induction of FGF21 by diverse stressors as a feedback mechanism that prevents excessive stress.

Citations

Citations to this article as recorded by  

• Fibroblast growth factor 21: An emerging pleiotropic regulator of lipid metabolism and the metabolic network
  Shuo Li, Tiande Zou, Jun Chen, Jiaming Li, Jinming You
  Genes & Diseases.2024; 11(3): 101064.     CrossRef
• From Beats to Metabolism: the Heart at the Core of Interorgan Metabolic Cross Talk
  Rafael Romero-Becera, Ayelén M. Santamans, Alba C. Arcones, Guadalupe Sabio
  Physiology.2024; 39(2): 98.     CrossRef
• Beneficial Effects of Low-Grade Mitochondrial Stress on Metabolic Diseases and Aging
  Se Hee Min, Gil Myoung Kang, Jae Woo Park, Min-Seon Kim
  Yonsei Medical Journal.2024; 65(2): 55.     CrossRef
• GDF15 is a dynamic biomarker of the integrated stress response in the central nervous system
  Jyoti Asundi, Chunlian Zhang, Diana Donnelly‐Roberts, Josè Zavala Solorio, Malleswari Challagundla, Caitlin Connelly, Christina Boch, Jun Chen, Mario Richter, Mohammad Mehdi Maneshi, Andrew M. Swensen, Lauren Lebon, Raphael Schiffmann, Subhabrata Sanyal,
  CNS Neuroscience & Therapeutics.2024;[Epub]     CrossRef
• Deciphering adipose development: Function, differentiation and regulation
  Ge Guo, Wanli Wang, Mengjie Tu, Binbin Zhao, Jiayang Han, Jiali Li, Yanbing Pan, Jie Zhou, Wen Ma, Yi Liu, Tiantian Sun, Xu Han, Yang An
  Developmental Dynamics.2024;[Epub]     CrossRef
• Inflammatory liver diseases and susceptibility to sepsis
  Hong Lu
  Clinical Science.2024; 138(7): 435.     CrossRef
• Fibroblast growth factor 21 and bone homeostasis
  Yan Tang, Mei Zhang
  Biomedical Journal.2023; 46(4): 100548.     CrossRef
• Chronic docosahexaenoic acid supplementation improves metabolic plasticity in subcutaneous adipose tissue of aged obese female mice
  Elisa Félix-Soriano, Neira Sáinz, Marta Fernández-Galilea, Eva Gil-Iturbe, Jon Celay, José A. Martínez-Climent, María J. Moreno-Aliaga
  The Journal of Nutritional Biochemistry.2023; 111: 109153.     CrossRef
• Fibroblast Growth Factor–Based Pharmacotherapies for the Treatment of Obesity-Related Metabolic Complications
  Leigang Jin, Ranyao Yang, Leiluo Geng, Aimin Xu
  Annual Review of Pharmacology and Toxicology.2023; 63(1): 359.     CrossRef
• The effect of FGF21 gene polymorphism (g. 940C/T) on biochemical metabolic parameters in blood serum of holstein cattle
  N. Yu. Safina, Sh. K. Shakrov, E. R. Gaynutdinova, Z. F. Fattakhova
  International Journal of Veterinary Medicine.2023; (4): 314.     CrossRef
• Fibroblast growth factor 21 is expressed and secreted from skeletal muscle following electrical stimulation via extracellular ATP activation of the PI3K/Akt/mTOR signaling pathway
  Manuel Arias-Calderón, Mariana Casas, Julián Balanta-Melo, Camilo Morales-Jiménez, Nadia Hernández, Paola Llanos, Enrique Jaimovich, Sonja Buvinic
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Fibroblast growth factor 21 as a potential master regulator in metabolic disorders
  Aayushi Velingkar, Sugunakar Vuree, Pranav Kumar Prabhakar, Rajender Rao Kalashikam, Aparna Banerjee, Suresh Kondeti
  American Journal of Physiology-Endocrinology and Metabolism.2023; 324(5): E409.     CrossRef
• Association of NAFLD with FGF21 Polygenic Hazard Score, and Its Interaction with Protein Intake Level in Korean Adults
  Hae Jin Lee, Jinyoung Shon, Yoon Jung Park
  Nutrients.2023; 15(10): 2385.     CrossRef
• Blood and liver telomere length, mitochondrial DNA copy number, and hepatic gene expression of mitochondrial dynamics in mid-lactation cows supplemented with l-carnitine under systemic inflammation
  S. Häussler, M.H. Ghaffari, K. Seibt, H. Sadri, M. Alaedin, K. Huber, J. Frahm, S. Dänicke, H. Sauerwein
  Journal of Dairy Science.2023; 106(12): 9822.     CrossRef
• Pharmacological Effects of Fibroblast Growth Factor 21 (FGF21) оn Carbohydrate-Lipid Metabolism: Sex Dependence
  N. M. Bazhan, E. N. Makarova
  Успехи физиологических наук.2023; 54(4): 93.     CrossRef
• The Nuanced Metabolic Functions of Endogenous FGF21 Depend on the Nature of the Stimulus, Tissue Source, and Experimental Model
  Redin A. Spann, Christopher D. Morrison, Laura J. den Hartigh
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Long-Term Dietary Taurine Lowers Plasma Levels of Cholesterol and Bile Acids
  Ryoma Tagawa, Masaki Kobayashi, Misako Sakurai, Maho Yoshida, Hiroki Kaneko, Yuhei Mizunoe, Yuka Nozaki, Naoyuki Okita, Yuka Sudo, Yoshikazu Higami
  International Journal of Molecular Sciences.2022; 23(3): 1793.     CrossRef
• Endocrine Fibroblast Growth Factors in Relation to Stress Signaling
  Makoto Shimizu, Ryuichiro Sato
  Cells.2022; 11(3): 505.     CrossRef
• Histone Deacetylases as Modulators of the Crosstalk Between Skeletal Muscle and Other Organs
  Alessandra Renzini, Marco D’Onghia, Dario Coletti, Viviana Moresi
  Frontiers in Physiology.2022;[Epub]     CrossRef
• Multidimensional Biomarker Analysis Including Mitochondrial Stress Indicators for Nonalcoholic Fatty Liver Disease
  Eunha Chang, Jae Seung Chang, In Deok Kong, Soon Koo Baik, Moon Young Kim, Kyu-Sang Park
  Gut and Liver.2022; 16(2): 171.     CrossRef
• FGF21: A Novel Regulator of Glucose and Lipid Metabolism and Whole-Body Energy Balance
  Ewa Szczepańska, Małgorzata Gietka-Czernel
  Hormone and Metabolic Research.2022; 54(04): 203.     CrossRef
• Exercise, Mitohormesis, and Mitochondrial ORF of the 12S rRNA Type-C (MOTS-c)
  Tae Kwan Yoon, Chan Hee Lee, Obin Kwon, Min-Seon Kim
  Diabetes & Metabolism Journal.2022; 46(3): 402.     CrossRef
• Counteracting health risks by Modulating Homeostatic Signaling
  Junqiang J. Tian, Mark Levy, Xuekai Zhang, Robert Sinnott, Rolando Maddela
  Pharmacological Research.2022; 182: 106281.     CrossRef
• Hesperidin abrogates bisphenol A endocrine disruption through binding with fibroblast growth factor 21 (FGF-21), α-amylase and α-glucosidase: an in silico molecular study
  P.M. Aja, J.N. Awoke, P.C. Agu, A.E. Adegboyega, E.M. Ezeh, I.O. Igwenyi, O.U. Orji, O.G. Ani, B.A. Ale, U.A. Ibiam
  Journal of Genetic Engineering and Biotechnology.2022; 20(1): 84.     CrossRef
• Circulating FGF21 vs. Stress Markers in Girls during Childhood and Adolescence, and in Their Caregivers: Intriguing Inter-Relations between Overweight/Obesity, Emotions, Behavior, and the Cared-Caregiver Relationship
  Eirini V. Christaki, Panagiota Pervanidou, Ioannis Papassotiriou, Aimilia Mantzou, Giorgos Giannakakis, Dario Boschiero, George P. Chrousos
  Children.2022; 9(6): 821.     CrossRef
• α‐Lipoic acid up‐regulates gene expression but reduces protein levels of fibroblast growth factor 21 in HepG2 cells
  Xiaochun Zhang, Yanyan Zhao, Xiangyan Liang, Lijun Zhang, Ke Li, Zhuo Sun, Yu‐Feng Zhao
  Basic & Clinical Pharmacology & Toxicology.2022; 131(4): 270.     CrossRef
• Multi-organ FGF21-FGFR1 signaling in metabolic health and disease
  Namrita Kaur, Sanskruti Ravindra Gare, Jiahan Shen, Rida Raja, Oveena Fonseka, Wei Liu
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• Management of patients with neuropathic pain
  Eun Joo Choi
  Journal of the Korean Medical Association.2022; 65(8): 505.     CrossRef
• FGF21–Sirtuin 3 Axis Confers the Protective Effects of Exercise Against Diabetic Cardiomyopathy by Governing Mitochondrial Integrity
  Leigang Jin, Leiluo Geng, Lei Ying, Lingling Shu, Kevin Ye, Ranyao Yang, Yan Liu, Yao Wang, Yin Cai, Xue Jiang, Qin Wang, Xingqun Yan, Boya Liao, Jie Liu, Fuyu Duan, Gary Sweeney, Connie Wai Hong Woo, Yu Wang, Zhengyuan Xia, Qizhou Lian, Aimin Xu
  Circulation.2022; 146(20): 1537.     CrossRef
• Performance and Metabolic, Inflammatory, and Oxidative Stress-Related Parameters in Early Lactating Dairy Cows with High and Low Hepatic FGF21 Expression
  Denise K. Gessner, Lena M. Sandrock, Erika Most, Christian Koch, Robert Ringseis, Klaus Eder
  Animals.2022; 13(1): 131.     CrossRef
• Relationship between FGF21 and drug or nondrug therapy of type 2 diabetes mellitus
  Chang Guo, Li Zhao, Yanyan Li, Xia Deng, Guoyue Yuan
  Journal of Cellular Physiology.2021; 236(1): 55.     CrossRef
• Skeletal Muscle and Bone – Emerging Targets of Fibroblast Growth Factor-21
  Hui Sun, Matthew Sherrier, Hongshuai Li
  Frontiers in Physiology.2021;[Epub]     CrossRef
• Transthyretin contributes to insulin resistance and diminishes exercise-induced insulin sensitivity in obese mice by inhibiting AMPK activity in skeletal muscle
  Yingzi He, Ruojun Qiu, Beibei Wu, Weiwei Gui, Xihua Lin, Hong Li, Fenping Zheng
  American Journal of Physiology-Endocrinology and Metabolism.2021; 320(4): E808.     CrossRef
• Metabolic Messengers: FGF21
  Kyle H. Flippo, Matthew J. Potthoff
  Nature Metabolism.2021; 3(3): 309.     CrossRef
• Circulating Fibroblast Growth Factor-21 Levels in Rheumatoid Arthritis: Associations With Disease Characteristics, Body Composition, and Physical Functioning
  Patrick W. Gould, Babette S. Zemel, Elena G. Taratuta, Joshua F. Baker
  The Journal of Rheumatology.2021; 48(4): 504.     CrossRef
• The transcription factors CREBH, PPARa, and FOXO1 as critical hepatic mediators of diet-induced metabolic dysregulation
  Zhao Yang, Katherine Roth, Manisha Agarwal, Wanqing Liu, Michael C. Petriello
  The Journal of Nutritional Biochemistry.2021; 95: 108633.     CrossRef
• Low‐Level Radiofrequency Exposure Induces Vasoconstriction in Rats
  Thi Cuc Mai, Anne Braun, Veronique Bach, Amandine Pelletier, Rene de Seze
  Bioelectromagnetics.2021; 42(6): 455.     CrossRef
• Anterograde regulation of mitochondrial genes and FGF21 signaling by hepatic LSD1
  Yang Cao, Lingyi Tang, Kang Du, Kitt Paraiso, Qiushi Sun, Zhengxia Liu, Xiaolong Ye, Yuan Fang, Fang Yuan, Hank Chen, Yumay Chen, Xiaorong Wang, Clinton Yu, Ira L. Blitz, Ping H. Wang, Lan Huang, Haibo Cheng, Xiang Lu, Ken W.Y. Cho, Marcus Seldin, Zhuyuan
  JCI Insight.2021;[Epub]     CrossRef
• Fibroblast growth factor 21 attenuates iron overload-induced liver injury and fibrosis by inhibiting ferroptosis
  Aimin Wu, Bin Feng, Jie Yu, Lijun Yan, Lianqiang Che, Yong Zhuo, Yuheng Luo, Bing Yu, De Wu, Daiwen Chen
  Redox Biology.2021; 46: 102131.     CrossRef
• Stress-induced FGF21 and GDF15 in obesity and obesity resistance
  Susanne Keipert, Mario Ost
  Trends in Endocrinology & Metabolism.2021; 32(11): 904.     CrossRef
• Fibroblast growth factor 21 in dairy cows: current knowledge and potential relevance
  Klaus Eder, Denise K. Gessner, Robert Ringseis
  Journal of Animal Science and Biotechnology.2021;[Epub]     CrossRef
• Weight regain after bariatric surgery: Promoters and potential predictors
  Hala Mourad Demerdash
  World Journal of Meta-Analysis.2021; 9(5): 438.     CrossRef
• αKlotho attenuates cardiac hypertrophy and increases myocardial fibroblast growth factor 21 expression in uremic rats
  Paulo Giovani de Albuquerque Suassuna, Paula Marocolo Cherem, Bárbara Bruna de Castro, Edgar Maquigussa, Marco Antonio Cenedeze, Júlio Cesar Moraes Lovisi, Melani Ribeiro Custódio, Helady Sanders-Pinheiro, Rogério Baumgratz de Paula
  Experimental Biology and Medicine.2020; 245(1): 66.     CrossRef
• Effect of Fibroblast Growth Factor 21 on the Development of Atheromatous Plaque and Lipid Metabolic Profiles in an Atherosclerosis-Prone Mouse Model
  Hyo Jin Maeng, Gha Young Lee, Jae Hyun Bae, Soo Lim
  International Journal of Molecular Sciences.2020; 21(18): 6836.     CrossRef
• A Land of Controversy: Fibroblast Growth Factor-23 and Uremic Cardiac Hypertrophy
  Jing-Fu Bao, Pan-Pan Hu, Qin-Ying She, Aiqing Li
  Journal of the American Society of Nephrology.2020; 31(7): 1423.     CrossRef
• Possible associations between plasma fibroblast growth factor 21 levels and cognition in bipolar disorder
  Favour Omileke, Sayuri Ishiwata, Junko Matsuo, Fuyuko Yoshida, Shinsuke Hidese, Kotaro Hattori, Hiroshi Kunugi
  Neuropsychopharmacology Reports.2020; 40(2): 175.     CrossRef
• FGF21-protection against fructose-induced lipid accretion and oxidative stress is influenced by maternal nutrition in male progeny
  Elena Fauste, Silvia Rodrigo, Lourdes Rodríguez, Cristina Donis, Antonia García, Coral Barbas, Juan J. Álvarez-Millán, María I. Panadero, Paola Otero, Carlos Bocos
  Journal of Functional Foods.2020; 64: 103676.     CrossRef
• Fibroblast growth factor 21 and grow differentiation factor 15 are sensitive biomarkers of mitochondrial diseases due to mitochondrial transfer-RNA mutations and mitochondrial DNA deletions
  Patrizia Formichi, Nastasia Cardone, Ilaria Taglia, Elena Cardaioli, Simona Salvatore, Annalisa Lo Gerfo, Costanza Simoncini, Vincenzo Montano, Gabriele Siciliano, Michelangelo Mancuso, Alessandro Malandrini, Antonio Federico, Maria Teresa Dotti
  Neurological Sciences.2020; 41(12): 3653.     CrossRef
• Novel Medicinal Mushroom Blend as a Promising Supplement in Integrative Oncology: A Multi-Tiered Study using 4T1 Triple-Negative Mouse Breast Cancer Model
  Elisa Roda, Fabrizio De Luca, Carmine Di Iorio, Daniela Ratto, Stella Siciliani, Beatrice Ferrari, Filippo Cobelli, Giuseppina Borsci, Erica Cecilia Priori, Silvia Chinosi, Andrea Ronchi, Renato Franco, Raffaele Di Francia, Massimiliano Berretta, Carlo Al
  International Journal of Molecular Sciences.2020; 21(10): 3479.     CrossRef
• High‐protein diet more effectively reduces hepatic fat than low‐protein diet despite lower autophagy and FGF21 levels
  Chenchen Xu, Mariya Markova, Nicole Seebeck, Anne Loft, Silke Hornemann, Thomas Gantert, Stefan Kabisch, Kathleen Herz, Jennifer Loske, Mario Ost, Verena Coleman, Frederick Klauschen, Anke Rosenthal, Volker Lange, Jürgen Machann, Susanne Klaus, Tilman Gru
  Liver International.2020; 40(12): 2982.     CrossRef
• Recharacterizing the Metabolic State of Energy Balance in Thrifty and Spendthrift Phenotypes
  Tim Hollstein, Alessio Basolo, Takafumi Ando, Susanne B Votruba, Mary Walter, Jonathan Krakoff, Paolo Piaggi
  The Journal of Clinical Endocrinology & Metabolism.2020; 105(5): 1375.     CrossRef
• Targeting of Secretory Proteins as a Therapeutic Strategy for Treatment of Nonalcoholic Steatohepatitis (NASH)
  Kyeongjin Kim, Kook Hwan Kim
  International Journal of Molecular Sciences.2020; 21(7): 2296.     CrossRef
• Discovery of a novel fibroblast activation protein (FAP) inhibitor, BR103354, with anti-diabetic and anti-steatotic effects
  Jae Min Cho, Eun Hee Yang, Wenying Quan, Eun Hye Nam, Hyae Gyeong Cheon
  Scientific Reports.2020;[Epub]     CrossRef
• Spontaneous ketonuria and risk of incident diabetes: a 12 year prospective study
  Gyuri Kim, Sang-Guk Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Ele Ferrannini, Yong-ho Lee, Nam H. Cho
  Diabetologia.2019; 62(5): 779.     CrossRef
• Combined docosahexaenoic acid and thyroid hormone supplementation as a protocol supporting energy supply to precondition and afford protection against metabolic stress situations
  Luis A. Videla
  IUBMB Life.2019; 71(9): 1211.     CrossRef
• Effects of exercise on brown and beige adipocytes
  Revati S. Dewal, Kristin I. Stanford
  Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.2019; 1864(1): 71.     CrossRef
• Manipulating mtDNA in vivo reprograms metabolism via novel response mechanisms
  Diana Bahhir, Cagri Yalgin, Liina Ots, Sampsa Järvinen, Jack George, Alba Naudí, Tatjana Krama, Indrikis Krams, Mairi Tamm, Ana Andjelković, Eric Dufour, Jose M. González de Cózar, Mike Gerards, Mikael Parhiala, Reinald Pamplona, Howard T. Jacobs, Priit J
  PLOS Genetics.2019; 15(10): e1008410.     CrossRef
• The Level of FGF 21 as a New Risk Factor for the Occurrence of Cardiometabolic Disorders amongst the Psoriatic Patients
  Paulina Kiluk, Anna Baran, Tomasz W. Kaminski, Magdalena Maciaszek, Iwona Flisiak
  Journal of Clinical Medicine.2019; 8(12): 2206.     CrossRef
• Docosahexaenoic acid‐thyroid hormone combined protocol as a novel approach to metabolic stress disorders: Relation to mitochondrial adaptation via liver PGC‐1α and sirtuin1 activation
  Romina Vargas, Bárbara Riquelme, Javier Fernández, Daniela Álvarez, Ignacio F. Pérez, Pamela Cornejo, Virginia Fernández, Luis A. Videla
  BioFactors.2019; 45(2): 271.     CrossRef
• Fibroblast growth factor 21 predicts outcome in community-acquired pneumonia: secondary analysis of two randomised controlled trials
  Fahim Ebrahimi, Carole Wolffenbuttel, Claudine A. Blum, Christine Baumgartner, Beat Mueller, Philipp Schuetz, Christian Meier, Marius Kraenzlin, Mirjam Christ-Crain, Matthias Johannes Betz
  European Respiratory Journal.2019; 53(2): 1800973.     CrossRef
• Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat
  Huating Li, Guangyu Wu, Qichen Fang, Mingliang Zhang, Xiaoyan Hui, Bin Sheng, Liang Wu, Yuqian Bao, Peng Li, Aimin Xu, Weiping Jia
  Nature Communications.2018;[Epub]     CrossRef
• Effects of supplementing rumen-protected niacin on fiber composition and metabolism of skeletal muscle in dairy cows during early lactation
  J.O. Zeitz, A. Weber, E. Most, W. Windisch, C. Bolduan, J. Geyer, F.-J. Romberg, C. Koch, K. Eder
  Journal of Dairy Science.2018; 101(9): 8004.     CrossRef
• The mitochondrial unfolded protein response and mitohormesis: a perspective on metabolic diseases
  Hyon-Seung Yi, Joon Young Chang, Minho Shong
  Journal of Molecular Endocrinology.2018; 61(3): R91.     CrossRef
• Berberine-induced activation of AMPK increases hepatic FGF21 expression via NUR77
  Feiye Zhou, Mengyao Bai, Yuqing Zhang, Qin Zhu, Linlin Zhang, Qi Zhang, Shushu Wang, Kecheng Zhu, Yun Liu, Xiao Wang, Libin Zhou
  Biochemical and Biophysical Research Communications.2018; 495(2): 1936.     CrossRef
• FGF21 Attenuates High-Fat Diet-Induced Cognitive Impairment via Metabolic Regulation and Anti-inflammation of Obese Mice
  Qingzhi Wang, Jing Yuan, Zhanyang Yu, Li Lin, Yinghua Jiang, Zeyuan Cao, Pengwei Zhuang, Michael J. Whalen, Bo Song, Xiao-Jie Wang, Xiaokun Li, Eng H. Lo, Yuming Xu, Xiaoying Wang
  Molecular Neurobiology.2018; 55(6): 4702.     CrossRef
• Leptin Mediates a Glucose-Fatty Acid Cycle to Maintain Glucose Homeostasis in Starvation
  Rachel J. Perry, Yongliang Wang, Gary W. Cline, Aviva Rabin-Court, Joongyu D. Song, Sylvie Dufour, Xian Man Zhang, Kitt Falk Petersen, Gerald I. Shulman
  Cell.2018; 172(1-2): 234.     CrossRef
• Improvement of Lipid and Glucose Metabolism by Capsiate in Palmitic Acid-Treated HepG2 Cells via Activation of the AMPK/SIRT1 Signaling Pathway
  Yufan Zang, Li Fan, Jihua Chen, Ruixue Huang, Hong Qin
  Journal of Agricultural and Food Chemistry.2018; 66(26): 6772.     CrossRef
• Fibroblast growth factor 21 as a biomarker for long‐term complications in organic acidemias
  F. Molema, E. H. Jacobs, W. Onkenhout, G. C. Schoonderwoerd, J. G. Langendonk, Monique Williams
  Journal of Inherited Metabolic Disease.2018; 41(6): 1179.     CrossRef
• The mitochondrial UPR: mechanisms, physiological functions and implications in ageing
  Tomer Shpilka, Cole M. Haynes
  Nature Reviews Molecular Cell Biology.2018; 19(2): 109.     CrossRef
• FGF21 Is Associated with Metabolic Effects and Treatment Response in Depressed Bipolar II Disorder Patients Treated with Valproate
  Hui Hua Chang, Po See Chen, Yung Wen Cheng, Tzu-Yun Wang, Yen Kuang Yang, Ru-Band Lu
  International Journal of Neuropsychopharmacology.2018; 21(4): 319.     CrossRef
• Circulating Fibroblast Growth Factor 21 is Associated with Subsequent Renal Injury Events in Patients Undergoing Coronary Angiography
  Cheng-Hsueh Wu, Ruey-Hsing Chou, Chin-Sung Kuo, Po-Hsun Huang, Chun-Chin Chang, Hsin-Bang Leu, Chin-Chou Huang, Jaw-Wen Chen, Shing-Jong Lin
  Scientific Reports.2018;[Epub]     CrossRef
• Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis
  Lucas D. BonDurant, Matthew J. Potthoff
  Annual Review of Nutrition.2018; 38(1): 173.     CrossRef
• Endocrine Regulator rFGF21 (Recombinant Human Fibroblast Growth Factor 21) Improves Neurological Outcomes Following Focal Ischemic Stroke of Type 2 Diabetes Mellitus Male Mice
  Yinghua Jiang, Ning Liu, Qingzhi Wang, Zhanyang Yu, Li Lin, Jing Yuan, Shuzhen Guo, Bum Ju Ahn, Xiao-Jie Wang, Xiaokun Li, Eng H. Lo, Xiaochuan Sun, Xiaoying Wang
  Stroke.2018; 49(12): 3039.     CrossRef
• Restricting branched‐chain amino acids: an approach to improve metabolic health
  Jacob G. Anderson, Kenzie Hintze, Erik D. Marchant
  The Journal of Physiology.2018; 596(13): 2469.     CrossRef
• Dietary Manipulations That Induce Ketosis Activate the HPA Axis in Male Rats and Mice: A Potential Role for Fibroblast Growth Factor-21
  Karen K Ryan, Amy E B Packard, Karlton R Larson, Jayna Stout, Sarah M Fourman, Abigail M K Thompson, Kristen Ludwick, Kirk M Habegger, Kerstin Stemmer, Nobuyuki Itoh, Diego Perez-Tilve, Matthias H Tschöp, Randy J Seeley, Yvonne M Ulrich-Lai
  Endocrinology.2018; 159(1): 400.     CrossRef
• Mitochondrial dysfunction in cancer: Potential roles of ATF5 and the mitochondrial UPR
  Pan Deng, Cole M. Haynes
  Seminars in Cancer Biology.2017; 47: 43.     CrossRef
• Modulation of energy balance by fibroblast growth factor 21
  Daniel Cuevas-Ramos, Carlos A. Aguilar-Salinas
  Hormone Molecular Biology and Clinical Investigation.2017;[Epub]     CrossRef
• Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis
  Kelvin H. M. Kwok, Karen S. L. Lam
  Endocrinology and Metabolism.2017; 32(2): 145.     CrossRef
• The U-shaped relationship between fibroblast growth factor 21 and microvascular complication in type 2 diabetes mellitus
  Chan-Hee Jung, Sang-Hee Jung, Bo-Yeon Kim, Chul-Hee Kim, Sung-Koo Kang, Ji-Oh Mok
  Journal of Diabetes and its Complications.2017; 31(1): 134.     CrossRef
• A combined docosahexaenoic acid–thyroid hormone protocol upregulates rat liver β-Klotho expression and downstream components of FGF21 signaling as a potential novel approach to metabolic stress conditions
  R. Vargas, B. Riquelme, J. Fernández, L. A. Videla
  Food & Function.2017; 8(11): 3980.     CrossRef
• Anti-inflammatory effects of exercise training in adipose tissue do not require FGF21
  Jay W Porter, Joe L Rowles, Justin A Fletcher, Terese M Zidon, Nathan C Winn, Leighton T McCabe, Young-Min Park, James W Perfield, John P Thyfault, R Scott Rector, Jaume Padilla, Victoria J Vieira-Potter
  Journal of Endocrinology.2017; 235(2): 97.     CrossRef
• Hepatic FXR/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice
  Kang Ho Kim, Sungwoo Choi, Ying Zhou, Eun Young Kim, Jae Man Lee, Pradip K. Saha, Sayeepriyadarshini Anakk, David D. Moore
  Hepatology.2017; 66(2): 498.     CrossRef
• Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease
  Marina Kohara, Takahiro Masuda, Kazuhiro Shiizaki, Tetsu Akimoto, Yuko Watanabe, Sumiko Honma, Chuji Sekiguchi, Yasuharu Miyazawa, Eiji Kusano, Yoshinobu Kanda, Yasushi Asano, Makoto Kuro-o, Daisuke Nagata, Tatsuo Shimosawa
  PLOS ONE.2017; 12(6): e0178971.     CrossRef
• Analysis of hepatic transcript profile and plasma lipid profile in early lactating dairy cows fed grape seed and grape marc meal extract
  Denise K. Gessner, Anne Winkler, Christian Koch, Georg Dusel, Gerhard Liebisch, Robert Ringseis, Klaus Eder
  BMC Genomics.2017;[Epub]     CrossRef
• The FGF21-CCL11 Axis Mediates Beiging of White Adipose Tissues by Coupling Sympathetic Nervous System to Type 2 Immunity
  Zhe Huang, Ling Zhong, Jimmy Tsz Hang Lee, Jialiang Zhang, Donghai Wu, Leiluo Geng, Yu Wang, Chi-Ming Wong, Aimin Xu
  Cell Metabolism.2017; 26(3): 493.     CrossRef
• Fibroblast growth factor 21 and its novel association with oxidative stress
  Miguel Ángel Gómez-Sámano, Mariana Grajales-Gómez, Julia María Zuarth-Vázquez, Ma. Fernanda Navarro-Flores, Mayela Martínez-Saavedra, Óscar Alfredo Juárez-León, Mariana G. Morales-García, Víctor Manuel Enríquez-Estrada, Francisco J. Gómez-Pérez, Daniel Cu
  Redox Biology.2017; 11: 335.     CrossRef
• FGF21 activates AMPK signaling: impact on metabolic regulation and the aging process
  Antero Salminen, Anu Kauppinen, Kai Kaarniranta
  Journal of Molecular Medicine.2017; 95(2): 123.     CrossRef
• The Role of Autophagy in Critical Illness-induced Liver Damage
  Steven E. Thiessen, Inge Derese, Sarah Derde, Thomas Dufour, Lies Pauwels, Youri Bekhuis, Isabel Pintelon, Wim Martinet, Greet Van den Berghe, Ilse Vanhorebeek
  Scientific Reports.2017;[Epub]     CrossRef
• Implication of hepatokines in metabolic disorders and cardiovascular diseases
  Tae Woo Jung, Hye Jin Yoo, Kyung Mook Choi
  BBA Clinical.2016; 5: 108.     CrossRef
• Upregulation of rat liver PPARα‐FGF21 signaling by a docosahexaenoic acid and thyroid hormone combined protocol
  Luis A. Videla, Virginia Fernández, Romina Vargas, Pamela Cornejo, Gladys Tapia, Nelson Varela, Rodrigo Valenzuela, Allan Arenas, Javier Fernández, María C. Hernández‐Rodas, Bárbara Riquelme
  BioFactors.2016; 42(6): 638.     CrossRef
• Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk
  Leigang Jin, Zhuofeng Lin, Aimin Xu
  Diabetes & Metabolism Journal.2016; 40(1): 22.     CrossRef
• Hepatic Fgf21 Expression Is Repressed after Simvastatin Treatment in Mice
  Panos Ziros, Zoi Zagoriti, George Lagoumintzis, Venetsana Kyriazopoulou, Ralitsa P. Iskrenova, Evagelia I. Habeos, Gerasimos P. Sykiotis, Dionysios V. Chartoumpekis, Ioannis G Habeos, Kostas Pantopoulos
  PLOS ONE.2016; 11(9): e0162024.     CrossRef
• Metabolic fibroblast growth factors (FGFs): Mediators of energy homeostasis
  Kathleen R. Markan, Matthew J. Potthoff
  Seminars in Cell & Developmental Biology.2016; 53: 85.     CrossRef
• miR‐212 downregulation contributes to the protective effect of exercise against non‐alcoholic fatty liver via targeting FGF‐21
  Junjie Xiao, Yihua Bei, Jingqi Liu, Jasmina Dimitrova‐Shumkovska, Dapeng Kuang, Qiulian Zhou, Jin Li, Yanning Yang, Yang Xiang, Fei Wang, Changqing Yang, Wenzhuo Yang
  Journal of Cellular and Molecular Medicine.2016; 20(2): 204.     CrossRef
• Fibroblast growth factor 21 and exercise-induced hepatic mitochondrial adaptations
  Justin A. Fletcher, Melissa A. Linden, Ryan D. Sheldon, Grace M. Meers, E. Matthew Morris, Anthony Butterfield, James W. Perfield, John P. Thyfault, R. Scott Rector
  American Journal of Physiology-Gastrointestinal and Liver Physiology.2016; 310(10): G832.     CrossRef
• New adipokines
  Bruno Fève, Claire Bastard, Soraya Fellahi, Jean-Philippe Bastard, Jacqueline Capeau
  Annales d'Endocrinologie.2016; 77(1): 49.     CrossRef
• Stress Signaling Between Organs in Metazoa
  Edward Owusu-Ansah, Norbert Perrimon
  Annual Review of Cell and Developmental Biology.2015; 31(1): 497.     CrossRef
• Dietary restriction in obese children and its relation with eating behavior, fibroblast growth factor 21 and leptin: a prospective clinical intervention study
  Lorena del Rocío Ibarra-Reynoso, Liudmila Pisarchyk, Elva Leticia Pérez-Luque, Ma. Eugenia Garay-Sevilla, Juan Manuel Malacara
  Nutrition & Metabolism.2015;[Epub]     CrossRef
• FGF21 as a mediator of adaptive responses to stress and metabolic benefits of anti-diabetic drugs
  Kook Hwan Kim, Myung-Shik Lee
  Journal of Endocrinology.2015; 226(1): R1.     CrossRef
• Effects of a plant product consisting of green tea and curcuma extract on milk production and the expression of hepatic genes involved in endoplasmic stress response and inflammation in dairy cows
  Anne Winkler, Denise K. Gessner, Christian Koch, Franz-Josef Romberg, Georg Dusel, Eva Herzog, Erika Most, Klaus Eder
  Archives of Animal Nutrition.2015; 69(6): 425.     CrossRef
• The effect of grape seed and grape marc meal extract on milk performance and the expression of genes of endoplasmic reticulum stress and inflammation in the liver of dairy cows in early lactation
  D.K. Gessner, C. Koch, F.-J. Romberg, A. Winkler, G. Dusel, E. Herzog, E. Most, K. Eder
  Journal of Dairy Science.2015; 98(12): 8856.     CrossRef
• Vascular protection with fibroblast growth factor 21 in diabetes: Its potential beyond glucose and lipid control
  Mi-Hua Liu
  International Journal of Cardiology.2015; 199: 403.     CrossRef

To maintain cholesterol homeostasis, the processes of cholesterol metabolism are regulated at multiple levels including transcription, translation, and enzymatic activity. Recently, the regulation of protein stability of some key players in cholesterol metabolism has been characterized. More and more ubiquitin ligases have been identified including gp78, Hrd1, TRC8, TEB4, Fbw7, and inducible degrader of low density lipoprotein receptor. Their working mechanisms and physiological functions are becoming revealed. Here, we summarize the structure, substrates and function of these ubiquitin ligases. Their potential application in drug discovery is also discussed.

Citations

Citations to this article as recorded by  

• Quantitative Assessment of Arsenite-Induced Perturbation of Ubiquitinated Proteome
  Ji Jiang, Yinsheng Wang
  Chemical Research in Toxicology.2022; 35(9): 1589.     CrossRef
• HRD1 inhibits fatty acid oxidation and tumorigenesis by ubiquitinating CPT2 in triple‐negative breast cancer
  Xin Guo, Aman Wang, Wen Wang, Ya Wang, Huan Chen, Xiaolong Liu, Tian Xia, Aijia Zhang, Di Chen, Huan Qi, Ting Ling, Hai‐long Piao, Hong‐jiang Wang
  Molecular Oncology.2021; 15(2): 642.     CrossRef
• The E3 Ubiquitin Ligase Ring Finger Protein 5 Ameliorates NASH Through Ubiquitin‐Mediated Degradation of 3‐Hydroxy‐3‐Methylglutaryl CoA Reductase Degradation Protein 1
  Qin Yang, Xi Chen, Yanfang Zhang, Sha Hu, Fengjiao Hu, Yongping Huang, Tengfei Ma, Heng Hu, Han Tian, Song Tian, Yan‐Xiao Ji, Zhi‐Gang She, Peng Zhang, Xiao‐Jing Zhang, Yufeng Hu, Hailong Yang, Yufeng Yuan, Hongliang Li
  Hepatology.2021; 74(6): 3018.     CrossRef
• Competitive oxidation and ubiquitylation on the evolutionarily conserved cysteine confer tissue-specific stabilization of Insig-2
  Zhang-Sen Zhou, Mei-Xin Li, Jie Liu, Hengwu Jiao, Jing-Ming Xia, Xiong-Jie Shi, Huabin Zhao, Liping Chu, Jingrong Liu, Wei Qi, Jie Luo, Bao-Liang Song
  Nature Communications.2020;[Epub]     CrossRef
• Twin enzymes, divergent control: The cholesterogenic enzymes DHCR14 and LBR are differentially regulated transcriptionally and post-translationally
  Isabelle M. Capell-Hattam, Laura J. Sharpe, Lydia Qian, Gene Hart-Smith, Anika V. Prabhu, Andrew J. Brown
  Journal of Biological Chemistry.2020; 295(9): 2850.     CrossRef
• Differential use of E2 ubiquitin conjugating enzymes for regulated degradation of the rate-limiting enzymes HMGCR and SQLE in cholesterol biosynthesis
  Josephine M.E. Tan, Emma C.L. Cook, Marlene van den Berg, Saskia Scheij, Noam Zelcer, Anke Loregger
  Atherosclerosis.2019; 281: 137.     CrossRef
• Ring finger protein 145 (RNF145) is a ubiquitin ligase for sterol-induced degradation of HMG-CoA reductase
  Lu-Yi Jiang, Wei Jiang, Na Tian, Yan-Ni Xiong, Jie Liu, Jian Wei, Kai-Yue Wu, Jie Luo, Xiong-Jie Shi, Bao-Liang Song
  Journal of Biological Chemistry.2018; 293(11): 4047.     CrossRef
• ER-associated ubiquitin ligase HRD1 programs liver metabolism by targeting multiple metabolic enzymes
  Juncheng Wei, Yanzhi Yuan, Lu Chen, Yuanming Xu, Yuehui Zhang, Yajun Wang, Yanjie Yang, Clara Bien Peek, Lauren Diebold, Yi Yang, Beixue Gao, Chaozhi Jin, Johanna Melo-Cardenas, Navdeep S. Chandel, Donna D. Zhang, Hui Pan, Kezhong Zhang, Jian Wang, Fuchu
  Nature Communications.2018;[Epub]     CrossRef
• Proteostatic Tactics in the Strategy of Sterol Regulation
  Margaret A. Wangeline, Nidhi Vashistha, Randolph Y. Hampton
  Annual Review of Cell and Developmental Biology.2017; 33(1): 467.     CrossRef
• Transcriptional and post-translational changes in the brain of mice deficient in cholesterol removal mediated by cytochrome P450 46A1 (CYP46A1)
  Natalia Mast, Joseph B. Lin, Kyle W. Anderson, Ingemar Bjorkhem, Irina A. Pikuleva, Jean-Marc A Lobaccaro
  PLOS ONE.2017; 12(10): e0187168.     CrossRef
• USP19-Mediated Deubiquitination Facilitates the Stabilization of HRD1 Ubiquitin Ligase
  Kumi Harada, Masako Kato, Nobuhiro Nakamura
  International Journal of Molecular Sciences.2016; 17(11): 1829.     CrossRef
• Effect of a Traditional Japanese Dish Consisting of Boiled Fish Paste on Lipid Metabolism in Rats
  Yausna Kitano, Yumiko Nakamura, Shuang E, Yu Hatakeyama, Kazushi Yamamoto, Yu Sakamoto, Tsuyoshi Tsuduki, Kiyotaka Nakagawa, Teruo Miyazawa
  NIPPON SHOKUHIN KAGAKU KOGAKU KAISHI.2015; 62(4): 182.     CrossRef
• Canalicular membrane MRP2/ABCC2 internalization is determined by Ezrin Thr567 phosphorylation in human obstructive cholestasis
  Jin Chai, Shi-Ying Cai, Xiaocong Liu, Wei Lian, Sheng Chen, Liangjun Zhang, Xinchan Feng, Ying Cheng, Xiaochong He, Yu He, Lei Chen, Rongquan Wang, Huaizhi Wang, James L. Boyer, Wensheng Chen
  Journal of Hepatology.2015; 63(6): 1440.     CrossRef
• The UPS and downs of cholesterol homeostasis
  Laura J. Sharpe, Emma C.L. Cook, Noam Zelcer, Andrew J. Brown
  Trends in Biochemical Sciences.2014; 39(11): 527.     CrossRef

For years, diabetic retinopathy has been defined based on vascular lesions, and neural abnormalities were not regarded as important. This review summarizes evidence that the neural retina has important effects on the retinal vasculature under normal conditions, and the interaction between the retinal neuroglial cells and vascular function is altered in diabetes. Importantly, new evidence raises a possibility that abnormalities within retinal neuroglial cells (notably photoreceptors) might actually be causing or initiating the vascular disease in diabetic retinopathy.

Citations

Citations to this article as recorded by  

• Thioredoxin 1 overexpression attenuated diabetes‐induced endoplasmic reticulum stress in Müller cells via apoptosis signal‐regulating kinase 1
  Xuebin Yu, Qiufeng Teng, Kaimin Bao, Maryam Chudhary, Hui Qi, Wenying Zhou, Hongxin Che, Junli Liu, Xiang Ren, Li Kong
  Journal of Cellular Biochemistry.2023; 124(3): 421.     CrossRef
• Implications of Diabetes-Induced Altered Metabolites on Retinal Neurodegeneration
  Dalia I. Aldosari, Ajamaluddin Malik, Abdullah S. Alhomida, Mohammad S. Ola
  Frontiers in Neuroscience.2022;[Epub]     CrossRef
• A Systematic Review of Carotenoids in the Management of Diabetic Retinopathy
  Drake W. Lem, Dennis L. Gierhart, Pinakin Gunvant Davey
  Nutrients.2021; 13(7): 2441.     CrossRef
• Bioactive Compound and Nanotechnology: A Novel Delivery Perspective for Diabetic Retinopathy
  Anima Debbarma, Probin Kr Roy, Samia B. Barbhuiya, Jayita Das, Laldinchhana, Hauzel Lalhlenmawia
  Current Bioactive Compounds.2021;[Epub]     CrossRef
• Looking Ahead: Visual and Anatomical Endpoints in Future Trials of Diabetic Macular Ischemia
  Chui Ming Gemmy Cheung, Elizabeth Pearce, Beau Fenner, Piyali Sen, Victor Chong, Sobha Sivaprasad
  Ophthalmologica.2021; 244(5): 451.     CrossRef
• Pharmacological Inhibition of Spermine Oxidase Reduces Neurodegeneration and Improves Retinal Function in Diabetic Mice
  Fang Liu, Alan B. Saul, Prahalathan Pichavaram, Zhimin Xu, Madhuri Rudraraju, Payaningal R. Somanath, Sylvia B. Smith, Ruth B. Caldwell, S. Priya Narayanan
  Journal of Clinical Medicine.2020; 9(2): 340.     CrossRef
• Targeting Neurovascular Interaction in Retinal Disorders
  Zhongjie Fu, Ye Sun, Bertan Cakir, Yohei Tomita, Shuo Huang, Zhongxiao Wang, Chi-Hsiu Liu, Steve S. Cho, William Britton, Timothy S. Kern, David A. Antonetti, Ann Hellström, Lois E.H. Smith
  International Journal of Molecular Sciences.2020; 21(4): 1503.     CrossRef
• Glycine receptor is differentially expressed in the rat retina at early stages of streptozotocin-induced diabetes
  Elizabeth Morales-Calixto, Miguel Ángel Velázquez-Flores, Gustavo Sánchez-Chávez, Ruth Ruiz Esparza-Garrido, Rocío Salceda
  Neuroscience Letters.2019; 712: 134506.     CrossRef
• Effect of Autophagy Modulators on Vascular, Glial, and Neuronal Alterations in the Oxygen-Induced Retinopathy Mouse Model
  Paula V. Subirada, María C. Paz, Magali E. Ridano, Valeria E. Lorenc, Claudio M. Fader, Gustavo A. Chiabrando, María C. Sánchez
  Frontiers in Cellular Neuroscience.2019;[Epub]     CrossRef
• Retinal Sensitivity Loss Correlates with Deep Capillary Plexus Impairment in Diabetic Macular Ischemia
  Fabio Scarinci, Monica Varano, Mariacristina Parravano
  Journal of Ophthalmology.2019; 2019: 1.     CrossRef
• Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy
  S. Priya Narayanan, Esraa Shosha, Chithra D Palani
  Pharmacological Research.2019; 147: 104299.     CrossRef
• Translational research in retinal vascular disease. An approach
  Toke Bek
  Acta Ophthalmologica.2019; 97(5): 441.     CrossRef
• Protective Effects of Leukemia Inhibitory Factor on Retinal Vasculature and Cells in Streptozotocin-induced Diabetic Mice
  Xiu-Fen Yang, Ying-Xiang Huang, Ming Lan, Tao-Ran Zhang, Jie Zhou
  Chinese Medical Journal.2018; 131(1): 75.     CrossRef
• SWATH-MS Proteomic Analysis of Oxygen-Induced Retinopathy Reveals Novel Potential Therapeutic Targets
  Maria Vähätupa, Janika Nättinen, Antti Jylhä, Ulla Aapola, Marko Kataja, Peeter Kööbi, Tero A. H. Järvinen, Hannu Uusitalo, Hannele Uusitalo-Järvinen
  Investigative Opthalmology & Visual Science.2018; 59(8): 3294.     CrossRef
• Association Between Vessel Density and Visual Acuity in Patients With Diabetic Retinopathy and Poorly Controlled Type 1 Diabetes
  Bénédicte Dupas, Wilfried Minvielle, Sophie Bonnin, Aude Couturier, Ali Erginay, Pascale Massin, Alain Gaudric, Ramin Tadayoni
  JAMA Ophthalmology.2018; 136(7): 721.     CrossRef
• Diabetic macular oedema: clinical risk factors and emerging genetic influences
  Ebony Liu, Jamie E Craig, Kathryn Burdon
  Clinical and Experimental Optometry.2017; 100(6): 569.     CrossRef
• Comparison of spectral-domain optical coherence tomography for intra-retinal layers thickness measurements between healthy and diabetic eyes among Chinese adults
  Shu-ting Li, Xiang-ning Wang, Xin-hua Du, Qiang Wu, Demetrios G. Vavvas
  PLOS ONE.2017; 12(5): e0177515.     CrossRef
• RORα modulates semaphorin 3E transcription and neurovascular interaction in pathological retinal angiogenesis
  Ye Sun, Chi‐Hsiu Liu, Zhongxiao Wang, Steven S. Meng, Samuel B. Burnim, John Paul SanGiovanni, Theodore M. Kamenecka, Laura A. Solt, Jing Chen
  The FASEB Journal.2017; 31(10): 4492.     CrossRef
• Flavonoid Naringenin Attenuates Oxidative Stress, Apoptosis and Improves Neurotrophic Effects in the Diabetic Rat Retina
  Dalia Al-Dosari, Mohammed Ahmed, Salim Al-Rejaie, Abdullah Alhomida, Mohammad Ola
  Nutrients.2017; 9(10): 1161.     CrossRef
• Do photoreceptor cells cause the development of retinal vascular disease?
  Timothy S. Kern
  Vision Research.2017; 139: 65.     CrossRef
• Putative protective role of lutein and zeaxanthin in diabetic retinopathy
  Kumari Neelam, Catherina J Goenadi, Katherine Lun, Chee Chew Yip, Kah-Guan Au Eong
  British Journal of Ophthalmology.2017; 101(5): 551.     CrossRef
• Neuroretinal hypoxic signaling in a new preclinical murine model for proliferative diabetic retinopathy
  Katherine J Wert, Vinit B Mahajan, Lijuan Zhang, Yuanqing Yan, Yao Li, Joaquin Tosi, Chun Wei Hsu, Takayuki Nagasaki, Kerstin M Janisch, Maria B Grant, MaryAnn Mahajan, Alexander G Bassuk, Stephen H Tsang
  Signal Transduction and Targeted Therapy.2016;[Epub]     CrossRef
• Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors Reduce Reactive Gliosis and Improve Angiostatin Levels in Retina of Diabetic Rats
  Mykhailo M. Guzyk, Artem A. Tykhomyrov, Victor S. Nedzvetsky, Irina V. Prischepa, Tatiana V. Grinenko, Lesya V. Yanitska, Tamara M. Kuchmerovska
  Neurochemical Research.2016; 41(10): 2526.     CrossRef
• Neuroprotective actions of progesterone in an in vivo model of retinitis pigmentosa
  V. Sánchez-Vallejo, S. Benlloch-Navarro, R. López-Pedrajas, F.J. Romero, M. Miranda
  Pharmacological Research.2015; 99: 276.     CrossRef
• Primary Retinal Cultures as a Tool for Modeling Diabetic Retinopathy: An Overview
  Andrea Matteucci, Monica Varano, Cinzia Mallozzi, Lucia Gaddini, Marika Villa, Sara Gabrielli, Giuseppe Formisano, Flavia Pricci, Fiorella Malchiodi-Albedi
  BioMed Research International.2015; 2015: 1.     CrossRef
• Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy
  Renu A. Kowluru, Anjan Kowluru, Manish Mishra, Binit Kumar
  Progress in Retinal and Eye Research.2015; 48: 40.     CrossRef
• Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence
  Rafael Simó, Cristina Hernández
  Progress in Retinal and Eye Research.2015; 48: 160.     CrossRef
• SOCS3 in retinal neurons and glial cells suppresses VEGF signaling to prevent pathological neovascular growth
  Ye Sun, Meihua Ju, Zhiqiang Lin, Thomas W. Fredrick, Lucy P. Evans, Katherine T. Tian, Nicholas J. Saba, Peyton C. Morss, William T. Pu, Jing Chen, Andreas Stahl, Jean-Sébastien Joyal, Lois E. H. Smith
  Science Signaling.2015;[Epub]     CrossRef
• Enriched Environment Protects the Optic Nerve from Early Diabetes-Induced Damage in Adult Rats
  Damián Dorfman, Marcos L. Aranda, Ruth E. Rosenstein, Rafael Linden
  PLOS ONE.2015; 10(8): e0136637.     CrossRef
• Epigenetic Modifications and Potential New Treatment Targets in Diabetic Retinopathy
  Lorena Perrone, Carmela Matrone, Lalit P. Singh
  Journal of Ophthalmology.2014; 2014: 1.     CrossRef

The vascular endothelium is a dynamic structure responsible for the separation and regulated movement of biological material between circulation and interstitial fluid. Hormones and nutrients can move across the endothelium either via a transcellular or paracellular route. Transcellular endothelial transport is well understood and broadly acknowledged to play an important role in the normal and abnormal physiology of endothelial function. However, less is known about the role of the paracellular route. Although the concept of endothelial dysfunction in diabetes is now widely accepted, we suggest that alterations in paracellular transport should be studied in greater detail and incorporated into this model. In this review we provide an overview of endothelial paracellular permeability and discuss its potential importance in contributing to the development of diabetes and associated complications. Accordingly, we also contend that if better understood, altered endothelial paracellular permeability could be considered as a potential therapeutic target for diabetes.

Citations

Citations to this article as recorded by  

• Use of 2-dimensional cell monolayers and 3-dimensional microvascular networks on microfluidic devices shows that iron increases transendothelial adiponectin flux via inducing ROS production
  Nanyoung Yoon, Seunggyu Kim, Hye Kyoung Sung, Thanh Q. Dang, Jessie S. Jeon, Gary Sweeney
  Biochimica et Biophysica Acta (BBA) - General Subjects.2021; 1865(2): 129796.     CrossRef
• Adiponectin Synthesis, Secretion and Extravasation from Circulation to Interstitial Space
  Simone C. da Silva Rosa, Meilian Liu, Gary Sweeney
  Physiology.2021; 36(3): 134.     CrossRef
• Tracking adiponectin biodistribution via fluorescence molecular tomography indicates increased vascular permeability after streptozotocin-induced diabetes
  Nanyoung Yoon, Keith Dadson, Thanh Dang, Teresa Chu, Nina Noskovicova, Boris Hinz, Adeline Raignault, Eric Thorin, Seunggyu Kim, Jessie S. Jeon, James Jonkman, Trevor D. McKee, Justin Grant, Jeffrey D. Peterson, Scott P. Kelly, Gary Sweeney
  American Journal of Physiology-Endocrinology and Metabolism.2019; 317(5): E760.     CrossRef
• Overview of the Components of Cardiac Metabolism
  Elizabeth A. Hausner, Susan A. Elmore, Xi Yang
  Drug Metabolism and Disposition.2019; 47(6): 673.     CrossRef
• Emerging Roles of Vascular Endothelium in Metabolic Homeostasis
  Xinchun Pi, Liang Xie, Cam Patterson
  Circulation Research.2018; 123(4): 477.     CrossRef
• Transendothelial movement of adiponectin is restricted by glucocorticoids
  Thanh Q Dang, Nanyoung Yoon, Helen Chasiotis, Emily C Dunford, Qilong Feng, Pingnian He, Michael C Riddell, Scott P Kelly, Gary Sweeney
  Journal of Endocrinology.2017; 234(2): 101.     CrossRef
• Insulin access to skeletal muscle is impaired during the early stages of diet‐induced obesity
  Josiane L. Broussard, Ana V.B. Castro, Malini Iyer, Rebecca L. Paszkiewicz, Isaac Asare Bediako, Lidia S. Szczepaniak, Edward W. Szczepaniak, Richard N. Bergman, Cathryn M. Kolka
  Obesity.2016; 24(9): 1922.     CrossRef
• Temporal and Molecular Analyses of Cardiac Extracellular Matrix Remodeling following Pressure Overload in Adiponectin Deficient Mice
  Keith Dadson, Subat Turdi, Stellar Boo, Boris Hinz, Gary Sweeney, Nikolaos Frangogiannis
  PLOS ONE.2015; 10(4): e0121049.     CrossRef

The Dose Adjustment for Normal Eating (DAFNE) programme of intensive insulin therapy for type 1 diabetes provides a structured educational intervention to improve glycemic control, reduce hypoglycemia and improve quality of life. Enhancement of self-management skills is a key element of DAFNE and patients acquire detailed skills in insulin dose adjustment. Following DAFNE training, patients report improved confidence in their ability to manage their own insulin dosing, but generally still seek and require the assistance of health professionals when making substantial changes to their insulin regimens. Some DAFNE trained patients may be able to assist their peers in aspects of diabetes management within a group environment, but widespread introduction of the expert patient/peer educator role in the self-management of type 1 diabetes, in particular related to insulin dose management, would require formal and detailed evaluation, preferably in randomized controlled clinical trials, before being introduced into routine clinical practice.

Citations

Citations to this article as recorded by  

• Factors Associated With Resilience During Long-Term Hemodialysis
  Pedro García-Martínez, Rafa Ballester-Arnal, Kavita Gandhi-Morar, María D. Temprado-Albalat, Eladio Collado-Boira, Carlos Saus-Ortega, Jesús Castro-Calvo
  Nursing Research.2023; 72(1): 58.     CrossRef
• Association Between Management of Continuous Subcutaneous Basal Insulin Administration and HbA1C
  Harry Rubin-Falcone, Ian Fox, Emily Hirschfeld, Lynn Ang, Rodica Pop-Busui, Joyce M. Lee, Jenna Wiens
  Journal of Diabetes Science and Technology.2022; 16(5): 1120.     CrossRef
• Perceived Stress in Relation to Quality of Life and Resilience in Patients with Advanced Chronic Kidney Disease Undergoing Hemodialysis
  Pedro García-Martínez, Rafael Ballester-Arnal, Kavita Gandhi-Morar, Jesús Castro-Calvo, Vicente Gea-Caballero, Raúl Juárez-Vela, Carlos Saus-Ortega, Raimunda Montejano-Lozoya, Eva María Sosa-Palanca, María del Rosario Gómez-Romero, Eladio Collado-Boira
  International Journal of Environmental Research and Public Health.2021; 18(2): 536.     CrossRef
• Determinants of blood glucose control among people with Type 2 diabetes in a regional hospital in Ghana
  Sampson Kafui Djonor, Ignatius Terence Ako-Nnubeng, Ewurama Ampadu Owusu, Kwadwo Owusu Akuffo, Pricillia Nortey, Eldad Agyei-Manu, Anthony Danso-Appiah, Lakshmi Pulakat
  PLOS ONE.2021; 16(12): e0261455.     CrossRef
• Recent advances in type 1 diabetes
  Mervyn Kyi, John M Wentworth, Alison J Nankervis, Spiros Fourlanos, Peter G Colman
  Medical Journal of Australia.2015; 203(7): 290.     CrossRef

The expansion of life-style related diseases, such as metabolic syndrome (MS) and type 2 diabetes mellitus (T2DM), appears to be unstoppable. It is also difficult to cease their complications in spite of many antidiabetic medications or intervention of public administration. We and our collaborators found that physical medicine using simultaneous stimulation of heat with mild electric current activates heat shock response, thereby reducing visceral adiposity, insulin resistance, chronic inflammation and improving glucose homeostasis in mice models of T2DM, as well as in humans with MS or T2DM. This combination therapy exerts novel action on insulin signaling, β-cell protection and body compositions, and may provide a new therapeutic alternative in diabetic treatment strategy.

Citations

Citations to this article as recorded by  

• Proteostasis defects: Medicinal challenges of imperfect aging & neurodegeneration
  Prashant Kumar, Akash Choudhary, Sumit Kinger, Yuvraj Anandrao Jagtap, Ankur Rakesh Dubey, Ravi Kumar Gutti, Deepak Chitkara, Anil K. Suresh, Amit Mishra
  Translational Medicine of Aging.2023; 7: 87.     CrossRef
• New opportunities of therapeutic hyperthermia (literature review)
  Orazakhmet K. Kurpeshev
  Russian Journal of Physiotherapy, Balneology and Rehabilitation.2022; 20(5): 429.     CrossRef
• eIF3j inhibits translation of a subset of circular RNAs in eukaryotic cells
  Zhenxing Song, Jiamei Lin, Rui Su, Yu Ji, Ruirui Jia, Shi Li, Ge Shan, Chuan Huang
  Nucleic Acids Research.2022; 50(20): 11529.     CrossRef
• Are Heat Shock Proteins an Important Link between Type 2 Diabetes and Alzheimer Disease?
  Joanne Elizabeth Rowles, Kevin Noel Keane, Thiago Gomes Heck, Vinicius Cruzat, Giuseppe Verdile, Philip Newsholme
  International Journal of Molecular Sciences.2020; 21(21): 8204.     CrossRef
• The effect of passive heating on heat shock protein 70 and interleukin-6: A possible treatment tool for metabolic diseases?
  S. H. Faulkner, S. Jackson, G. Fatania, C. A. Leicht
  Temperature.2017; 4(3): 292.     CrossRef
• Emerging Role of Nitric Oxide and Heat Shock Proteins in Insulin Resistance
  Marisa Nile Molina, León Ferder, Walter Manucha
  Current Hypertension Reports.2016;[Epub]     CrossRef
• αB-crystallin and HspB2 deficiency is protective from diet-induced glucose intolerance
  Daniel J. Toft, Miles Fuller, Matthew Schipma, Feng Chen, Vincent L. Cryns, Brian T. Layden
  Genomics Data.2016; 9: 10.     CrossRef
• DNAJB3/HSP-40 cochaperone improves insulin signaling and enhances glucose uptake in vitro through JNK repression
  Mohamed Abu-Farha, Preethi Cherian, Irina Al-Khairi, Ali Tiss, Abdelkrim Khadir, Sina Kavalakatt, Samia Warsame, Mohammed Dehbi, Kazem Behbehani, Jehad Abubaker
  Scientific Reports.2015;[Epub]     CrossRef
• Reduced nuclear protein 1 expression improves insulin sensitivity and protects against diet-induced glucose intolerance through up-regulation of heat shock protein 70
  H.C. Barbosa-Sampaio, R. Drynda, B. Liu, A.M. Rodriguez De Ledesma, C. Malicet, J.L. Iovanna, P.M. Jones, D.S. Muller, S.J. Persaud
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2015; 1852(5): 962.     CrossRef
• Mild Electrical Stimulation Increases Stress Resistance and Suppresses Fat Accumulation via Activation of LKB1-AMPK Signaling Pathway in C. elegans
  Shingo Matsuyama, Masataka Moriuchi, Mary Ann Suico, Shuichiro Yano, Saori Morino-Koga, Tsuyoshi Shuto, Kunitoshi Yamanaka, Tatsuya Kondo, Eiichi Araki, Hirofumi Kai, Deyu Fang
  PLoS ONE.2014; 9(12): e114690.     CrossRef

Diabetic peripheral neuropathy (DPN) is the most common complication associated with diabetes. DPN can present as a loss of sensation, may lead to neuropathic ulcers, and is a leading cause of amputation. Reported estimates of the prevalence of DPN vary due to differences in study populations and diagnostic criteria. Furthermore, the epidemiology and clinical characteristics of DPN in Korean patients with type 2 diabetes mellitus (T2DM) are not as well understood as those of other complications of diabetes such as retinal and renal disease. Recently, the Diabetic Neuropathy Study Group of the Korean Diabetes Association (KDA) conducted a study investigating the impact of DPN on disease burden and quality of life in patients with T2DM and has published some data that are representative of the nation. This review investigated the prevalence and associated clinical implications of DPN in Korean patients with diabetes based on the KDA study.

Citations

Citations to this article as recorded by  

• Shear wave elastography of tibial nerve in patients with diabetic peripheral neuropathy—A cross-sectional study
  Dhiri Ranjan Pradhan, Sudhir Saxena, Ravi Kant, Mirtunjai Kumar, Sonal Saran
  Skeletal Radiology.2024; 53(3): 547.     CrossRef
• Association of Sensory Nerve Action Potential Amplitude and Velocity With Type 2 Diabetic Peripheral Neuropathy
  Anwar H Siddiqui, Nazia Tauheed, Hamid Ashraf, Jamal Ahmad
  Cureus.2023;[Epub]     CrossRef
• A review on extraction, purification, structural characteristics and bioactivities of polysaccharides from Polygonatum odoratum (Mill.) Druce
  Xin-Yan Zong, De-Chang Xu, Jun-Yi Yin, Shao-Ping Nie, Ming-Yong Xie
  Bioactive Carbohydrates and Dietary Fibre.2022; 27: 100284.     CrossRef
• Development and characterisation of a rat model that exhibits both metabolic dysfunction and neurodegeneration seen in type 2 diabetes
  Katherine Southam, Chantal de Sousa, Abraham Daniel, Bruce V. Taylor, Lisa Foa, Dino Premilovac
  The Journal of Physiology.2022; 600(7): 1611.     CrossRef
• Renal impairment is one of appropriate predictors of future diabetic peripheral neuropathy: a hospital-based 6-year follow-up study
  Chi-Sheng Wang, Yen-Wei Pai, Ching-Heng Lin, I-Te Lee, Ming-Hong Chang
  Scientific Reports.2022;[Epub]     CrossRef
• Pathogenesis and Treatment of Diabetic Peripheral Neuropathy
  Seon Mee Kang
  The Journal of Korean Diabetes.2022; 23(4): 222.     CrossRef
• Compound XiongShao Capsule ameliorates streptozotocin-induced diabetic peripheral neuropathy in rats via inhibiting apoptosis, oxidative - nitrosative stress and advanced glycation end products
  Mei-xiang Yu, Bo Lei, Xin Song, Yong-mei Huang, Xiao-qin Ma, Chen-xia Hao, Wan-hua Yang, Man-li Pan
  Journal of Ethnopharmacology.2021; 268: 113560.     CrossRef
• Etiology, diagnosis, complications, and treatments of diabetic foot
  Dong-Kyo Seo
  Journal of the Korean Medical Association.2021; 64(8): 523.     CrossRef
• A nationwide study of patients with monoclonal gammopathy of undetermined significance with a 10-year follow-up in South Korea
  Ka-Won Kang, Ji Eun Song, Byung-Hyun Lee, Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Se Ryeon Lee, Hwa Jung Sung, Chul Won Choi, Yong Park, Byung Soo Kim
  Scientific Reports.2021;[Epub]     CrossRef
• Acupuncture for diabetic peripheral neuropathy: study protocol for a randomized, placebo-controlled trial
  Haiping Deng, Yu Shu, Peiran Lv, Ling Zhao, Ke Cheng, Tingting Zhang, Yi Song, Hua Yang, Hong Tang, Jian Pei, Xueyong Shen
  Trials.2020;[Epub]     CrossRef
• Identify the Key Active Ingredients and Pharmacological Mechanisms of Compound XiongShao Capsule in Treating Diabetic Peripheral Neuropathy by Network Pharmacology Approach
  Meixiang Yu, Xin Song, Wanhua Yang, Ziwei Li, Xiaoqin Ma, Chenxia Hao
  Evidence-Based Complementary and Alternative Medicine.2019; 2019: 1.     CrossRef
• Deep phenotyping neuropathy: An underestimated complication in patients with pre-diabetes and type 2 diabetes associated with albuminuria
  Stefan Kopf, Jan B. Groener, Zoltan Kender, Thomas Fleming, Sandra Bischoff, Johann Jende, Carsten Schumann, Stefan Ries, Martin Bendszus, Sigrid Schuh-Hofer, Rolf-Detlef Treede, Peter P. Nawroth
  Diabetes Research and Clinical Practice.2018; 146: 191.     CrossRef
• Role of neopterin as a biochemical marker for peripheral neuropathy in pediatric patients with type 1 diabetes: Relation to nerve conduction studies
  Nancy Samir Elbarbary, Eman Abdel Rahman Ismail, Rana Ahmed El-Hilaly, Fatma Salama Ahmed
  International Immunopharmacology.2018; 59: 68.     CrossRef
• Association between diabetic peripheral neuropathy and heart rate variability in subjects with type 2 diabetes
  S.K.M. Azizul Islam, Dongkyu Kim, Young-Sil Lee, Seong-Su Moon
  Diabetes Research and Clinical Practice.2018; 140: 18.     CrossRef
• Diagnosis and Management of Diabetic Peripheral Neuropathy
  Seong-Su Moon
  The Journal of Korean Diabetes.2018; 19(3): 153.     CrossRef
• Clinical Importance of Diabetic Neuropathy
  Tae Sun Park
  The Journal of Korean Diabetes.2018; 19(3): 147.     CrossRef
• The U-shaped relationship between fibroblast growth factor 21 and microvascular complication in type 2 diabetes mellitus
  Chan-Hee Jung, Sang-Hee Jung, Bo-Yeon Kim, Chul-Hee Kim, Sung-Koo Kang, Ji-Oh Mok
  Journal of Diabetes and its Complications.2017; 31(1): 134.     CrossRef
• Retinal Neurodegeneration Associated With Peripheral Nerve Conduction and Autonomic Nerve Function in Diabetic Patients
  Kiyoung Kim, Seung-Young Yu, Hyung Woo Kwak, Eung Suk Kim
  American Journal of Ophthalmology.2016; 170: 15.     CrossRef
• Letter: Cardiovascular Disease Predicts Severe Hypoglycemia in Patients with Type 2 Diabetes (Diabetes Metab J 2015;39:498-506)
  Mi-Kyung Kim
  Diabetes & Metabolism Journal.2016; 40(1): 83.     CrossRef
• Associations of serum anti-ganglioside antibodies and inflammatory markers in diabetic peripheral neuropathy
  Shengjie Ge, Jing Xie, Lequn Zheng, Lijuan Yang, Hong Zhu, Xingbo Cheng, Feixia Shen
  Diabetes Research and Clinical Practice.2016; 115: 68.     CrossRef
• Axonopathy in peripheral neuropathies: Mechanisms and therapeutic approaches for regeneration
  Lila M. Landowski, P. James B. Dyck, JaNean Engelstad, Bruce V. Taylor
  Journal of Chemical Neuroanatomy.2016; 76: 19.     CrossRef
• Adiponectin gene polymorphisms are associated with increased susceptibility to diabetic peripheral neuropathy
  Yao Chen, Jian Wang, Lijing Wang, Peiji Huang, Zeng-Xian Tan, Huai-Jun Liu
  Biomarkers.2015; 20(6-7): 474.     CrossRef
• Effect of Socio-Economic Status on the Prevalence of Diabetes
  Yu Jeong Kim, Ja Young Jeon, Seung Jin Han, Hae Jin Kim, Kwan Woo Lee, Dae Jung Kim
  Yonsei Medical Journal.2015; 56(3): 641.     CrossRef
• Morphologic Changes in Autonomic Nerves in Diabetic Autonomic Neuropathy
  Heung Yong Jin, Hong Sun Baek, Tae Sun Park
  Diabetes & Metabolism Journal.2015; 39(6): 461.     CrossRef
• Diabetic neuropathy and the sensory apparatus “meissner corpuscle and merkel cells”
  Salma Alsunousi, Husnia I. Marrif
  Frontiers in Neuroanatomy.2014;[Epub]     CrossRef
• Arterial Stiffness and Carotid Intima-Media Thickness in Diabetic Peripheral Neuropathy
  Bulent Behlul Altunkeser
  Medical Science Monitor.2014; 20: 2074.     CrossRef